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Abstract
Metacaspases are proteins, with some sequence similarity to caspases, that have
now been identified in plants, fungi and parasitic protozoa, but not mammals,
Caspases ai'e a conserved family of central effector cysteine peptidases involved
in inflammatory disease, neurodegenerative disorders and apoptosis. Little was
known about metacaspase function in any organism, although several studies have
linked the metacaspases to apoptotic-like phenomena in both yeast and plants.
Five metacaspase genes were identified in Trypanosoma brucei {MCA1-MCA5)
whereas only one, syntenic with MCA5, has been identified in Leishmania major.
MCA2, MCA3 and MCA5 encode for predicted cysteine peptidases, while MCAl ,
and MCA4 have substitutions at the putative active site residues which suggest
.that they may have a peptidase-independent function. MCA2, MCA3 and MCA5 
also contain predicted WW binding domain motifs, suggesting the metacaspases |
may interact with other proteins.
Antibodies against MCA2, MCA3 and MCA5 were raised, and Western blotting 
revealed that MCA5 is expressed in both the bloodstream form (BSF) and 
procyclic form (PCF) while MCA2 and MCA3 expression is BSF specific in 
vitro. None of the proteins showed any large scale processing events, all being 
detected at around their predicted full-length masses. MCA2, MCA3 and MCA5 
localised to the same compartment -  vesicles located primarily between the 
nucleus and kinetoplast. Analysis revealed that the metacaspases co-localise with 
Rabll in both PCF and BSF parasites. In BSF T. brucei^ Rabll positive 
recycling endosomes are involved in the recycling of both variable surface 
glycoprotein (VSG) and the transferrin receptor.
Metacaspase function was investigated by RNAi and subsequently gene 
knockouts. While the RNAi results were inconclusive, the gene knockouts 
revealed that MCA2, MCA3 and MCA5 are non-essential genes, both in vitro and 
in vivo. Upon generation of BSF iymca2/3tsmca5 parasites, an initial reduced 
growth rate was observed, although after successive passages growth rate returned 
to wild type levels. A comparative analysis of both VSG and transferrin receptor 
recycling processes revealed that these were the same in wild type and
11
Amca2/3Amca5 BSF parasites. The possibility of metacaspase involvement in 
cell death processes was also examined. Parasites were exposed to heat shock and 
salt stress, but no differences between wild type and Amca2/3Amca5 parasites 
were detected. These data suggest that the metacaspases are associated with 
Rabll positive recycling endosomes, but are not essential for either VSG or 
ti’ansferrin receptor recycling, nor anti-VS G antibody or transferrin degradation.
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Chapter 1 
Introduction
1.1 Trypanosomiasis.
Certain species of parasitic trypanosomatid protozoa still represent a major 
problem in the developing countries of the world. Their associated diseases are 
the cause of both serious economic and medical problems throughout large areas 
of Africa, Asia and South America. Problem species include the African 
trypanosome (Trypanosoma brucei)^ the South American trypanosome 
{Trypanosoma cruzi) and a Avidespread variety of species of Leishmania. The 
trypanosomatids have very ancient evolutionary origins, believed to have 
diverged early in evolution from the other eukaryotic lineages and are classified 
together in the Order Kinetoplastida. The Kinetoplastida are characterized by a 
number of peculiarities such as the presence of the kinetoplast, which contains 
the mitochondrial DNA and is found within the single large mitochondrion.
All members of the genus Trypanosoma, with the exception of T. equiperdum, 
have indirect, or heteroxenous, life cycles. Members of this genus parasitise all 
classes of vertebrates, residing in the blood and tissues of infected animals, 
although some also occupy intracellular locations, most notably T. cruzi. The 
vector for T. brucei transmission, which causes diseases in both humans 
(sleeping sickness) and livestock (nagana), is the tsetse fly. Sleeping sickness, a 
disease that in the 1960’s was believed to be under control, is now a daily threat 
to more than 60 million people in 36 countries of sub-Saharan Africa, which 
include some of the least developed countries in the world. It is estimated that 
between 300,000 and 500,000 people may be affected by the disease (World 
Health Organisation - www.who.int). Following infection, the trypanosomes 
multiply in the blood and lymph glands before eventually invading the central 
nervous system (CNS) by crossing the blood-brain barrier. This invasion of the 
CNS results in ofren-irreversible neurological alterations and without treatment 
the patient falls into a coma and invariably dies.
There are three subspecies of T brucei: T. brucei brucei, which is not human 
infective, and T brucei rhodesiense and T. brucei gambiense that aie. T brucei 
rhodesiense infection results in an acute illness, lasting several months and is 
prevalent in countries of eastern and southern Africa. In contrast, T. brucei 
gambiense infection results in a more chronic illness lasting several years and is
1
prevalent in mainly western and central African countries. Death in T. brucei 
gambiense infections is often from secondary causes such as malnutrition or 
other parasitic infections prior to symptoms of late sage infection developing.
T b
T b rhodesie 'iS 'i
Figure 1.1: Geographical distribution of human infective T. brucei species.
The current treatment for trypanosomiasis is based on four main drugs, namely 
suramin, pentamidine, melarsoprol, and eflomithine. No new drugs have been 
developed in the last 25 years and most were introduced in the first half of the 
20^ century. Some of these drugs have very severe side effects and it is 
doubtful if they would be registered if developed today. Early stage infections 
are treated with pentamidine or suramin for T. brucei gambiense or T. brucei 
rhodesiense respectively. These treatments are usually effective and prevent 
disease progression. For late stage infections, the only effective drug for both 
human infective forms is the trivalent arsenical melarsoprol, due to its ability to 
cross the blood brain barrier. However, melarsoprol is also highly toxic, the 
most serious side effect is post treatment reactive encephalopathy (PTRE), 
which occurs in 5-10% of cases with a fatality rate of approximately 50% 
(Pepin and Milord, 1994). In addition to these problems, resistance to 
melarsoprol has also begun to emerge, with treatment failure rates of 30% 
reported among patients in Northern Uganda (Legros et al., 2002). Eflomithine 
has been used successfully to treat late stage disease, especially in melarsoprol- 
refractory T. brucei gambiense infections, but seldomly for T. brucei 
rhodesiense which is more resistant to this dmg (Burri and Brun, 2003).
However, eflomithine is expensive, difficult to administer and was non- 
profitable for drug companies. Only in recent years has this drug become 
available once more for treatment of the disease (Kennedy et ah, 2002).
Our imderstanding of the biology of the these organisms has been increased 
dramatically over the years but despite over a 100 years of research the diseases 
associated with these infections are still highly prevalent. The coming of 
genomics, however, has opened up new possibilities in kinetoplastid research 
and hopefully the coming decade will see major advances in the drugs available 
for treatment of these diseases.
1.2 Trypanosome biology.
The study of the cell biology of T. brucei, and indeed the kinetoplastids, has 
uncovered a number of strange and unique features. As described above, the 
Kinetoplastida possess a single large mitochondrion and in T. brucei this 
extends for virtually the length of the cell body (Figure 1.2). Located within the 
mitochondrion, is a specialised structure known as the kinetoplast, which 
contains the mitochondrial genome (kDNA) and within this structure a unique 
form of RNA editing occurs. The kDNA is made up of thousands of interlocked 
circular DNA molecules, composed of several thousand minicircles intertwined 
with a few dozen maxicircles. The maxicircles have a role similar to 
mitochondrial DNA in conventional eukaryotes, encoding for mitochondrial 
ribosomal RNA and subunits of the respiratory complexes. The minicircles, 
however, encode for guide RNAs that act as templates for the editing of 
maxicircle transcripts. This reaction is catalysed by a multi protein complex 
termed the editosome, and 16 proteins which make up this complex have been 
identified (Stuart and Panigrahi, 2002; Panigrahi et al., 2003). This editing is 
essential for the generation of mature functional mRNAs, and involves the 
insertion or deletion of uridine residues at specific sites within the transcripts. 
The extent of editing of mitochondrial transcripts varies, fiom four uridine 
insertions to the insertion and deletion of hundreds of uridine residues (Benne et 
al., 1986),
Flagellar
pocket
Flagellum
Kinetoplast Endosomes Lysosome Mltochondiion VSG coat
Figure 1.2: Illustration of bloodstream form (BSF) trypanosome, taken from 
Overath et al., 2004).
Another unique structure to kinetoplastids are organelles termed glycosomes. 
These structures, related to peroxisomes of higher eukaryotes, have a specialised 
role in glucose metabolism (Clayton and Michels, 1996). In all Kinetoplastida 
studied, the major part of the glycolytic pathway is located within these 
organelles. Although glycolytic enzymes are the major enzymes found in 
glycosomes (up to 90% in Bloodstream form (BSF) T. brucei), other enzymes 
are also present which are common to peroxisomes, such as enzymes involved 
in fatty acid oxidation or lipid biosynthesis (Parsons et al., 2001). In BSF T. 
brucei, in which the mitochondrion is not fully functional, the parasites use this 
organelle to facilitate ATP generation independent of oxidative phosphorylation. 
Although this rapid oxidation of glucose and production of ATP is much less 
efficient than oxidative phosphorylation, this is irrelevant due to the high 
availability of glucose available from the host’s blood. Procyclic form (PCF) T. 
brucei have a more complex metabolic pathway that also involves the 
mitochondrion, although it has been suggested that the Kreb’s cycle activity is 
not essential for energy production (van Weelden et al., 2003).
With regard to the endocytic apparatus, it is believed that the trypanosomatids 
are similar to other eukaryotes. Homologues of several proteins associated with 
various components of the endosomal system have been described. These 
include BiP, an endoplasmic reticulem (ER) chaperone (Bangs et al., 1993), the 
lysosomal protein p67 (Kelley et al., 1999), and numerous Rab proteins which
are involved in vesicular trafficking (Field et aL, 1998; Field et aL, 1999; 
Jeffries et aL, 2001; Denny et aL, 2002; Jeffries et aL, 2002; Pal et aL, 2003; 
Dhir et aL, 2004). Through the study of the endocytic system in 
trypanosomatids it has been concluded that the system operates similarly to 
higher eukaryotes. For example, early endocytic vesicles are associated with 
Rab5 (Pal et aL, 2002) while recycling endosomes are associated with Rabll 
(Jeffries et a i, 2001), and this has been observed across the genera (Gorvel et 
aL, 1991; Bucci et aL, 1992; Ullrich et aL, 1996; Green et aL, 1997).
In trypanosomatids, however, endo and exocytosis are limited to a region termed 
the flagellar pocket, an invagination of the plasma membrane representing 
approximately 0,5-3% of the cell surface. This is due to the presence of a sub- 
pellicular microtubule sheath underneath the plasma membrane but which is 
absent in the flagellar pocket region (Coppens et aL, 1987; Balber, 1990; 
Overath et aL, 1997). This pocket, from where the flagellum emerges, is located 
at the anterior end of the cell and is surrounded at its opening by a region 
referred to as an adhesion zone (Balber, 1990). This results in the formation of a 
secluded, yet extracellular, compartment (Brickman and Balber, 1993), with 
macromolecules entering or leaving the flagellar pocket having to pass through 
this adhesion zone.
To protect themselves from the harsh environments they inhabit, both life stages 
of r. brucei possess a densely packed surface coat. In the bloodstream and 
metacyclic foims, this is composed of more than 10^  variable surface 
glycoprotein (VSG) molecules (Cross, 1975). This represents approximately 
10% of the total cellular proteins and they ar e attached to the membrane via a 
glycosylphosphatidylinositol (GPI) anchor. The PCF coat is composed of an 
invariant surface molecule termed procyclin (Mowatt and Clayton, 1987; 
Richardson et aL, 1988), which, like VSG, is also attached to the membrane via 
a GPI anchor (Field et aL, 1991) and forms a protective surface coat (Ferguson, 
1997)
1,3 Life cycle of J. brucei
1.3.1 Parasite development in mammalian host,
r. brucei is a digenetic pathogen whose complete life cycle involves alteration 
between mammalian host and insect vector, the tsetse fly. The parasites are 
transmitted to their mammalian hosts through an infected bite of a tsetse fly. 
The injected parasites termed metacyclic trypomastigotes initially form a lesion, 
and after multiplying for several days gain access to the blood through the 
lymphatic system. Initially, the parasites take on a long-slender form and 
rapidly divide, but as the parasitaemia advances these gradually differentiate 
into a non-proliferative short stumpy foim. The stimulus which induces this 
change has been termed stumpy induction factor (SIF), although the 
identification of this molecule has eluded investigators. SIF is believed to be a 
trypanosome-produced factor which induces differentiation in a density- 
dependent manner (Vassella et aL, 1997), The slender form is exquisitely 
adapted for exploiting the rich source of glucose within the blood, rapid 
glycolysis occurring within the glycosomes (Opperdoes and Borst, 1977). 
Within the stumpy form, which accumulates at the peak of the parasitaemia, the 
mitochondrial respiratory chain which had been previously defunct becomes 
partially active (Feagin et aL, 1986; Michelotti and Hajduk, 1987; Bienen et aL,
1991). This is an essential change in the cellular biochemistry that enables the 
parasite to quickly adapt to the decrease in glucose concentrations experienced 
upon transfer to the insect host. Thus the parasite has fulfilled both rapid 
proliferation within the mammalian host and maximised the chances of 
successful transmission into the vector.
1.3.2 Antigenic variation.
Within the mammalian host, the trypanosomes are exposed to the immune 
system and evasion of this response is facilitated through the process of 
antigenic variation (Cross, 1975; Vickerman, 1978). Bloodstream and 
metacyclic form trypanosomes both possess a VSG coat, and while these 
molecules serve to protect the parasites from non-specific host immunity 
(Overath et aL, 1994), they are themselves highly immunogenic. The immune 
response mounted by the host results in the parasitaemia going into remission as
parasites are eliminated by complement-mediated lysis. However, through the 
process of antigenic variation a proportion of the parasites within the total 
population will have switched their variable antigen type (VAT). These 
different VATs perform the same protective function, but provide the variation 
required to evade the immune response. This antigenic variation is behind the 
waves of parasitaemia observed in T, brucei infections. As the trypanosome 
population increases, attack by the immune system reduces the level of 
parasitaemia, subsequently followed by another wave of growth through VAT 
switching. Each VAT arises from the expression of a single VSG gene, from an 
estimated repertoire of approximately 1000 genes (Van der Ploeg et al., 1982), 
although it is believed that only around 5% of these are functional (L. Marcello - 
personal communication). Many of these VSG genes at'e located in large arrays 
in the interior of chromosomes (Van der Ploeg et ah, 1982) while others are 
subtelomeric or found on minichromosomes. To ensiue the exclusive 
expression of one VSG gene and maintain silence of all others, the parasites 
restrict transcription of VSG to transcriptionally active sites known as 
bloodstream expression sites (BSEs). For silent VSG genes to become active 
they must move to a BSE and this occurs via homologous recombination (Barry 
and McCulloch, 2001), the silent gene remaining intact while the active gene is 
replaced. The frequency of VAT switching is estimated at 1 switch per 10^  cell 
divisions in pleomorphic trypanosomes (Turner and Barry, 1989) and this 
process appear to be spontaneous and independent of immunity (Hajduk et aL, 
1992). However, the parasites also contain multiple copies of the BSEs within 
the genome, and only one BSE is active at anyone time. The exclusive 
expression from only one BSE is attained tlirough a unique structure termed the 
expression site body (ESB) (Navarro and Gull, 2001). The ESB is believed to 
facilitate expression from a single BSE while excluding expression from all 
others. Also located at the BSEs are a number of expression site associated 
genes (ESAGs) (Cully et aL, 1985; Alexandre et aL, 1988; Pays et aL, 1989; 
Son et aL, 1989; Stadnyk et aL, 1991). These include a number of genes 
encoded for proteins destined for the cell surface, including ESAG6 and ESAG7, 
which encode for the two subunits of the transferrin receptor (Steverding et aL, 
1994; Salmon er a/., 1994).
1.3.3 Parasite development in tsetse fly vector.
Upon ingestion by a blood-feeding tsetse fly, parasites initially enter the lumen 
of the midgut where they experience radical changes in their environment, 
including a drop in temperature from 37°C to between 22-28°C, digestive 
enzymes and a reduction in glucose concentration. The short-stumpy form is 
able to make this transition very efficiently, while the majority of long-slender 
form trypanosomes ingested do not survive. As the availability of glucose 
reduces during blood meal digestion, oxidative phosphorylation takes over the 
energy requirements of the cell, utilising proline as fuel (Evans and Brown, 
1972). Within 48-72 hours post-ingestion, the short-stumpy form begins to 
differentiate into the procyclic form (Vickerman, 1985), involving loss of VSG 
coat (Overath et aL, 1983), an increase in length, less dependence on 
glycosomal activity and expansion of the mitochondrion. The procyclic form 
also replaces the VSG coat with procyclin (Mowatt and Clayton, 1987; 
Richardson et al., 1988). The procyclic form then invades the space between 
the peritrophic membrane and midgut epithelium (Evans and Ellis, 1983), where 
it resides and proliferates for the life span of the vector. A proportion of this 
population then further migrates towards the proventriculus, growing in length 
and ceasing division, at which stage they are termed mesocyclic trypanosomes. 
Invasion of the endoperitropic space then occurs, followed by movement into 
the salivary glands via the oesophagus, mouth parts and salivary ducts 
(Vickerman, 1985). Once within the salivary glands, several stages of 
differentiation occur. Initially they become epimastigotes, the main proliferative 
stage in the salivary glands, and attach to the epithelial cell microvilli by means 
of their flagellum. This is followed by differentiation into premetacyclic 
trypanosomes and subsequent differentiation into nascent metacyclic 
trypanosomes, involving cessation of cell division and acquisition of a VSG coat 
(Tetley and Vickerman, 1985). This form, while still attached to epithelial 
microvilli, possesses an acristate mitochondrion and functional giycosomes. 
Upon final transfoimation into mature metacyclic trypanosomes they detach 
from the epithelium, are free in the lumen of the salivary glands and are fully 
preadapted for life within a mammalian host.
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Figure 1.3: Diagrammatic representation of T. brucei life cycle, taken from 
Vickerman (1985).
1.4 Apoptosis and Programmed Cell Death (PCD).
The phenomena of programmed cell death (PCD) and apoptosis are mechanisms 
whereby specific cells in an organism are led down a suicidal pathway, which is 
more favourable than necrosis (Searle et al., 1982). Necrosis is a passive, 
degenerative process induced by a cytotoxic event, commonly involving 
irreversible plasma membrane damage or inhibition of ATP synthesis. Such 
cytotoxic events lead to a collapse of membrane potential and result in a loss of 
ionic homeostasis (Choi, 1988). Unregulated increases in calcium 
concentrations result in a disruption of the cytoskeleton, along with the 
activation of degradative enzymes, and the influx of sodium results in a loss of 
cellular volume control and the cell ultimately ruptures, releasing its contents 
into the surrounding environment (Hall et aL, 1997). This can result in 
neighbouring cell damage or local inflammation and such a crude process can be 
very damaging to an organism or tissue. The actual resultant release of cellular 
contents can be more damaging than the initial cytotoxic insult.
PCD/apoptosis in comparison, are regulated forms of cell death that avoid the 
problems associated with necrosis (Syntichaki and Tavernarakis, 2002). Cells 
marked for destruction are removed without causing damage to local 
cells/tissues. The terms PCD and apoptosis are sometimes used collectively to 
refer to the same processes although this classification strictly is not correct. 
PCD should be thought of as cell death occurring during development under 
pre-determined genetic control, whereas apoptosis can be considered as an 
active process in which a specialised signalling pathway is responsible for the 
death of the cell (Kaufmann and Hengartner, 2001). While the stimuli for the 
two processes may be distinct, the intercellular effector pathways utilised to 
accomplish the cellular disassembly processes aie similai". The effectors of 
these processes are the caspases, the targets of which have been studied 
extensively (Fischer et a l, 2003). Some of these include various members of 
the Bcl-2 family of proteins (Xue and Horvitz, 1997; Cheng et al., 1997); these 
are mitochondrial-associated proteins involved in the regulation of among other 
things of the mitochondrial permeability transitional pore (MPTP). A nuclear 
protein, termed Acinus (apoptotic chromatin condensation inducer), has been 
identified that following caspase cleavage, elicits cliromatin condensation and
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Inuclear fragmentation (Zamzami and Kroemer, 1999). Other targets include 
laminins, cytoskeletal proteins and DNA repair enzymes including poly (ADP- 
ribose) polymerase (Gu et aL, 1995).
Kerr et al. first described apoptosis morphologically in 1972 and in the past 
decade there has been a vast amount of research into the field. The onset of 
apoptosis/PCD is characterised by shrinkage of the cell and nucleus, together 
with condensation of nuclear chromatin, which is later followed by the complete 
break-up of nuclear material, termed karyorrhexis (Kerr et al., 1972), The cell 
body becomes detached from the surrounding tissue and cellular extensions 
proceed to bud away from the plasma membrane. These apoptotic bodies, 
densely packed with intracellular organelles and fragments of nucleus, are 
rapidly phagocytosed by macrophages or neighbouring cells. This process 
usually occurs with no local inflammation or neighbouring cell damage and is 
thus tlie most common type of physiological cell death. Research into the 
processes behind PCD/apoptosis have clarified that it represents the facet of cell 
death that is actively driven by complex signalling pathways within the cells. 
On the flip side, necrosis represents a passive consequence of gross injury to the 
cell.
1.5 Apoptotie/PCD-like phenomena in single cell organisms.
Although apoptosis/PCD has only ever been fully characterised in multi-cellular 
organisms, there have been many claims of such pathways existing in single cell 
organisms also. The slime mould Dictyostelium discoideum spends the majority 
of its life cycle as a unicellular protist. However, under low nutrient conditions 
a dramatic transformation is induced, involving aggregation, differentiation and 
morphogenesis, resulting in the formation of a structure called a sorocarp. This 
is a multicellular fungus-like structure consisting mainly of spores and stalk 
cells. It is within these stalk cells that several features reminiscent to PCD have 
been observed (Cornillon et aL, 1994). Cytoplasmic and chromatin 
condensation was evident, although the presence of cellular vacuolisation and 
lack of DNA fragmentation do not agree with the classical definition of PCD. 
Caspase inhibitors have been used in an attempt to attenuate cell death within 
these stalk cells with no effect (Olie et aL, 1998) and recently it has been shown
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In the human malarial parasite Plasmodium falciparum it has been shown that 
application of the drug chloroquine, results in the formation of oligonucleosomal 
DNA fragments within sensitive parasites (Picot et aL, 1997). More recently, it 
has been documented that apoptotic markers and caspase-like activity have been 
detected in P. berghei mosquito midgut stages both in vitro and in vivo (A1 
Olayan et aL, 2002).
that this type of cell death is independent of paracaspase activity, the sole 
caspase-like gene identified in D. discoideum (Roisin-Bouffay et aL, 2004),
The ciliated protozoon Tetrahymena thermophila contains two distinct nuclei
separating somatic and germ line functions, termed macro- and micronuclei,
respectively. During the sexual process of this organism the micronucleus,
normally transcriptionally silent, gives rise to both new macro- and micronuclei. |
The macronucleus ceases transcription, progressively reducing in size, which is
followed by rapid chromatin condensation and DNA fragmentation (Davis et aL,
1992). This apparent programmed nuclear death bears a resemblance to nuclear 
degeneration in eukaryotic cells undergoing PCD/apoptosis and suggests that 
some aspects of programmed death at least may be a common biological 
phenomenon.
PCD/apoptotic-like morphological and biochemical features have also been 
reported in the human intestinal protozoan parasite Blastocystis hominis, upon 
exposure to a cytotoxic monoclonal antibody (Nasirudeen et aL, 2001) and the 
drug metronidazole (Nasirudeen et aL, 2004). Several of the key features of 
apoptosis were reported: nuclear condensation, DNA fi'agmentation, reduced 
cytoplasmic volume, maintenance of plasma membrane integrity and the 
formation of apoptotic bodies.
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1.6 Apoptotic/PCD-Iike phenomena in trypanosomatids.
1.6.1 Apoptotie/PCD-like phenomena in Leishmania.
Some of the morphological criteria associated with PCD/apoptosis have also 
been reported within various species of this kinetoplastid. Part of the life cycle 
involves a shift from 22-28°C to 34-37°C on movement from sandfly vector to 
mammalian host, and it is within this promastigote to amastigote transition that 
apoptotic-like features have been reported. In the case of Leishmania 
amazonensis, the resulting heat shock has been shown to induce apoptotic-like 
features within approximately 20% of dying promastigote cells (Moreira et aL,
1996). This process is dependent on calcium ions, as none of the structural 
features associated with apoptosis were observed in the presence of EGTA. The 
similarities with apoptosis include chromatin clumping, breakdown of nuclear 
membrane, DNA fragmentation and preservation of cytoplasmic organelles, 
although no membrane blebbing or apoptotic bodies were observed. This type 
of cell death is clearly distinct from the cell death within the remaining 80% of 
cells in which the cytoplasm swells, nuclear chromatin is dispersed in irregular 
clumps and there follows rupture and dissolution of almost all organelles. Late 
stationary cultures of L. donovani have been reported as displaying DNA 
laddering and nuclear chromatin condensation, followed by concurrent cleavage 
of a caspase substrate and loss of membrane integrity (Lee et aL, 2002). 
However, this apparent caspase activity was only partially reduced using 
caspase inhibitors, therefore it is possible that other, non-caspase-like peptidases 
are responsible for this activity. Also in L. donovani, it was shown that 
exposure to H2O2 resulted in nuclear condensation, DNA ladder formation, and 
induction of caspase-like activity (Das et aL, 2001), and pre-treatment with 
caspases inhibitors reduced the number of cells displaying these features. It has 
also been reported in L. major that treatment with staurosporine, a general 
protein kinase inhibitor believed to induce apoptosis in all nucleated mammalian 
cells (Weil et aL, 1996), resulted in almost the entire culture of promastigote 
cells dying within 5 days (Amoult et aL, 2002). Cell shrinkage and DNA 
fragmentation were detected at 24 hours post-exposure, while membrane 
integrity was maintained over the same period. Nuclear degeneration was
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reduced using a general caspase inhibitor, although there was no concurrent 
reduction in cell death, and similar results were obtained using the broad 
cysteine peptidase inhibitor E64. More recently, it has been claimed that 
camptothecin (CPT), an inhibitor of DNA topoisomerase I, induces PCD in both 
amastigote and promastigote forms of L. donovani (Sen et aL, 2004). Following 
application of CPT, the cleavage of PARP, a substrate of caspase-3 in higher 
eukaryotes (Tewari et aL, 1995), externalisation of phosphatidyl serine and 
genomic DNA fragmentation were presented as evidence pointing to a PCD-like 
phenomenon. In addition, a caspase-like activity was also detected using the 
caspase substrates DEVD-AFC and LEHD-AMC. Whether or not caspase-like 
activity is present within Leishmania is somewhat contentious at present, other 
researchers having shown that this apparent activity may be the result of 
cathepsin L-like cysteine peptidases (Zangger et aL, 2002). Cleavage of the 
caspase-3 substrate DEVD-AMC was observed in amastigote cell cultures, 
although this activity was absent in cysteine peptidase CPA and CPB double 
null mutants, which raises doubts about reports of other caspase-like activities in 
Leishmania.
1.6.2 Apoptotic/PCD-like phenomena in Trypanosoma cruzL 
The life cycle of this parasite also involves movement between insect vector and 
mammalian host, and is the causative agent of Chagas’ disease in humans. 
Within the insect vector, the epimastigote form differentiates into tire non­
dividing metacyclic trypomastigote form, which are then infective for the 
vertebrate host. This differentiation has been associated with massive 
epimastigote death in vitro, displaying features similar to those seen during 
apoptosis (Ameisen et aL, 1996). Epimastigote cells in culture exponentially 
increase in number until a plateau is reached. During this exponential increase 
the differentiation into the trypomastigote form progressively increases, 
becoming maximal during the stationaiy period, when a large number of 
epimastigote cells begin to die. Examination of these dying cells revealed 
membrane blebbing, chromatin condensation and DNA fragmentation.
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1.6.3 Apoptotic/PCD-like phenomena in Trypanosoma brucei.
Within T. brucei, again there are reports of apoptotic-like features being present 
under certain conditions. DNA isolated from procyclic form parasites incubated 
with the lectin Concanavalin A showed some evidence of genomic laddering 
and DNA fragmentation, wliile the kinetoplast DNA remained unaffected over 
the same period (Welburn et aL, 1996). Membrane integrity was maintained, 
and along with signs of chromatin rearrangement, was suggested to be the result 
of an active cellular death mechanism. This process was also shown to be 
associated with an increase in expression of two genes; prohibitin, belonging to 
a poorly characterised mitochondrial protein family with possible roles in cell 
cycle regulation, and TRACK, the suggested trypanosome receptor for activated 
kinase (Welburn and Murphy, 1998).
Other investigations have linked reactive oxygen species (ROS) to apoptotic- 
like cell death via a Ca^^-dependent pathway. Procyclic trypanosomes exposed 
in vitro to xanthine and xanthine oxidase (XO), wliich results in the production 
of ROS, displayed several features similar to apoptosis (Ridgley et aL, 1999). 
At 5 hours post-induction, the cells displayed a complete loss of mobility, 
nuclear fragmentation, but no loss of membrane integrity. The intracellular 
addition of the calcium chelator EGTA attenuated all of these features, 
implicating calcium as a mediator. ROS and changes in calcium homeostasis in 
multicellular organisms have been linked to apoptosis (Lipton and Nicotera, 
1998), and the delayed onset of permeability changes relative to loss of mobility 
and nuclear damage suggests die possibility of a regulated form of cell death.
There have been many suggestions as to why a single cell organism might want 
to regulate population size through a suicidal pathway. It has been suggested 
that an apoptotic-like pathway might be advantageous to unicellular organisms 
to regulate population size when resources are limited (Welburn et aL, 1997; 
Lee et aL, 2002; A1 Olayan et aL, 2002). The idea is that a reduction in cell 
numbers is more beneficial to the population as whole if this aids in long term 
survival, and will increase the chance of successfril transmission. It has also 
been proposed that death by an apoptotic-like mechanism might prevent the
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release of immunogenic antigens, and therefore reducing the scale of the 
immune response raised against the organism (Lee et a l, 2002).
While there are numerous reports of apoptotic like phenomena within the lower 
eukaryotes there is still no definitive proof that single celled organisms have 
within them a mechanism for suicide. While the evidence might point to the 
possibility of such a mechanism, as yet no pathways or proteins have been 
identified which could facilitate such a process. If indeed there is an apoptotic- 
like machinery within single celled organisms it has yet to be identified and it is 
likely to be very different to that seen in higher eukaryotes, and until such 
system has been characterised, all the evidence must be seen as circumstantial.
1.7 Clans and families of peptidases.
Peptidases represent approximately 2% of the of the total number of proteins 
present in all types of organism (Barrett, 2004). The MEROPS database 
(merops.sanger.ac.uk) is an integrated source of information about peptidases, 
with each peptidase assigned to a family on the basis of statistically significant 
similarities in amino acid sequence. Families that are believed to have the same 
lineage are grouped into Clans, defined by MEROPS as peptidases that have 
arisen from a single evolutionary origin and contain similar tertiary structures 
and/or share common protein sequence motifs around the catalytic residues.
There are four major catalytic mechanisms by which peptidases cleave peptide 
bonds. These are cysteine, serine, aspartic and metallopeptidases. The catalytic 
mechanisms for cysteine and serine peptidases are similar, in that both a 
nucleophile and proton donor are required. In cysteine peptidases the 
nucleophile that attacks the peptide bond is the sulfhydryl group of the cysteine 
residue, while in serine peptidases this is the hydroxyl group of the serine 
residue. The histidine residue functions as the proton donor in both types of 
peptidase. The aspartic and metallopeptidases are catalytically very different to 
both the cysteine and serine peptidases, in that the nucleophile which attacks the 
peptide bond is an activated water molecule. In aspartic peptidases, there are 
usually two aspartate residues which act together to bind and activate the 
catalytic water molecule. With metallopeptidases, a metal ion, usually zinc, is
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held in place through several amino acid residues, and in turn activates a water 
molecule.
Within the cysteine peptidases there have been identified several Clans (Figure 
1.4), the most characterised of which are Clan CA and Clan CD, Clan CA, 
which contains 27 families, is typified by the plant enzyme papain. Papain, 
classified in family C l, was the first clearly recognised cysteine peptidase. It 
was also the first cysteine peptidase to have its three dimensional structure 
determined (Drenth et aL, 1968), and consequently is considered the archetypal 
cysteine peptidase. Indeed, family Cl is referred to as the papain family but it 
also includes the mammalian cathepsins B, C, K, L and S. Besides the cysteine 
and histidine residues of papain and related peptidases, there ar e other conserved 
residues important in catalysis. A glutamine residue that aids in formation of 
the “oxyanion hole”, an electrophilic centre that stabilises the reaction 
intermediates, and a conserved asparagine/aspartate thought to orientate the 
imidazole ring of the catalytic histidine residue. The order of these residues in 
the polypeptide sequence is Gin, Cys, His, Asn/Asp. Members of Clan CA are 
all irreversibly inhibited by the compound E-64 (L-trans epoxysuccinyl- 
leucylamidO"(4-guanidino)-butane).
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Figure 1.4: Classified Clans of cysteine peptidases, taken Ifom Mottram et aL, 
2003.
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Clan CD enzymes are distinct from those of Clan CA in that only two residues, 
histidine and cysteine, are involved in the catalysis and are they located in the 
polypeptide in the order His, Cys. The Clan CD peptidases are unaffected by 
the ‘classical’ cysteine peptidase inhibitor E-64. The reason for this 
insensitivity is the strict substrate specificity of the Clan CD enzymes. Clan CA 
peptidases have a preference for large or hydrophobic residues at the S2 sub­
site, but have little selectivity at the SI sub-site. Thus, these peptidases readily 
accommodate the leucine located at the P2 of E-64 and aie unaffected by the 
lack of a PI residue. In contrast, most Clan CD enzymes have very strict, 
unequivocal specificity at the SI sub-site for a single amino acid. For Clan CD 
peptidases, a productive interaction between the SI sub-site of the enzyme and 
the PI of the substrate is vital for binding. For this reason, E-64, which has no 
corresponding PI residue, cannot bind, and so does not inhibit Clan CD 
peptidases. The lack of a selective, irreversible inhibitor initially hampered 
progress in the biochemical and cellular characterization of Clan CD peptidases. 
However, recent work has uncovered selective inhibitors of Clan CD peptidases, 
the aza-peptide epoxides, which inhibit caspases and asparaginyl 
endopeptidases, but not Clan CA enzymes (Asgian et aL, 2002), This class of 
inhibitor should pave the way towards elucidating the cellular functions of Clan 
CD enzymes and chemically validating them as drug targets. To date, Clan CD 
contains the sub families C ll (clostripains), C13 (legumains, GPI8), C14 
(caspases), C25 (gingipain R) and C50 (separins) (Figure 1.4).
1.8 Clan CD peptidase family.
1.8.1 Caspases.
The caspases are the most well-known and characterised members of Clan CD 
due to their involvement in apoptosis and programmed cell death (PCD). 
Caspases (cysteinyl aspartate-specific proteinases) are a class of cysteine 
peptidases that form a central part of the cellular machinery, converting an 
apoptotic signal into the cellular disassembly process, and as the name suggests 
the substrate specificity at the PI position is an aspartate residue. Cysteine 
peptidases were first implicated in cell death when it was discovered that CED- 
3, a gene product involved in PCD in the nematode Caenorhadbitis elegans
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(Ellis and Horvitz, 1986), was structurally similar to the mammalian interleukin- 
Ip-converting enzyme (ICE) (Yuan et a l, 1993). Subsequently, it was shown 
that overexpression of eitlier ICE or the C  elegans CED-3 gene induced 
apoptosis in fibroblasts (Miura et aL, 1993). These enzymes, subsequently 
categorised as caspases, became the first of a large family of related peptidases 
to be discovered which are widely distributed across the genera.
In addition to their sequence similarity to CED-3/ICE, all caspases contain a 
conserved QACXG pentapeptide motif surrounding the active site cysteine 
residue, together with conservation of other residues wliich participate directly 
in catalysis (Nicholson and Thornberry, 1997). Caspases are expressed 
constitutively as relatively inactive proenzymes, varying in size between 30 and 
50 kDa and containing three domains: an amino terminal domain of varying 
size, a small subunit (-10 kDa) and a large subunit (-20 kDa).
Caspases can be activated through a variety of stimuli and a system has evolved 
to link upstream signalling pathways with downstream executioner processes. 
The caspases that perform these upstream functions are teimed initiator 
caspases, such as caspase-8, -9 and -10, while downstream caspases are known 
as executioner caspases, such as caspase-3 and caspase-7 (Chang and Yang, 
2000). Initiator caspases possess long prodomains and typically possess one of 
two identified domains. The first is the death effector domain (DED), identified 
in caspase-8 and caspase-10, linking ligand activated deatli receptors such as 
CD95 or TNFRl (Boldin et aL, 1996) to caspase activation. The second 
domain, termed a caspase recruitment domain (CARD), is present in CED-3 and 
caspases-1, -2, -4, and -9 and is involved in interaction with Apaf-1 following 
release of cytochrome c from the mitochondria (Duan and Dixit, 1997). In 
response to upstream apoptotic signals, it has been proposed that the initiator 
caspases through an proximity-induced dimérisation model autocatalytically 
process and become active (Boatright et aL, 2003). Once activated, initiator 
caspases specifically cleave and hence activate effector caspase proenzymes. 
Processing of the proenzymes occui s at specific aspartate residues and results in 
cleavage into tliree domains (Ramage et aL, 1995). This results in removal of
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the prodomain and the formation of a heterodimer composed of the large and 
small subunits. The X-ray crystal structure has been determined for several 
activated human caspases, including caspase-3 (Rotonda et aL, 1996), caspase-7 
and -8 (Wei et aL, 2000), and caspase-9 (Renatus et aL, 2001). Thus, structures 
have been solved for human initiator and effector caspases. These structures 
reveal that the heterodimer of lai’ge and small subunits associates with another 
heterodimer to form a tetramer, with both the large and small subunits 
contributing residues that form the active site pocket.
There is believed to be a hierarchy within the caspases, the initiator caspases, 
following activation, subsequently cleaving and activating the downstream 
executioner caspases resulting in a branched cascade of caspase activation. 
These executioner caspases then induce apoptosis/PCD through the cleavage of 
various structural and repair proteins, such as keratin, nuclear lamins and poly 
(ADP-ribose) polymerase (PARP) (Utz and Anderson, 2000; Fischer et aL, 
2003). The highly specific cleavage of a specific subset of proteins, is in 
agreement with the observation that apoptosis/PCD is not the result of 
indiscriminate protein degradation but rather a change in cellular metabolism 
leading to a co-ordinated cell suicide.
1.8.2 Other Clan CD peptidases.
The Gingipains, cysteine peptidases of the bacterium Porphyromonas gingivalis, 
a major pathogen in periodontal disease, have been identified as key virulence 
factors in this bacterium (Potempa and Travis, 1996). Gingipain R falls into 
Clan CD and is particularly interesting due to the possession of a catalytic 
domain very similar to that of the caspases. This protein has been crystallised 
and shows topological homology with caspase-1 (Eichinger et aL, 1999), wiüi 
identically positioned cysteine and histidine residues, an equivalent oxyanion 
hole and a similarly placed and shaped SI pocket. However, with the caspases 
the SI pocket is optimised for aspartate side chains, while with Gingipain R 
arginine is the favoured amino acid. Clostripain, another bacterial peptidase 
identified from the bacterium Clostridium histolyticum (Mitchell and 
Harrington, 1968) also shows a strict specificity for arginine at the SI pocket 
(Mitchell, 1977). The legumains aie cysteine peptidases that were first
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identified in the leguminous seed of the mouth bean, Vigna aconitofolia 
(Kembhavi et aL, 1993), This was later shown to be homologous to an enzyme 
from Schistosoma mansoni (Hara-Nishimura et aL, 1993) and homologues have 
also been identified in mammals (Chen et aL, 1997), all showing specificity for 
asparagine at tlie PI position. Along with the legumains in the C l3 family are 
classified the glycosylphosphatidylinositol (GPI) transamidases, and as this class 
of peptidase has been identified within the trypanosomatids are discussed in 
more detail below. As are the separases, the most recently classified members 
of Clan CD, which are essential for correct sister chromatid separation during 
mitosis in eukaryotic cells (Uhlmann et aL, 1999; Nasmyth, 1999).
1.9 Importance of cysteine peptidases in parasitic protozoa.
There are more than 500 types of cysteine peptidases currently known (Bairett 
and Rawlings, 2001; Rawlings et aL, 2004) and many have been shown to carry 
out vital functions or be involved in disease processes (Lecaille et aL, 2002). 
Cysteine peptidases of parasitic protozoa have been implicated in a variety of 
biological events, including invasion of host cells, immune evasion, 
pathogenesis and virulence (Mottram et aL, 1998; Rosenthal, 1999; Frame et aL, 
2000; Klemba and Goldberg, 2002; Sajid and McKerrow, 2002; Denise et aL, 
2003), and some have also been validated as drug targets of high promise 
(McKen’ow et aL, 1999; Sajid and McKerrow, 2002). Most cysteine peptidases 
of parasitic protozoa that have been characterized are located in Clan CA, family 
Cl. This family includes cruzain of Trypanosoma cruzi (Eakin et aL, 1992), 
CPA (Souza et aL, 1994), CPC (Bart et aL, 1995), the CPB (Robertson and 
Coombs, 1994) multigene family of Leishmania mexicana, and the falcipains of 
Plasmodium falciparum (Francis et aL, 1996; Shenai et aL, 2000).
Clan CA enzymes are believed to represent excellent drug tai’gets with which to 
rationally design inhibitors to treat parasitic infections. The inhibition of the T. 
brucei cathepsin-L like cysteine peptidase rhodesain with selective dipeptidyl 
inhibitors was shown to have anti-trypanosomal activities comparable with those 
of drugs used in the tieatment of sleeping sickness (Nkemgu et aL, 2003). A 
separate study has also reported the screening of a library of thiosemicarbazone 
cysteine protease inhibitors against the parasitic cysteine peptidases cruzain,
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falcipain-2, and rhodesain from T. cruzi, P. falciparum, and T. brucei, 
respectively. Some of the compounds tested effectively inhibited the enzymes, 
were parasiticidal and displayed no observable toxicity in mice (Greenbaum et 
aL, 2004). Thus, it is believed that the development of specific peptidase 
inhibitors may aid in the creation of new treatments for parasitic infections.
The advent of extensive genome sequence data has led to the identification in 
parasitic protozoa of cysteine peptidases belonging to Clan CD, and their 
discovery has led to a reassessment of the importance and roles of cysteine 
peptidases in parasitic protozoa. Moreover, it appears that these enzymes have 
much greater substi*ate specificity and therefore functions than the Clan CA 
enzymes, and so perhaps provide better targets for drug attack.
1.10 Clan CD peptidases identified in T, brucei,
1.10.1 Glycosylphosphatidylinositol (GPI) transamidases.
GPI8 is essential for the attachment of GPI anchors to VSG and procyclin in 
both the BSF and PCF life stages of T. brucei, respectively (Lillico et aL, 2003). 
The use of GPI anchoring to attach proteins to the cell surface is widespread 
throughout eukaryotes, and GPI8 has been identified as being essential for this 
process in both yeast (Benghezal et aL, 1996) and mammalian cells (Yu et aL,
1997). In T. brucei, GPI8 has been shown to be essential for BSF but not for the 
PCF survival in vitro, although the PCF parasites were unable to establish an 
infection in vivo (Lillico et ah, 2003). Within the biosynthetic pathway there are 
numerous proteins involved in the formation of the GPI anchor.
It has been shown that the human and Saccharomyces cerevisiae GPI complex is 
well conserved, containing five homologous components (Hong et aL, 2003). 
The human components, GAAl, GPI8, PIG-S, PIG-T, and PIG-U are 
homologous to yeast Gaalp, GpiSp, Gpil7p, Gpil6p, and Cdc91p, respectively. 
Within T. brucei, it is believed that the GPI complex shares only three 
components with humans and S. cerevisiae, 77>GPI8, TbGAAl and T6GPI16. 
Additionally, however, there are two specific components termed 
trypanosomatid transamidase 1 (TTAl) and TTA2 (Nagamune et aL, 2003).
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The GPI8 protein shows a high level of sequence identity with the legumains 
and thus has been classified within the C l3 family. Whether they should be 
classified separately is open to debate, as they are clearly distinct from the 
legumains in the fimctions they perform. Legumains are general proteolytic 
enzymes with various fimctions across the genera (Manoury et aL, 1998; Muntz 
and Shutov, 2002), while GPI8 is universally involved in the attachment of GPI- 
anchors to polypeptides (Benghezal et aL, 1996; Yu et aL, 1997; Lillico et aL,
2003).
1.10.2 Separases.
An enzyme of such importance to the effective functioning of the eukaryotic cell 
cycle would be expected to be present in parasitic protozoa, and indeed a separin 
gene has been identified in T. brucei (Mottram et aL, 2003). This gene encodes 
for a large protein of >1000 amino acids with two major domains, a conserved 
cysteine peptidase domain at the C-terminus and a less conserved N-teiminai 
securin-binding domain (Ross and Cohen-Fix, 2002). Securin is a regulatory 
protein that inhibits the activity of separase until all pairs of chi'omatids have 
established bipolar spindle attachments (Hornig et a l, 2002). Separases are 
thought to have specific cleavage sites (hydrolysis at the C-terminal side of 
arginine residues), with only a few substrates present in the cell (Ross and 
Cohen-Fix, 2002).
1.10.3 Metacaspases.
The metacaspases, which were first identified in 2000 by researchers in 
California (Uren et aL, 2000), have not yet officially been classified within Clan 
CD by MEROPS. Several sequences with distant but significant similarities to 
caspases had previously been identified in human and Dictyostelium discoideum 
databases (Ai*avind et aL, 1999). Further iterative database searches using these 
sequences identified two novel families of caspase-like proteins which were 
termed the paracaspases and the metacaspases (Uren et aL, 2000). Until these 
discoveries, no caspases-like peptidases had been identified in plants, fimgi, or 
protists. Based upon domain structure and sequence similarity, the metazoan 
and Dictyostelium sequences identified were classified as paracaspases while 
sequences from plants, fungi and protozoa were termed metacaspases (Uren et
23
a l, 2000). Interestingly, no metacaspase genes have been identified in 
mammals suggesting that they might provide a good drug target.
1.11 Functions of metacaspases.
1.11.1 Functions of plant metacaspases.
Plant metacaspases have been classified into two types (Uren et a l, 2000). 
Type-I metacaspases contain a pro-domain that is proline rich and contains a 
zinc finger motif with similarities to that in LSDl, a protein involved in the 
hypersensitivity response pathway. The hypersensitive response is a plant 
response to infection by microbial pathogens and is often accompanied by rapid 
cell death in and around the initial infection site. This response is associated 
with restricted pathogen growth and has been suggested to represent a form of 
PCD (Greenberg, 1996). Type-II metacaspases do not posses a prodomain, but 
have an insertion of approximately 180 amino acids (Uren et a l, 2000). A type- 
II metacaspase, termed TcMCAl, has been cloned from the tomato plant 
{Lycopersicon esculentum) and gene expression during cell death in Botrytis 
cinerea infected tomato leaves observed (Hoeberichts et al., 2003). Infection of 
Arabidopsis thaliana with B. cinerea has been shown to induce an oxidative 
bui'st accompanied by the activation of hypersensitive cell death (Govrin and 
Levine, 2000). As in A. thaliana, it is believed that B. cinerea infection induces 
the hypersensitive sensitive response and LcMCAl mRNA was only detected in 
infected leaves. Thus it was suggested that the metacaspases have a caspase-like 
role in the plant hypersensitivity response.
A further role for the metacaspases in cell death in plants has been reported 
using the model system of somatic embryogenesis In the Norway spruce (Picea 
abies). In this developmental pathway, autophagic cell death has been 
implicated in the transition from proembryogenic mass (PEM) to somatic 
embryo and correct embryonic pattern formation (Filonova et al., 2000). A 
type-II metacaspase cDNA was identified from embryogénie cell cultures and in 
situ hybridization analysis revealed accumulation of metacaspase mRNA in 
embryonic tissues and structures coimnitted to death (Suarez et al,, 2004). 
Silencing of the metacaspase gene by RNAi was accompanied by loss of
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embryonic pattern formation. Tliis silencing also resulted in a reduction in 
VEIDase activity, a caspase-like activity previously reported to be essential for 
embryo development (Bozhkov et aL, 2004). It was suggested that the plant 
metacaspases are part of the developmental cell death machinery, involved in 
maintenance of the balance between death and proliferation required for plant 
embryogenesis
In A. thaliana there have been nine metacaspase genes identified, three of which 
were classified as type-I metacaspases, while the remaining six ai*e type-II 
metacaspases. Expression of N-terminally tagged type-II metacaspases in E. 
coli revealed that there was an apparent autocatalytic processing similai' to 
caspases (Vercammen et aL, 2004), which was absent following substitution of 
the putative active site cysteine residues. Analysis of the cleaved fragments 
revealed that this autoprocessing occurred after either a conserved arginine or 
lysine residue. Additionally, it was demonstrated that the activity of the 
recombinant enzymes was dependant on this autoprocessing, and that all 
substrates tested with either arginine or lysine at the PI position were cleaved 
efficiently. No cleavage of classical caspase substrates was detected using the 
recombinant enzymes. It is interesting to note that no processing pattern was 
detected when type-I metacaspases were overexpressed, presumably due to fact 
that the cleavage site identified is located in the insert region chaiacteristic of 
type-II metacaspases. These findings suggest that the metacaspases, like other 
Clan CD peptidases, are specific for the PI residue. However, unlike the 
caspases they display a preference for tlie basic amino acids similar to the 
separases, clostripains and gingipains.
1.11.2 Functions of yeast metacaspases.
Potential roles for metacaspase involvement in cell death in Saccharomyces 
cerevisiae have also been reported (Madeo et aL, 2002; Herker et aL, 2004; 
Wadskog et aL, 2004). Yeast possesses a single metacaspase gene and the 
overexpression of an epitope tagged metacaspase (YCAl) revealed apparent 
processing, which was absent when substitution of the putative active site 
residues was performed (Madeo et a l, 2002). Following exposure of yeast to 
H2O2, a stimulus previously suggested to induce apoptotic-like death in yeast
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(Madeo et aL, 1999), caspase-like activity was detected using FITC-VAD-fmk, 
a fluorescent inhibitor which should only bind to active caspases. Additionally, 
the overexpression of YCAl for 44 hours resulted in the appearance of apoptotic 
markers. Fragmented DNA and chiomatin condensation were observed in 90% 
and 20% of the cells, respectively. Both of these phenomena were almost 
completely abolished by the co-incubation with the caspase inhibitor z-VAD- 
fink. It has also been also proposed that high salinity is able to induce apoptosis 
in yeast, with ectopic expression of the anti-apoptotic protein Bcl-1 enhancing 
NaCl tolerance (Huh et aL, 2002), and an increased sensitivity to NaCl stress 
observed following deletion of the SR07  gene (Wadskog et aL, 2004). SR07 is 
the yeast homologue of a Drosophilia tumour suppressor gene required for 
development of epithelial cell polarity (Bilder et aL, 2000). On exposure to 
growth inhibiting concentrations of NaCl, the Asro7 cells displayed a rapid loss 
in viability that was accompanied by markers of apoptosis (Wadskog et a l,
2004). The additional deletion of YCAl, was shown to reduce the fast initial 
drop in viability and reduce DNA fragmentation. Caspase-like activity was also 
observed using FITC-VAD-fmk, while only basal activity was detected in 
Eycal mutants. Further reports of metacaspase involvement in apoptotic-like 
cell death have also been claimed in yeast with regard to chronological aging. A 
hypothesis has been suggested whereby certain yeast cells commit altruistic 
suicide to spare resources for other younger and fitter cells in aging cultures 
(Herker et aL, 2004), An analysis of chronologically aged cultures revealed that 
markers of apoptosis (DNA fragmentation, chromatin condensation and 
phosphatidly serine externalisation) were all present together with caspase-like 
activity, assessed using FITC-VAD-fink.
However a recent paper has questioned the validity of using fluorochrome- 
conjugated caspase inhibitors, such as FITC-VAD-fink, to detect caspase-like 
activity in dying yeast cells. It was demonstrated that dead or inviable yeast 
cells non-specifically bind fluorescent-conjugated caspase inhibitors (Wysocki 
and Kron, 2004). An exponentially growing culture of wild type yeast cells was 
split, with one half incubated at 80°C for 5 minutes to rapidly kill the cells and 
denature all proteins. Staining of both live and heat-killed cells with FITC-
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VAD-fmk revealed that the heat-killed cells accumulated the fluorescent caspase 
inhibitor. A separate study examining the specificity of caspase inhibitors such 
as z-VAD-fink has also highlighted potential problems with the interpretation 
when using these small peptide inhibitors. It was shown that a range of these 
peptides linked to chloromethylketone (cmk) or fluoromethylketone (fmk) 
groups efficiently inhibited legumain and various cathepsins in addition to the 
caspases (Rozman-Pungercar et ah, 2003). These findings suggest that the 
detection of caspase-like activity, in the previously described reports, may not 
have been due to metacaspase activity. Rather they may have been due to non­
specific interactions with FITC-VAD-fmk inhibitor, or the detection of Clan CA 
peptidases witli z-VAD-fmk.
Additional to work on the endogenous yeast metacaspase, it has also been 
reported that the heterologous expression of a T. brucei metacaspase (T6MCA4) 
in Saccharomyces cerevisiae resulted in growth inhibition, mitochondrial 
dysfunction and cell death (Szallies et aL, 2002). All five T. brucei, as well as 
the single Schizosaccharomyces pombe metacaspase, were expressed, but of 
these, only T6MCA4 resulted in any phenotypic consequences and these were 
lost following mutation of the putative active site residues. Both endogenous 
and T. brucei metacaspase GFP fusion proteins showed apparent nuclear 
localisation, and the endogenous metacaspase displayed a genetic interaction 
with WWMl. This protein was identified as a potential hydrophilin, these 
proteins are often involved in osmotic stress responses (Garay-Arroyo et aL, 
2000). Interestingly, WWMl overexpression resulted in a growth arrest, similar 
to effects of TbMCA4 expression, and which was suppressed by concurrent 
expression of the endogenous metacaspase.
In addition to reports where the metacaspase have been suggested to play a role 
in cell death, there are examples of apoptotic-like phenomena reported in yeast 
unrelated to metacaspase function. In both Saccharomyces cerevisiae and the 
filamentous fungus Aspergillus nidulans, induction of cell death with markers 
typically associated with apoptosis were shown to be unaffected by deletion of 
the single metacaspase present in both organisms (Cheng et aL, 2003; Wysocki 
and Kron, 2004). Whether or not apoptosis actually exists in yeast is open to
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debate, there is evidence to suggest that such a process may exist, although tlie 
majority of the components required for apoptosis in multicellular organisms are 
absent from the yeast genome. If such a pathway does exist in yeast, it is likely 
to be a much more primitive form and definitive linkage of metacaspase 
function to such a phenomenon has not been demonstrated.
That the metacaspases might function as a part of this controversial process is a 
tempting hypothesis to postulate. Investigations into their functions in both 
yeast and plants have suggested that the metacaspases might be involved in cell 
death processes (Madeo et ah, 2002; Szallies et aL, 2002; Hoeberichts et aL, 
2003; Herker et aL, 2004; Wadskog et aL, 2004; Suarez et aL, 2004). The 
apoptotic pathways are extremely complex in higher eukaryotes, utilising 
numerous different signalling pathways and domain aggregations (Koonin and 
Aravind, 2002). Assuming that the metacaspases do represent the ancestral 
caspases, it is possible that during evolution they were recruited to the 
developing process of PCD/apoptosis and at which time they diverged and 
diversified to become modern day caspases.
Other than in yeast, there have been no documented functions assigned to the 
metacaspases in any single cell organisms. Their functions in protozoa may, or 
may not be, similar to that in yeast, but, whatever the case, this novel family of 
peptidases demands study and may well offer opportunities for further insights 
into the cell biology of the trypanosomatids.
Aims of the project:
1) To identify and characterise the metacaspase genes of T brucei
- expression profile and localisation
2) To analysis of metacaspase function through RNAi
3) To analysis of metacaspase function through targeted gene disruption
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Chapter 2 
Materials and methods
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Details of oligonucleotide sequences together with a list of buffers and solutions 
used follow these methods.
2.1 Culturing, harvesting and cryopreservation of trypanosomes.
Genetic knockouts in the bloodstream form (BSF) were performed in 
Trypanosoma brucei strain 427. These were maintained at 37°C with 5% CO2 in 
HMI-9 (Hirumi and Hirumi, 1989) supplemented with 10% (v/v) heat-inactivated 
fetal calf serum (FCS) (Gibco) and 10% (v/v) serum plus (JHR Biosciences). 
Genetic knockouts in the procyclic form (PCF) were performed in T. brucei 
EATR0795. These were cultured at 27°C in complete SDM79 medium (Brun 
and Schonenberger, 1979) supplemented with 10% (v/v) heat-inactivated FCS 
(Gibco). For the RNAi study, the procyclic 427 pLewl3 pLew29 and the 
bloodstream form 427 pLewl3 pLew90-6 cell lines were used (Wirtz et a l, 1999) 
and maintained as above.
Final antibiotic concentrations used for maintenance and selection of transgenic 
trypanosomes were as follows. In the BSF: hygromycin (Roche) at 5 pg mf^ , 
neomycin at 2 pg ml"\Calbiochem), blasticidin (Calbiochem) at 2 pg ml % 
puromycin (Calbiochem) at 2 pg mf^ and phleomycin (Cayla) at 2.5 pg m f \  In 
the PCF: hygromycin (Roche) at 50 pg m f \  neomycin (Calbiochem) at 15 pg ml' 
\  zeocin (Cayla) at 10 pg ml"\
Harvesting of the BSF and PCF parasites was performed by centrifugation at 
1500g or lOOOg for 5 mins at room temperature, respectively. Culture medium 
was removed and cells resuspended in an equal volume of sterile PBS. Parasites 
were then centrifiiged once more before use in downstream applications.
Cryopreservation of both BSF and PCF parasites was performed as follows. 
Typically, a 10 ml culture of mid logarithmic phase parasites was harvested as 
previously described and re-suspended in an equal volume of appropriate culture 
medium supplemented with 10% (v/v) sterile glycerol (Sigma). 1 ml aliquots 
were then transferred into cryovials (Sterillin) and slow-frozen at -80°C. The 
following day cryovials were transferred to liquid nitrogen for long term storage.
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Recovery of trypanosomes was performed by thawing at room temperature prior 
to immediate transfer to appropriate medium.
2.2 Transfection and cloning of parasites.
Transfection and cloning of PCF parasites was performed as follows. Parasites 
were grown to a mid logarithmic density of approximately 8x10^  cells mf^ and 
3x10^ parasites harvested as previously described. Parasites were then 
resuspended in 0.5 ml Zimmermans post fusion medium (ZPFM) in a 0.4-cm 
pulse cuvette (Bio-Rad) with between 1 to 5 pg of linearised plasmid DNA. 
Cuvettes were then pulsed twice using a Bio-Rad puiser II set at 1.5 kV, 25 pF 
before immediate re-suspension of parasites in 5 ml of SDM-79 prewarmed to 
27°C. After overnight recovery, appropriate antibiotics and a final concentration 
of 25% (v/v) conditioned medium was added to cultures. Conditioned medium 
was taken fi-om a wild type culture grown to excess of 2 x 10  ^ cells m f \  the 
parasites were removed by centrifugation and the medium passed through a 0.22 
pm filter. Various dilutions of the transfected parasites were llien plated out on 
96-well plates, the plates were sealed with parafilm, placed in an airtight box and 
incubated at 27°C for several weeks or until clonal populations grew.
Transfection and cloning out of BSF parasites was performed as follows. 
Parasites were grown to a mid logarithmic density of 1 x 10*^  cells ml'^ and 5x10^ 
parasites harvested as previously described. Parasites were then resuspended in 
0.5 ml ZPFMG in a 0.4-cm pulse cuvette (Bio-Rad) with between 5 - 20 pg of 
linearised plasmid DNA. Cuvettes were then pulsed once using a Bio-Rad puiser 
II set at 1.2 kV, 25 pF before immediate re-suspension of parasites in 50 ml of 
HMI-9 prewarmed to 37°C. After overnight recovery, appropriate antibiotics 
were added to the cultures. Various dilutions of the transfected parasites were 
then plated out on 24-well plates and incubated at 37°C, 5% CO2 until clonal 
populations grew up.
2.3 PCR reactions.
PCR reactions were performed using two different enzymes, Taq {Thermus 
aquaticus) (Abgene) or the high-fidelity Pfu {Pyrococcus furiosus) (Stratagene)
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depending on the requirements. PCR was typically performed in 20 pi reactions 
with the following constituents: 50 pg template DNA, 5 pmol of each primer, 0.3 
units of Taq or 1 unit of Pfu and 2 pi of respective lOx PCR mix. Reaction 
mixtures were overlaid with mineral oil and reactions performed in a PCR 
Express machine (Hybaid).
2.4 DNA gel electrophoresis.
Gel electrophoresis was performed using agarose from either Gibco or SeaKem in 
conjunction with 0.5x TRIS borate buffer (TBE) or Ix TRIS acetate buffer (TAE), 
respectively. TBE buffer was used for day to day analysis, while TAE buffer was 
used when DNA was to be excised from the gel or for Southern blotting. The 
molecular weight marker used was a 1 kb ladder (Invitrogen) at a concentration of 
0.5 pg per lane.
DNA was visualised by the addition of ethidium bromide (Sigma) to the gel mix 
at a final concentration of 0.5 pg m f \  Visualisation was by exposure to UV light 
using a Gel Doc 2000 (BioRad).
DNA was extracted from agarose gels using a Gel Extraction Kit (Qiagen) as 
specified in the manufacturer’s instructions. When DNA was to be used for 
further cloning steps, or for use in transfections, the DNA was subsequently 
ethanol-precipitated. This was performed by the addition of 2.5 volumes 100% 
ethanol and 10% 3 M NaAc (pH5.2) and incubated at -20°C for 30 mins prior to 
centrifugation at 18,000g for 10 mins. The resultant pellet was then washed twice 
in 70% (v/v) ethanol and re-suspended in a suitable volume of sterile water and 
kept at -20°C until required.
2.5 Cloning of PCR products.
PCR products, generated as described previously, were ligated into either pGEM- 
T Easy vector (Promega) or pCR-Script (Stratagene) depending on whether 
amplification was performed using Taq or Pfu, respectively, and according to the 
manufacturer’s guidelines. These ligations were then used to transform heat- 
shock competent XL-1 blue cells (Stratagene) according to the manufacturer’s 
guidelines, and transformants selected by their ability to grow on LB (Luria-
32
Bertani) agar plates supplemented with 50 |ig ml'^ ampicillin. The presence of 
PCR products within vectors was initially determined by blue/white selection of 
colonies using 0.5 mM IPTG and 80 gg mf^ X-gal, following which positives 
were screened by colony PCR using the SP6 and T7 (pGEM-T) or T3 and T7 
(pCR-Script) RNA Polymerase Promoter Sequencing Primers.
2.6 Colony PCR.
Bacterial colonies were screened for DNA insertion as follows: using a 200 gl 
pipette tip, white colonies were selected from agar plates and suspended in 20 |il 
of sterile distilled water. 2 pi were then used to substitute for template DNA in a 
PCR reaction using Taq DNA polymerase as described above. PCR products 
were analysed on an agarose gel as described previously. Clones of interest were 
then used to inoculate 5 ml of LB medium and incubated overnight at 37°C at 220 
rpm. Cells were cryopreserved by addition of 1 ml of overnight bacterial culture 
to 1 ml of a 2% (w/v) peptone 40% (v/v) glycerol solution and placed at -70°C for 
long term storage.
2.7 Plasmid preparation.
Plasmid preparation from bacterial cultures was perfonned in two ways depending 
on the amount of DNA required. For general cloning or sequencing, plasmids 
were prepared from 5-10 ml overnight bacterial cultures using a MiniPrep kit 
(Qiagen) according to the manufacturer’s guidelines. If larger amounts of DNA 
were required, for transfections for example, 50 ml bacterial cultuies were grown 
and DNA extracted using a MidiPrep kit (Qiagen) according to the manufacturer’s 
guidelines.
2.8 Plasmid generation.
2.8.1 MCA2/3 RNAi construct.
A 668 base-pair fragment, sharing 100% identity with MCA2 and MCA3, was 
amplified by PCR from genomic DNA (strain 427) with Pfu (Stratagene) using 
the primer pair OL905 (BamHl) and OL906 (LTmdlll). The engineered restriction 
sites added are indicated in brackets. This fragment was cloned into pCR-script 
and sequenced to ensure fidelity before excision with BamHl and HindlU, This
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fragment was then cloned into pGL571 pre-digested with BamHl and Hindlll to 
generate pGL671. For transfection purposes, pGL671 was digested with Notl and 
purified by agarose gel electrophoresis as previously described.
2.8.2 MCA5 RNAi construct.
A 416 base-pair fragment of MCA5 was amplified by PCR from genomic DNA 
(strain 427) with Pfu (Stratagene) using the primer pair OL944 {BamHl) and 
OL945 (7/z«dlll), the engineered restriction sites added are indicated in brackets. 
This fragment was cloned into pCR-script and sequenced to ensure fidelity before 
excision with BamHl and Hindlll. This fragment was then cloned into pGL571 
pre-digested with BamHl and Hindlll to generate pGL714. For transfection 
purposes, pGL714 was digested witli Notl and purified by agarose gel 
electrophoresis as previously described.
2.8.3 MCA2/3/5 RNAi construct.
The 668 base pair MCA2/3 fragment was excised from pGL670 with Hindlll and 
cloned into pGL714 pre-digested with Hindlll to generate pGL905. For 
transfection purposes, pGL905 was digested with Notl and purified by agarose gel 
electrophoresis as previously described.
2.8.4 MCA2 & MCA3 knockout constructs.
The 5' flank of MCA2 and the 3' flank of MCA3 were amplified by PCR from 
genomic DNA (strain 427) with Pfu (Stratagene) using the primer pairs OL969 
{Xbal) / OL970 {Xbal) and OL971 (Apal) / OL972 (Apal), respectively, the 
engineered restriction sites added are indicated in brackets. These fragments were 
then cloned into pCR-script and sequenced to ensuie fidelity before excision of 
the 5’ and 3’flanking regions with Jdbal and Apal, respectively. These were then 
cloned sequentially into pGL699 pre-digested firstly with Nbal and subsequently 
with Apal to generate pGL802, the BSD MCA2/3 knockout construct. Exchange 
of resistance genes was achieved by excising the PAC gene from pGL698 using 
EcoBl and cloning into pGL802 pre-digested with EcoBl, generating pGLSOS, the 
FAC MCA2/3 knockout construct. For transfection purposes, pGL802 and 
pGL808 were digested with Notl/Xhol and appropriate fragments purified by 
agarose gel electrophoresis as previously described.
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2.8.5 MCA5 knockout construct.
The 5' and 3’ flanks of MCA5 were amplified by PCR from genomic DNA (strain 
427) with Pfu (Stratagene) using the primer pairs OL1135 {NotV) / OLl 131 {Xba\) 
and OLl 132 (Apal) / OLl 134 (Apal), respectively, the engineered restriction sites 
added are indicated in brackets. These fragments were then cloned into pCR- 
script and sequenced to ensure fidelity before excision of the 5’ and 3’ flanking 
regions with Notl/Nbal and Apal, respectively. These were then cloned 
sequentially into pGL802 pre-digested firstly with Notl/Xhal and subsequently 
with Apal to generate pGL904. The primer pairs OLl307 / OLl308 and OLl309 
/ OLl310, engineered to contain EcoRl restriction sites, were used to amplify both 
the HYG and NEO resistance genes, respectively, from pGL893 and pGL227. 
These were then inserted into pCR-Script, sequenced to ensure fidelity before 
excision with ÆcoRl and cloned individually into pGL904 pre-digested witli 
ÆcuRl to generate pGL905 and pGL906. For transfection purposes, pGL906 and 
pGL907 were digested with JVotl/EcoRV and appropriate fragments purified by 
agarose gel electrophoresis as previously described.
2.8.6 Generation of recombinant MCAS expression vector.
MCA5 was amplified by PCR from genomic DNA (strain 427) with Pfu using the 
primer pair OLl029 (vfj-el) and O Ll030 (Xhol), the engineered restriction sites 
added are indicated in brackets. This fragment was then cloned into pCR-script 
and sequenced to ensure fidelity before excision with Asel and Xhol. This 
fragment was then used to ligate into the E. coli expression vector pET-28a(+) 
pre-digested with Ndel and Xhol to generate pGL805.
2.8.7 MCA2, MCA3 and MCA5 re-expression constructs.
MCA2 and MCA3 ORF’s were excised from pGL863 and pGL864, respectively, 
using Ndel and Xhol while MCA5 was excised from pGL805 using Asel and Xhol. 
Fragments were then blunt ended using Klenow (NEB) as stated in 
manufacturer’s guidelines. These fragments were then cloned individually into 
pGL884 pre-digested with EcoRY and dephosphorylated witli calf intestinal 
alkaline phosphate CIP (NEB) as stated in manufacturer’s guidelines to generate 
pGL867, pGL868 and pGL927. For transfection purposes, pGL867 and pGL868
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were digested with XbaVHindlll, while pGL927 was digested with BamHl and 
Hindlll, and appropriate fragments purified for tiansfection.
2.8.8 HA-tagged MCA2 & MCA3 constructs.
Equal molar concentrations of OLl225 and OLl226 were heated together at 95°C 
for 10 mins and subsequently allowed to cool slowly to room temperatuie to allow 
annealing to occur. These complementary primers encode for the last 12 amino 
acids of MCA2 and MCA3 with the addition of the sequence for an hemagglutin 
(HA) epitope tag. Additionally, these were engineered, once annealed, to possess 
overhanging sequences compatible with Bglll and Xhol restriction digests. These 
annealed primers were then cloned into pGL863 and pGL864 pre-digested with 
Bglll and Xhol, which removes the last 12 base pairs of both MCA2 and MCA 3 
respectively, to generate pGL865 and pGL866. These modified genes were then 
excised from pGL865 and pGL866 with Ndel and Xhol and fragments blunt ended 
using Klenow (NEB) as stated in manufacturer’s guidelines. These fragments 
were then cloned individually into pGL884 pre-digested with EcoRV and 
dephosphorylated with CIP (NEB) as stated in manufacturer’s guidelines to 
generate pGL878 and pGL879. For transfection purposes, pGL878 and pGL879 
were digested with BamHl and Hindlll and appropriate fragments purified for 
transfection.
2.9 DNA Sequencing and analysis.
Sequencing of cloned DNA was performed by the University of Glasgow 
Molecular Biology Support Unit (MBSU) using an ABI automatic sequencer. 
Raw sequence data were imported, edited and individual sequence fragments 
compiled into contigs using AlignX (Informax Inc.). Homology searches were 
carried out through the Gene DB (http://www.genedb.org) and National Centre for 
Biotechnology Information (NCBI) [http://www.ncbi.nlm.nih.gov] BLAST 
servers.
2.10 Expression and purification of recombinant MCA5 in Escherichia coli.
The MCA5 expression vector pGL805 was transformed into E. coli BL21 cells 
(Stratagene) and 500 ml of LB inoculated. Once the CD reached approximately 
0.6, expression was induced with a final concentration of ImM IPTG. At 4 hours
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post-induction, cells were harvested by centrifugation at 5000g for 10 mins at 
4°C. The pellet was then lysed in 40 ml of Bacterial Protein Extraction Reagent 
(B-PER) (Pierce) on a rotary shaker for 15 mins at room temperature, followed by 
centrifugation at 24,000g for 10 mins. The resultant pellet was then resuspended 
in 30 ml B-PER with the addition of 200 pg mf^ lysozyme (Sigma) and incubated 
at room temperature for 10 mins. A further 10 mins centrifugation at 24,000g was 
performed and the resultant pellet washed twice in 20 ml of a 1:10 dilution of B- 
PER. A series of washes with different solutions was then used:
- 1  X H 2O
- 1 x 5 0  mM Tris, 5 mM EDTA, 5% (w/v) sucrose, pH 8
- 1 X 75 mM Tris, 500mM NaCl, 0.1% TxlOO, pH 7.5
- 1 X H2O
- 1 X 100 mM Tris, 5 mM EDTA, 1 M Urea, pH 8
- 2 X H2O
The pellet was finally re-suspended in 10 ml 8 M urea, 100 mM NaH2P0 4 , 10 
mM Tris, pH 8, and left on a rotary shaker overnight at 4°C. Protein purification 
was then performed using nickel agarose beads (Qiagen) as per manufacturer’s 
guidelines for purification under denaturing conditions and eluted in 4 x 0.5 ml 
fractions of first buffer D and then buffer E (see section 2.27). Tlie fraction with 
the highest concentration of purified protein was identified and a volume of this 
elution fraction containing approximately 800 pg of protein electrophoresed via 
SDS-PAGE and the MCA5 band excised. This material was then frozen in liquid 
nitrogen, ground with a pestle and mortar, resuspended in PBS and sent for 
antibody production in sheep at Diagnostics Scotland.
2.11 Affinity purification of anti-MCA2/3 antiserum.
Anti-MCA2/3 antiserum raised against a 80mer peptide with 100% identity 
between MCA2 and MCA3 (Figure 3.5B) had previously been generated 
(N.Fasel, University of Lausanne, Switzerland). Generation of an affinity matrix 
using the peptide was performed using an Amino Link Immobilisation Kit 
(Pierce) as detailed in the manufacturer’s guidelines. 2 ml of the antiserum was 
mixed with 2 ml of Binding buffer (BB) (Pierce) and the column left on a rotary
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shaker for 1 hour at room temperature. The column was then drained and washed 
with 15 ml of BB. Antibodies were then eluted with 4 ml of Elution buffer (EB) 
(Pierce) into 0.5 ml of a 1 OX PBS solution. Eluted antibodies were then 
concentrated by centrifugation in a 2 ml 10,000 MW exclusion concentrator 
(VivaScience) witli 10 ml Ix PBS added during the concentration process to lower 
the salt concentration. A volume of approximately 300 pi was then mixed with 
glycerol to a final concentration of 50% and stored at -20°C.
2.12 Electrophoresis of proteins.
SDS-PAGE gels were cast and run according to the method of Lammeli as 
adapted for the BioRad Mini-PROTEAN II system. Typically, resolving gel 
acrylamide concentration was 12% (w/v) and SDS-PAGE running buffer was 
made as a 1 OX stock and used at IX concentration. Cell pellets were resuspended 
in Laemmli sample buffer containing 0.25% Triton-XlOO and samples heated at 
100°C for 5 mins. Usually, gels were run at 180V until the dye front reached the 
bottom of the gel, although occasionally migration was allowed to progress 
further for better separation of closely migrating proteins.
2.13 Coomassie staining of gels.
Protein gels were simultaneously fixed and stained by immersion in Coomassie 
stain solution for 1 hour at room temperature. Gels were destained with several 
changes of destain solution until optimum staining/background was observed, 
following which they were washed in several changes of distilled water and 
vacuum dried.
2.14 Western blotting of gels and immuno-detection of proteins.
Protein gels were equilibrated in transfer buffer for 15 mins and then blotted onto 
PVDF membrane (Pierce) using a Trans-Blot Semi-Dry Electrophoretic Transfer 
Cell (BioRad) set at lOV, 15mA for 30 mins. After transfer of proteins, the 
membrane was stained with Ponceau Red (Sigma) to visualise the molecular 
weight marker and to check for efficient transfer of proteins. The membranes 
were then destained with water, followed by blocking with 5% (w/v) dried 
skimmed milk powder in PBS with 0.05% Tween-20 (Sigma) (PBST) for 1 hour 
at room temperature or overnight at 4°C. Membranes were then incubated with
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varying titres of primary aatibody/antiserum in PBST on a roller for 1 hour at 
room temperature. Membranes were then washed 3 x with 5 ml PBST for 5 mins 
each and then incubated with secondary antibody-HRP conjugates (Promega) in 
PBST on a roller for 1 houi' at room temperature. Blots were developed by 
incubation with SuperSignal Chemiluminescent Substrate Stable Peroxide 
Solution (Pierce) and SuperSignal Chemiluminescent Substrate 
Luminol/Enhancer (Pierce) for 1 min. Membranes were then encased in plastic 
film and exposed to X-Ray film for varying periods of up to 5 mins depending on 
intensity of the signal.
2.15 Immunofluorescence microscopy.
Logarithmic phase BSF or PCF parasites were harvested as previously described 
and resuspended in PBS. Cells were then spread onto slides and allowed to settle 
until an appropriate cell density was achieved, following which slides were air 
dried and subsequently fixed and peimeabilised in first -20°C methanol for at least 
15 mins followed by -20°C acetone for 2 mins. After drying, slides were blocked 
with 5% (w/v) dried skimmed milk in PBST for 30 mins in a dark moist chamber. 
Slides were then incubated with varying titres of primary antibodies/antiserum in 
PBST for 30 mins at room temperature. Slides were washed thoroughly with 10 
ml PBST and incubated with appropriate secondary antibody fluorophore 
conjugates (Molecular Probes/Sigma). Following thorough washing with 10 ml 
PBST, slides were mounted with PBS/50 % (v/v) glycerol containing 2.5 % (w/v) 
1, 4-diazabicyclo[2.2.2]octane (DABCO) (Sigma) as antifade and 1 pg m f' 4',6- 
diamidino-2-phenylindole (DAPl) (Sigma) to label DNA. Microscopy was 
carried out using a Zeiss UV microscope and images were captured with an Orca- 
ER camera (Hammamatsu) and Openlab software v 3.1.5 (Improvision).
Tomato lectin staining was performed on live mid-logarithmic phase BSF 
parasites. Cells were washed in serum-fi*ee HMl-9 medium and resuspended in 
100 pi of prewarmed serum-free HMI9 at 1 x 10  ^cells m f \  1 pi of FlTC-tomato 
lectin (Sigma) was added and incubated in the dark at 4°C for 30 mins, washed 
and followed by a further incubation for a 30 mins period at 4°C in serum-free 
HM19. Lysosomes were also selectively stained using live mid-logarithmic phase
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BSF parasites. Cells were washed and resuspended in 100 pi of serum-free HMI9 
at 1 X 10  ^m f \  1 pi of Lysotracker Red DND-99 (Molecular Probes) was added 
and incubated at 37°C for 20 mins. Following incubation with either tomato 
lectin or Lysotracker, parasites were washed, re-suspended in PBS and air dried 
onto slides as previously described. Golgi apparatus staining was performed on 
fixed parasites previously adhered to slides. 1 pi of Bodipy-Texas Red ceramide 
(Molecular Probes) was added to 1 ml of 1.8% (w/v) fatty acid free BSA (Sigma) 
in PBS, applied to slides and incubated for 1 hour in a dark moist chamber.
2.16 Preparation of T. brucei genomic DNA for PCR.
Typically 10 ml of mid-logarithmic phase BSF or PCF were harvested and 
washed in PBS as previously described. Cell pellets were then re-suspended in 
0.5 ml TELT (Medina-Acosta and Cross, 1993) and incubated at room 
temperature for 5 mins. 0.5 ml of a 1:1 ratio of phenol/chloroform was added and 
gently mixed for 5 mins, followed by a centrifugation at 16,000g for 5 mins. The 
aqueous phase was extracted and a further 0.5 ml of phenol/chloroform added and 
gently mixed for 5 mins followed by a further centrifugation at 16,000g for 5 
mins. The aqueous phase was then extracted and DNA ethanol precipitated by the 
addition of 2.5 volumes of 100% EtOH with 10% (v/v) 3 M sodium acetate and 
centrifuged at 16,000g for 30 mins at 4°C. The resultant DNA pellet was then 
washed twice in 70% (v/v) EtOH, air dried for 5 mins and re-suspended in sterile 
distilled water. DNA was quantified spectrophotometrically at 260 nm and stored 
atd^^C.
2.17 Preparation of T, brucei genomic DNA for Southern blotting.
1 X 10  ^ parasites were harvested and washed in PBS as previously described. 
Cells were then re-suspended in 3 ml NTE and 150 pi of a 10% SDS solution 
added, gently mixed and incubated for 15 mins at 37°C. 150 pi of 10 mg mf^ 
RNase A (Sigma) was then added and incubated for 1 hour at 37°C. Subsequently 
120 pi of 5 mg ml'^ Proteinase K (Sigma) was added and incubated overnight at 
37°C. 1 volume of phenol was then added and gently mixed for 15 mins at room 
temperature followed by centrifugation at 2000g for 15 mins at 4°C. The aqueous 
phase was then extracted, mixed with 1 volume of chloroform, mixed gently for
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15 mins at room temperature followed by centrifugation at 2000g for 15 mins at 
4°C. The aqueous phase was extracted and mixed with 3 ml of isopropanol by 
gently inverting the tube until DNA became visible as white fluff. This material 
was then removed using a blue tip, transferred into 70% (v/v) EtOH and 
centrifuged at 16,000g for 5 mins at 4°C. After 1 further wash in 70% (v/v) EtOH 
the DNA pellet was air dried and resuspended in sterile distilled water. DNA was 
quantified spectrophotometrically at 260 nm and stored at 4°C.
2.18 Southern blotting.
Southern blotting was performed as follows. Following agarose gel 
electrophoresis of restriction enzyme digested DNA, a photograph was taken of 
the gel with a ruler laid alongside. The gel was then immersed in depurination 
buffer for 15 mins and then rinsed 3x in water. Next the gel was immersed in 
dénaturation buffer for 30 mins and rinsed 3x in water. Finally the gel was 
immersed in neutralisation buffer for 30 mins. The DNA was transferred onto 
Hybond XL membrane (Amersham) soaked in neutralisation buffer by blotting 
overnight using 20x SSC as tlie transferrant. DNA was then fixed to the 
membrane using a UV Stratalinker 2400 (Stratagene). The membrane was then 
incubated with 10 ml of hybridisation mix with the addition of 200 pg mf^ 
denatured salmon sperm (Sigma) at 65°C for 2 hours on a rotary shaker. 25 r\g of 
labelled probe was then added to the hybridisation mix and left incubating with 
the blot overnight at 65°C on a rotary shaker. The blot was then rinsed with 2 x 
SSC/0.1% SDS prior to washing for 30 mins with the same solution at 65°C. The 
blots were then sequentially washed with 1 x SSC/0.1% SDS, 0.5 x SSC/0.1% 
SDS and 0.1 x SSC/0.1% SDS all for 30 mins at 65°C. The membrane was then 
sealed in plastic film, a storage phosphor screen exposed for 2 days and developed 
using a Typhoon 8600 variable mode imager.
2.19 VSG recycling pathway.
BSF parasites were harvested at mid logarithmic growth phase, and after three 
washes with ice-cold trypanosome dilution buffer (TDB) the cell density adjusted 
to 1 X 10^  cells ml'^ in ice-cold TDB. The parasites surface coat was then labelled 
using a final concentration of 1 mM sulfo-NHS-SS-biotin (Pierce) for 10 mins on 
ice and the reaction terminated by the addition of 10 mM Tris-HCl, pH 8.5. After
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three washes with ice-cold TDB, parasites were re-suspended to a density of 1 x 
10  ^ mf^ in pre-warmed HMI9 and endocytosis allowed for 5 mins at 37°C 
followed by three washes with ice-cold TDB at 4°C. Biotin probe remaining on 
the surface was then cleaved through incubation of parasites with HMI-9, 10% 
(v/v) fetal calf serum, 50 mM glutathione, pH 9, on ice for 10 mins. Parasites 
were washed a further three times in ice eold TDB before returning to HMI9 for 1 
hour at 37°C. Samples were taken at various points for analysis by Western blot 
and immunofluorescence analysis (IFA) and processed as previously described. 
VSG-biotin was detected using either a streptavidin-Texas Red conjugate 
(Molecular Probes) or a streptavidin-HRP conjugate (Sigma).
2.20 Anti-VSG221 degradation.
BSF parasites were harvested at mid logarithmic phase and re-suspended at 1 x 
10  ^ cells mf^ in HMI-9. Parasites were then labelled with rabbit anti-VSG221 
antibodies at 4°C for 30 mins. Parasites were then washed three times in ice cold 
serum-free HMI9 and incubated at 37°C for 30 mins. Following this incubation 
period, parasites were prepared for analysis by both Western blot and IF A as 
previously described. The culture medium following this period was also TCA 
precipitated. 1 volume of a 0.5 mg mf^ TCA solution was added to 4 volumes of 
culture medium, gently mixed and incubation on ice for 10 mins. Following 
centrifugation at 18,000g for 5 mins, the pellet was washed twice in ice cold 
acetone and briefly air dried before re-suspension in 1 x Laemmli sample buffer. 
Rabbit anti-VSG antibodies were detected directly using a anti-rabbit IgG-HRP 
conjugate (Promega).
2.21 Transferrin uptake assay.
BSF parasites were harvested at mid logarithmic phase and washed twice in ice- 
cold serum-lfee HMI9. Cell density was adjusted to 1 x 10^  parasites mf^ and a 
final concentration of 50 pg ml"^  transferrin-biotin conjugate (Molecular Probes) 
added. Individual 250 pi aliquots of the cell suspension were then placed at 37°C 
for 5, 10, 15 and 60 mins before centrifugation at 1500g and washing of cell 
pellets three times in ice-cold PBS and prepared for Western blot analysis. 
Following the 60 mins incubation, one aliquot was washed three times in ice-cold
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HMI9 before incubation in HMI9 for 10 mins at 37°C. Following this, the 
parasites were centrifuged at 1500g for 5 mins at 4°C, washed three times in ice- 
cold PBS and prepared for Western blot analysis. Transferrin-biotin conjugate 
was detected using streptavidin-HRP conjugate (Sigma).
2.22 Heat shock experiments.
BSF and PCF parasites were harvested at mid logarithmic phase and re-suspended 
at 5 X 10^  or 5 X 10  ^cells mf^ in HMI9 or SDM79, respectively. PCF parasites 
were exposed to either a 37°C or 42°C heat shock for 2 hours. BSF parasites were 
exposed to a 42°C heat shock for 2 hours. Following heat shock, the parasites 
were prepared for Western blot analysis as previously described. BSF recovery 
from heat shock was examined by monitoring the growth rate of parasites over 
several days following the initial heat shock.
2.23 Salt stress experiments.
BSF parasites were harvested at mid logarithmic phase and re-suspended at 4 x 
10  ^cells ml"^  in HMI9 with the addition of 125 mM NaCl and cell numbers were 
monitored over a 5 hour period. Following this period, parasites were washed 
three times in HMI9 and resuspended to 5 x 10"^  cells ml"^  and recovery monitored 
over a period of several days.
2.24 Reactive oxygen species experiments.
BSF and PCF parasites were harvested at mid logarithmic phase and re-suspended 
at 5 X 10^  or 5 X 10  ^ cells mf^ in HMI9 and SDM79, respectively. A final 
concentration of 1 pM xanthine (Sigma) was added to the cultures together with 
the addition of a 1/1000 dilution of xanthine oxidase (Sigma). BSF and PCF 
cultures were incubated in these conditions for 2 and 4 hours, respectively, before 
washing in PBS and being prepared for Western blot analysis as previously 
described.
2.25 Concanavalin A experiments.
PCF parasites were harvested at mid logarithmic phase and re-suspended at 5 x 
10  ^ cells mf^ in SDM79. A final concentration of 50 pg mf^ Concanavalin A 
(Con A) was added and parasites incubated for 6 and 24 hour periods. After this
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period, parasites were washed in PBS and prepared for Western blot as previously 
described.
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2.26 Oligonucleotide sequences.
O Ll 5 CCGTGGGCTTGTACTCGGTCA
O L 16 ACCCGCAAGCCCGGTGCCTGA
OL536 TTGAGACAAAGGCTTGGCCAT
OL537 GGTTATGTGTGGGAGGGCTAA
OL905 AGGATCCATGGGTCGCGACACCTCTTC
OL906 GAAGCTTAGCGCCTGTAGAACCCGTACC
OL944 GCGAATTCATGGACGCAGCTCTCGCTTTGC
OL945 GCAAGCTTACATCGTACACAAGCCATGCC
OL969 AATCTAGAGCGGCCGCAAGGGGTGACGAAACAGGAGC
OL970 AATCTAGACTCATCCGCATATGTATTCG
O L 971 TTGGGCCCGTTTCTGCCCTTTGGTTCGC
OL972 AAGGGCCCCTCGAGTTATGTCCAATAGCGGTGGC
O L l 130 AAGCGGCCGCCTTGTTCTCCCTTTCGTGTGGC
O L l 133 ATGGGCCCGATATCTTTCGTCTCCTTTCCGTTGACC
OL1307 GCGAATTCATGAAAAAGCCTGAACTCACCGC
OL1308 GCGAATTCCTATTCCTTTGCCCTCGGACG
OL1309 GCGAATTCATGGGATCGGCCATTGAACAAGATGG
OL1310 GCGAATTCTCAGAAGAACTCGTCAAGAAGG
OL1373 GCGATATCATGGACGCAGCTCTCGCTTTGC
OL1374 GCGATATCTCACTTGCGGCCGGGTTTACC
O L l 029 GCATTAATGACGCAGCTCTCGCTTTGC
OL1030 GCGAATTCTCACTTGCGGCCGGGTTTACCCTG
O L l 131 AGTCTAGAGCTTCACCCTCTTTTCCCGAAC
O L l 132 ATGGGCCCATGTCTATGACCCACCCTTCCC
O L l 134 ATGGGCCCGATATCAGTCGGAAGTGGTCACATGACC
O L l 135 AAGCGGCCGCATGTTTCGTATCCGAGGGTTGG
O L l 151 GAGTGGCTTTTGGAACAAGAGC
O Ll 152 TAGCACCAACACAAAGCGATGC
OL1225 GATCCATCCAATACCCCTACGACGTCCCGGACTATGCCTAGC
OL1226 TCGAGCTAGGCATAGTCCGGGACGTCGTAGGGGTATTGGATG
SP6 ATTTAGGTGACACTATAGAATAC
T3 AATTAACCCTCACTAAAGGG
T7 GTAATACGACTCACTATAGGGC
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2.27 Buffers and solutions.
Coomassie Stain
Methanol 50% (v/v)
Acetic acid 10% (v/v)
Coomassie Brilliant Blue 0.125% (w/v)
Destain
Methanol 10% (v/v)
Acetic acid 10% (v/v)
Buffer D for protein elution
Urea 8 M
NaH2P04 0.1 M
Tris 10 mM
pH 5.9
Buffer E for protein elution
Urea 8 M
NaH2P04 0.1 M
Tris 10 mM
pH 4.5
Denhardts (50x)
Ficol 400 l%(w/v)
Polyvinylpyrrolidone (PVP) 1% (w/v)
BSA 1% (w/v)
DNA dénaturation solution
NaCl 1.5 M
NaOH 0.5 M
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DNA dénaturation solution
HCl 0.25 M
DNA loading buffer (6x)
Ficoll 15% (w/v)
Orange G 0.2 % (w/v)
Xylene cyanol 0.1 % (w/v)
DNA neutralisation solution
NaCl 3 M
Tris (pH 7.5) 1 M
Ethidium bromide
10 mg ml'^ stock solution in dHiO
Hybridisation solution
SSC 6 x
SDS 1% (w/v)
Denhardts 5 x
EDTA 5 mM
NaH2P0 4  20 mM
pH 6.5
Laemmli sample buffer (4x)
SDS 4 % (w/v)
Glycerol 10% (v/v)
2-mercaptoethanol 10 % (v/v)
Trizma base 0.125 M
Bromophenol blue to colour 
pH 6.8
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Luria-Bertani (LB) medium
g/litre
Bacto-tryptone 10
Bacto-yeast extract 5
NaCl 10
Solutes were dissolved in 950 ml deionised water and the pH adjusted to 7.0 with 
5 M NaOH. The volume was adjusted to 1 litre prior to autoclaving.
LB agar
LB medium as described above with addition of 15 g litre'^ bacto-agar 
NTE
Tris 10 mM
NaCl 100 mM
EDTA 5 mM
pH 7.5
Phosphate buffered saline (PBS)
K H 2PO 4/K 2H P O 4 (pH 7.4) 10 mM
NaCl 137 mM
Pfu DNA polymerase reaction buffer
KCl 50 mM
Tris-HCl (pH 9.0) 10 mM
Triton®X-100 0.1% (v/v)
SSC (20x)
NaCl 3 M
Trisodium citr ate 3 M
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TAE (50 x)
Tris 2 M
Sodium acetate trihydrate 2 M
EDTA 50 mM
pH7.2
TBE (0.5 x)
Tris 20 mM
Boric acid 20 mM
EDTA 0.5 mM
pH 7.2
Taq DNA polymerase reaction buffer
KCl 50 mM
Tris-HCl (pH 9.0) 10 mM
Triton®X-100 0.1% (v/v)
TDB (Trypanosome dilution buffer)
KCl 5 mM
NaCl 80 mM
MgS0 4  1 mM
Na2HP0 4  20 mM
NaH2P0 4  2 mM
Glucose 20 mM
pH 7.4
TELT
Tris 50 mM
EDTA 62.5 mM
LiCl 2.5 M
Triton X-100 4% (w/v)
pH 8.0
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Western running buffer (lOX)
Tris 250 mM
Glycine 1.92 M
SDS 87 mM
Western transfer buffer
Tris 48 mM
Glycine 39 mM
SDS 15 mM
ZPFM
NaCl 132 mM
KCl 8 mM
Na2HP04 8 mM
KH2PO4 1.5 mM
Mg acetate 0.5 mM
Ca acetate 90 pM
pH 7
ZPFMG
NaCl 132 mM
KCl 8 mM
Na2HP04 8 mM
KH2PO4 1.5 mM
Mg acetate 0.5 mM
Ca acetate 90 pM
Glucose 55 mM
pH 7
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Chapter 3 
Characterisation of metacaspases
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3.1 Analysis of metacaspase genes in T, brucei.
The identification of metacaspase genes within plants, fungi and protozoa (Uren 
et aL, 2000) allowed the discovery of several metacaspase genes within T. brucei. 
BLAST searches of the T. brucei genome database (www.genedb.org), using the 
Saccharomyces cerevisiae metacaspase sequence, identified five distinct 
metacaspase genes, all present as single copies. An independent study also 
identified these same five genes within the J! brucei genome (Szallies et ah,
2002). MCAJ (T b ll.02.0730) is located on cliromosome 11, MCA2 
(Tb06.3A7.310) and MCA3 (Tb06.3A7.290) are both located on chromosome 6, 
MCA4 (Tbl 0.70.5250) is located on chromosome 10, while MCA5 
(Tb09.211.4760) is located on cliromosome 9. A cartoon representation of the 
five predicted proteins illustrates that MCA 1-4 have a similar domain structure, 
while MCA5 is unique in that it possesses a C-terminal extension (Figure 3.1). 
Alignments of the metacaspases witli human caspase-3 identified the putative 
active site histidine and cysteine residues (Szallies et al., 2002; Mottram et al.,
2003). These active site histidine and cysteine residues are highlighted in figure 
3.1. Of note is that MCAl and MCA4 have cysteine to serine substitutions wliile 
MCAl also has a histidine to tyrosine substitution. Post-translational 
modification software - NetOGlyc, NetNGlyc, SignalP (ca.expasy.org) - predicts 
that MCAl, MCA2 and MCA3 have 1 predicted N-glycosylation site each, 
MCA4 has none while MCA5 has eight predicted sites. The software also 
predicts the presence of a signal peptide on MCA5, while the probability of the 
other metacaspases possessing one is very low. Also identified within the 
metacaspases of T. brucei are possible Class III WW binding domain motifs. 
WW binding domains act as ligands for WW domains, which are modules 
mediating protein-protein interactions in a diverse range of cellular processes 
(Sudol and Hunter, 2000). Class III WW binding domains are characterised by 
poly-proline motifs flanked by arginine or lysine residues (Macias et al., 2002), 
Motifs fulfilling these requirements were identified in the N-terminal regions of 
MCAl, MCA2 and MCA3 and the C-terminal extension of MCA5. An alignment 
of the amino acid sequences of these five proteins highlights in more detail these 
features, together with illustrating the major blocks of homology between the 
metacaspases (Figure 3.2).
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Examination of the amino acid sequence of the MCA5 C-terminal extension 
reveals that it is both proline-rich and contains repeating stretches of sequences of 
proline, glutamine, alanine and tyrosine residues. A BLAST search of this 
extension was performed in June 2004 against the T. brucei predicted peptide 
database at GeneBD (www.genedb.org) and produced two significant hits. These 
are both hypothetical proteins (Tbl 1.33.0008 and TblO.389.1920) located on 
chromosome 11 and 10, respectively. An alignment of these two hypothetical 
proteins with the MCA5 C-terminal extension shows that they share a high level 
of sequence identity over these repeating motifs (Figure 3.3). Particularly of note 
is the motif QPPxxA, which is repeated five times in all three proteins. These two 
identified hypothetical proteins are also highly similar around the region that 
aligns with the MCA5 extension.
A comparison of the active site regions of the T. brucei metacaspases with 
metacaspases from other protozoa and fungi reveals some interesting features 
(Figure 3.4). Firstly, the histidine to tyrosine substitution observed in TbMCAl is 
also present in one of the two metacaspases identified in both Plasmodium 
falciparum and P. berghei (named MCAy). Interestingly, these two metacaspases 
also have a substitution at the predicted active site cysteine residue, with a 
threonine in this position. Secondly, adjacent to the predicted active site cysteine 
in all the T. brucei, T. cruzi and L, major metacaspases is a second cysteine 
residue, which might in reality be the active site cysteine. However, in yeast and 
P. falciparum (MCAx) there is a serine residue located at this position, although 
in P. berghei (MCAx) there is a cysteine at this position and the alignment reveals 
a proline at the predicted active site position. Uniquely, the Theileria annulata 
metacaspase has no cysteine residue in either the putative or adjacent position, 
instead encoding for a serine residue at the putative active site location.
T. brucei MCA2 (Tb06.3A7.310) and MCA3 (Tb06.3A7.290) are found adjacent 
to each other, localised to chromosome 6 (Figuie 3.5A). Located 5’ of this locus 
is a putative cysteinyl-tRNA synthetase gene while 3’ there is a putative ATP- 
dependent RNA helicase gene. Alignment of predicted MCA2 and MCA3 protein 
sequences show that these two genes are also highly homologous, sharing 91% 
identity at both the DNA and protein level (Figure 3.5B). The divergence
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between the two proteins occurs almost exclusively within the N-terminal region 
of the proteins, where MCA3 also has a small extension of 10 amino acids 
relative to MCA2. Taken together, the sequential positioning and high homology 
displayed between MCA2 and MCA3 is strong evidence for a past gene 
duplication event giving rise to tlie current genomic locus.
A phylogenetic analysis of metacaspase genes from Trypanosoma brucei, T 
cruzi, Leishmania major, P. falciparum, P. berghei, Theileria annulata and yeast 
was generated using the eentral catalytic domain only using alignX (InforMax) 
(Figure 3.6). As expected T6MCA5 groups with MCA5 homologues identified in 
both L, major and Trypanosoma cruzi. This was predicted due to high sequence 
identity and synteny around the respective genomic loci of the three 
trypanosomatid species. Genomic synteny was also identified between the 
TbMCA2 and TbMCA3 locus and T. cruzi MCAx and MCAy locus (these two 
genes are also present as a tandem repeat) and the phylogenetic analysis 
confirmed their close relationship. Not surprisingly, the metacaspases in 
apicomplexa parasites form a subgroup, but which, interestingly, groups closer to 
yeast than the trypanosomatid metacaspases. The analysis also suggests that this 
grouping of apicomplexan and yeast metacaspases is most similar to the MCA5 
homologues identified in T. brucei, T  cruzi and L  major.
3.2 Analysis of MCA2 and MCA3 expression in T. brucei.
To generate specific antibodies against MCA2 and MCA3, an 80-mer peptide was 
generated that encompassed both the histidine and cysteine catalytic residues of 
MCA2 (N. Fasel, University of Lausanne, Switzerland). MCA2 is virtually 
identical to MCA3 over this region with only one alanine to valine substitution 
(Figure 3.5B). This peptide was then used to immunise a rabbit at Diagnostics 
Scotland and affinity purification of the antiserum performed using an affinity 
matrix generated with the 80-mer peptide used in the immunisation.
Western blot analysis was then used to determine the expression profile of MCA2 
and MCA3 in both procyclic (PCF) and bloodstream (BSF) life stages in vitro. 
Analysis of whole cell lysates was able to detect several proteins recognised by 
the affinity purified antibody (Figure 3.7). One protein, estimated to be 48 kDa,
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and a less abundant protein estimated, at aiound 35 kDa, were detected in both the 
PCF and BSF parasite cell extracts. However, unique to the BSF cell lysates were 
two further proteins detected at around the predicted sizes of MCA2 and MCA3 
(of 38 and 39 kDa, respectively). The confirmation of the identity of these 
proteins as MCA2 and MCA3 was performed by both RNAi and gene knockouts 
(Chapters 4 and 5). While these two proteins closely match the predicted sizes of 
MCA2 and MCA3, there appears to be a difference in size greater than 1 kDa. 
The detection of MCA2 and MCA3 at around their predicted full-length sizes 
suggested, however, that these two proteins do not undergo any large scale 
processing events. The identities of the 35 and 48 kDa proteins are unknown but 
the masses do not correspond to the predicted sizes of any other identified 
metacaspases within T. brucei.
While the anti-peptide antibodies were sufficient for the identification of MCA2 
and MCA3 by Western blot analysis, they were not suitable for use in 
immunofluorescence studies, as they also detected the proteins of 48 and 35 kDa, 
as discussed above. Therefore, it was decided to generate HA epitope tagged 
versions of MCA2 and MCA3 to allow the specific detection of the proteins. The 
HA tag is derived from an epitope of the influenza hemagglutinin protein, wliich 
has been used successfully to epitope-tag proteins in T. brucei (McManus et al., 
2001; Wang et al., 2003). The sequence for an HA tag was cloned, in frame, onto 
the 3’ terminal end of both MCA2 and MCA3. These tagged genes were then 
sub-cloned into a trypanosome expression vector designed to integrate and drive 
expression from the ap  tubulin array (Figure 3.8A), which was kindly provided 
by R. McCulloch, University of Glasgow. These two separate constructs were 
subsequently transfected into wild type BSF parasites and clonal populations 
obtained, using the BLE gene as the resistance marker.
Western blot analysis of whole cell lysates was then used to determine if 
expression of MCA2HA and MCA3HA was successful. Probing with a mouse 
monoclonal anti-HA antibody detected one major protein in both MCA2HA and 
MCA3HA transfectants (Figure 3.8B). The addition of an HA-tag adds 
approximately 1 kDa to the mass of subjeet protein. Therefore, the predicted
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sizes of MCA2HA and MCA3HA are 39 and 40 kDa, respectively, closely 
matching the Western blot results. This demonstrated that expression of MCA2 
and MCA3 with the addition of an HA tag was successful and that it was possible 
to detect specifically these proteins individually in BSF parasites.
3.3 Cellular localisation of T. brucei metacaspases.
The specific detection of MCA2HA and MCA3HA enabled the study of the 
cellular localisation of MCA2HA and MCA3FIA using immunofluorescence 
analysis (IFA). BSF parasites expressing either MCA2HA or MCA3HA were 
prepared for analysis and stained with mouse anti-HA monoclonal antibodies 
(Figure 3.9). The IF A images revealed that both MCA2HA and MCA3HA 
localised within several punctate regions, located exclusively between die nucleus 
and kinetoplast. This labelling suggests that MCA2HA and MCA3HA are 
associated with an organellar structure, present between the nucleus and 
kinetoplast and that the proteins are not located in the cytosol.
It was planned to produce recombinant MCA5 for both antibody production and 
for biochemical studies. Full-length MCA5 was cloned into the pET-28(a)+ 
expression vector and used to transfect BL21 E. coli; this vector is designed for 
expression of subject protein with the addition of a polyhistidine tag at the N- 
terminus. Induction of expression at 37°C with 1 mM IPTG resulted in a very 
good expression level of His tagged protein, however, unfortunately these 
conditions resulted in 100% insoluble material. All subsequent attempts at 
producing soluble enzyme by altering both the IPTG concentration and/or 
induction temperature were unsuccessful; the protein being always found 
exclusively in the pellet fraction. Further avenues were also pursued in an effort 
to produce soluble protein. The polyhistidine tag was moved to the C-terminus, 
with no success in terms of solubility, while various truncated forms of MCA5- 
His were also expressed, but again only insoluble material was produced.
Despite this failure to produce soluble protein, the insoluble protein was still 
suitable for antibody production. The full-length MCA5 recombinant protein 
with a N-terminal histidine tag, of predicted size 58 kDa, was used for this
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purpose. A 500 ml culture of MCA5-His expressing BL21 E. coli was grown and 
expression induced with 1 mM IPTG at 37°C, as these conditions had been 
observed to produce the highest levels of recombinant protein. At 4-hours post 
induction, the bacteria were harvested, inclusion bodies extracted and extensively 
washed to remove contaminants. These inclusion bodies were then solubilised in 
8 M Urea at 4°C overnight. To purify MCA5-His from native inclusion body 
proteins, the material was passed through a nickel-agarose column. After 
washing, elution from the column was performed via a drop in pH to break the 
physical bond between nickel-agarose and the polyhistidine tag. Two separate pH 
values where used in the elution, pH 6.3 and pH 4.5, and fractions collected. A 
coomassie stain of SDS PAGE gels of these elution fractions shows that the 
majority of MCA5-His was eluted in the pH 4.5 fraction (Figure 3.10)
It was clear, however, that there were still several non-desirable contaminating 
proteins within the purified material. Therefore, a volume of eluted protein, 
containing approximately 800 pg of recombinant protein, was electrophoresed via 
SDS-PAGE and the MCA5-His protein excised. This material was subsequently 
ground into a paste and resuspended in PBS. This suspension was then sent for 
antibody production in sheep at Diagnostics Scotland.
Western blot analysis was performed to determine the expression profile of 
MCA5 in both PCF (strain EATRO 795) and BSF (strain 427) life stages in vitro. 
Analysis of whole cell lysates revealed that the antiserum recognised a single 60 
kDa protein, present in both PCF and BSF extracts (Figme 3.11). The predicted 
size of MCA5 is 55 kDa. The specificity of this antiserum was confirmed by both 
RNAi and gene knockout (Chapters 4 and 5). This constitutive expression of 
MCA5 in both life stages is distinct to that observed for MCA2 and MCA3, which 
appear to be BSF-specific. MCA5 was detected at approximately its predicted 
size, so no large-scale processing events were evident, as had been observed also 
for MCA2 and MCA3.
The high specificity of the sheep polyclonal anti-MCA5 antiserum enabled its use 
directly in immunofluorescence studies, with no firrther purification being
57
necessary. Botii wild type PCF (strain EATRO 795) and BSF (strain 427) were 
prepared for IF A and stained with the sheep polyclonal anti-MCA5 antiserum 
(Figure 3.12). MCA5 displayed a punctate distribution localised primarily 
between the nucleus and kinetoplast in both PCF and BSF parasites, consistent 
with an organellar location. The pattern of staining was similar to that observed 
with MCA2HA and MCA3HA. Interestingly, while total protein levels were very 
similar in both life stages when examined by Western blot (Figure 3.11), this 
compartment was stained much less extensively in the PCF compared to BSF 
parasites.
The localisation studies previously described for MCA2HA, MCA3HA and 
MCA5 all pointed to their association with an organellar structure situated 
between the nucleus and kinetoplast. However, the individual experiments did 
not reveal whether these individual metacaspases are localised to separate 
compartments or are present within the same structures. Therefore double­
labelling experiments with MCA2HA or MCA3HA and MCA5 were performed 
to determine if the metacaspases are co-localised. BSF parasites expressing 
MCA2HA or MCA3HA were prepared for IF A and probed with mouse 
monoclonal anti-HA antibodies and sheep polyclonal anti-MCA5 antiserum 
(Figure 3.13). A very liigh level of co-localisation was observed for both 
MCA2HA and MCA3HA with MCA5. Assuming that the HA-tagged MCA2 and 
MCA3 are targeted to the same compartment as the native proteins, this result 
demonstrates that MCA5 is associated with the same structures as MCA2 and 
MCA3 in BSF parasites.
3.4 Identification of metacaspase positive compartment.
While the IF A studies showed that the metacaspases are associated with an 
organellar compartment localised between the nucleus and kinetoplast, it does not 
provide any real insights into the possible functions or roles of the proteins. 
Therefore the organellar compartment in which the metacaspases are localised 
was investigated by utilising various commercially available markers. Between 
the nucleus and kinetoplast in T. brucei there ai'e several well-characterised 
organellar structures for which fluorescent markers are available. For initial 
studies the endosomal system and the Golgi apparatus were examined.
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3.4.1 Early endosomes.
The early endosomes of T. brucei can be labelled for detection by IF A using a 
tomato lectin fluorophore conjugate (Nolan et aL  ^ 1999; Jeffries et aL, 2001). 
This lectin binds selectively to poly-N-acetyllactosamine (pNAL) residues present 
on proteins located in early endosomal membranes. BSF parasites were incubated 
with this lectin for 1 horn at to allow up-take and association with early 
endosomal membranes. Parasites were then prepared for IF A and stained with 
sheep polyclonal anti~MCA5 antiserum (Figure 3.14A). Examination of the 
merged image of tomato lectin and anti-MCA5 labelling clearly shows that there 
is no co-localisation between these two compartments, ruling out metacaspase 
association with the tomato lectin-labelled component of the early endosomal 
system in T. brucei.
3.4.2 Lysosomes.
To label the lysosomal compartment of T. brucei we utilised the commercially 
available probe Lysotracker. This molecule, upon uptake, is targeted to the 
lysosomal compartment where the reduction in pH results in a large increase in 
fluorescence, thus allowing the specific detection of this compartment (Magez et 
aL, 1997). BSF parasites were incubated with Lysotracker for 1 hour at 37°C to 
allow sufficient material to accumulate in the lysosome. Parasites were 
subsequently prepared for IF A and stained with sheep polyclonal anti-MCA5 
antiserum (Figure 3.14B). Analysis of the merged image of lysosomal and anti- 
MCA5 labelling clearly shows that there is no co-localisation between these two 
compartments, thus ruling out metacaspase association with the lysosome in T. 
brucei.
3.4.3 Golgi apparatus.
Having ruled out metacaspase association with both the early endosomes and the 
lysosome, it was investigated whether the metacaspases are associated with the 
Golgi apparatus. To label this compartment we utilised the probe BODIPY- 
Ceramide, a reliable marker of the mammalian Golgi apparatus and also shown to 
specifically label the Golgi apparatus in T. brucei (Field et al., 2000). Wild type
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BSF parasites were incubated with the BODIPY-Ceramide dye for 1 hour at 37°C 
to allow accumulation within the Golgi apparatus. Parasites were then prepared 
for IFA and stained with sheep polyclonal anti-MCA5 antiserum (Figure 3.14C). 
There was no co-localisation between the BODIPY-Ceramide and MCA5, 
suggesting that the Golgi is not the location of the metacaspases.
3.4.4 Recycling endosomes.
Having ruled out metacaspase association with early endosomes, the lysosomal 
compartment and Golgi apparatus, an analysis of recycling endosomes was 
carried out with an antibody specific to recycling endosomes in T, brucei. This 
antibody was raised against TèRabll, a small GTPase known to localise to 
recycling endosomal membranes in T. brucei (Jeffries et a l, 2001). To determine 
if the metacaspases localised to this compartment of the endosomal system, PCF 
and BSF wild type parasites were prepared for IFA. These were then labelled 
with immunopurified polyclonal rabbit anti-TôRabll antibodies and sheep 
polyclonal anti-MCA5 antiserum (Figure 3.15). MCA5 labelling was consistent 
with previous observations (Figure 3.12) and Rabll labelling gave a very similar 
pattern to that seen with MCA5, in that many more structures were labelled in the 
BSF compared to PCF parasites. Furthermore, upon the merging of MCA5 and 
R abll labelling, a very high level of co-localisation in both PCF and BSF 
parasites was revealed. This evidence is highly suggestive that the metacaspases 
are associated with the recycling compartment in T. brucei. Interestingly, Rabll 
is the only characterised Rab family member that displays a stage-regulated 
expression in T. brucei, exhibiting a much higher expression level in the BSF 
(Jeffries et a l, 2001). This observation was confirmed by performing Western 
blot analysis on total cell extracts prepared from the PCF and BSF parasite 
cultures used in the IFA analysis. Rabll expression in the BSF was greatly 
increased relative to the PCF (Figure 3.16).
3.4.5 MCA5 positive structures traffic recycled material.
Although immunofluorescence analysis suggested that the metacaspases are 
associated with recycling endosomes in T. brucei, we wanted to confirm this by 
determining if MCA5 positive structures were also trafficking recycled material.
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To investigate this, we utilised the anti-VSG antibody recycling pathway for 
which Rabll positive endosoine involvement has been documented (Pal et al., 
2003). It is known that, in vivo, host anti-VSG antibodies bound to the parasite’s 
surface are rapidly internalised as part of the normal VSG recycling process 
(Russo et ah, 1993). Initially these antibodies enter Rab5 positive early 
endosomes (Pal et a l, 2003), prior to their secretion via Rabl 1 positive recycling 
endosomes (Jeffries et a l, 2001).
Therefore a co-localisation of internalised anti-VSG antibodies with MCA5 
would further confirm metacaspase association with recycling endosomes. Wild 
type BSF parasites were labelled with rabbit polyclonal anti-VSG antibodies at 
4°C prior to a 30 mins incubation at 37°C. Parasites were then prepared for IFA 
and stained with sheep polyclonal anti-MCA5 antiserum. Internalised rabbit anti- 
VSG antibodies were detected using an anti-rabbit TRITC conjugate, while anti- 
MCA5 labelling was detected using an anti-sheep FITC conjugate (Figure 3.17). 
Internalised anti-VSG antibodies were located between the nucleus and 
kinetoplast, consistent with uptake by the endosomal system. No surface 
labelling remained, suggesting that the majority was internalised over this 30 min 
period. A merged image of internalised anti-VSG antibodies and MCA5 
labelling, however, showed only a partial co-localisation between anti-VSG and 
MCA5 signals. This is not unexpected, and could be due to the dynamics of the 
endosomal system. It is feasible to suggest that some of the labelled anti-VSG 
antibody would be associated with eai’ly endosomes and therefore would not be 
detected when staining with MCA5. Conversely, not all recycling endosomes 
would be trafficking these internalised antibodies, especially after a 30 min chase 
when, as suggested by the lack of surface labelling, the recycling process was 
almost complete. Therefore, this partial co-localisation of MCA5 with material 
known to be recycled, taken together with the identification of MCA5 association 
with Rabll positive endosomes, is further evidence of metacaspase association 
with recycling endosomes in T. brucei.
61
3.5 Attempts to activate processing of metacaspases.
It is known that caspases require processing prior to their becoming active and it 
has also been reported that the yeast metacaspase may undergo possible caspase- 
like processing (Madeo et a l, 2002). From the Western blot analysis (Figures 3.7 
and 3.11) it appears that the T. brucei metacaspases do not undergo any such 
processing events in parasites grown under normal in vitro conditions. It is 
possible, however, that the metacaspases require a stimulus, such as a stressful 
event, to trigger their processing and activation. In an attempt to investigate this 
hypothesis, we exposed both PCF and BSF parasites to a variety of stressful 
conditions - ones documented to induce apoptotic-like cell death in protozoa 
(Moreira et aL, 1996; Welbum et ah, 1999; Ridgley et aL, 1999). Heat shock was 
performed on PCF parasites by incubating at either 37°C or 42°C for 2 hours, 
while BSF parasites were incubated at 42®C for 2 hours. PCF and BSF parasites 
were also exposed to reactive oxygen species. These were generated by the 
addition of both xanthine and xanthine oxidase to the culture medium. 
Additionally PCF parasites were also treated with the lectin Concanavalin A and 
incubated for 6 and 24 hours. Following these stimuli, whole cell lysates were 
prepared and analysed by Western blot to determine if any processing of the 
metacaspases was evident. No processing events were detected, the sizes of 
MCA2, MCA3 and MCA5 were unchanged in all lysates analysed (not shown).
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3.6 Discussion.
3.6.1 Characterisation of metacaspases
We have been able to identify five distinct metacaspase genes (TbMCAl- 
TbMCAS) within the T. brucei genome. Analysis of the predicted proteins 
revealed that MCAl, MCA2, MCA3 and MCA4 are all roughly equivalent in 
size, ranging between 38 and 40 kDa. MCA2 and MG A3 share a very high level 
of sequence identity, 91% at the protein level, and their sequential positioning on 
chromosome 6 is consistent with a gene duplication event. The region of 
divergence between these two proteins is located at the N-terminal domain, where 
MCA3 has a 10 amino acid extension. This is suggestive that the N-terminal 
region may be important for some differential function or targeting of the two 
proteins, although neither MCA2 nor MCA3 are predicted to posses signal 
peptides. The maintenance of almost 100% sequence identity over the remainder 
of the two proteins, however, allows us to speculate that they will have very 
similar, if not identical, substrate recognition. It is possible, however, that this 
divergence at the N-terminus affects neither the localisation nor activity of the 
peptidases and is not important to their function. In fact, the syntenic T. cruzi 
MCA2 and MCA3 homologues, MCAx and MCAy, are of equal size with no N- 
terminal extension on either.
The identification of five metacaspase genes in T. brucei is of interest as this is 
the largest known repertoire of metacaspase genes of any protozoon. Searches of 
genome databases for other protozoa identified MCA2, MCA3 and MCA5 
homologues witliin T. cruzi, while L. major possesses a sole MCA5 homologue. 
These homologous genes also display strong genomic synteny between these 
three trypanosomatids.
MCA5 is different from the four other metacaspases from T, brucei in that it 
possesses a large C-terminal extension of roughly 15 kDa. This extension is 
proline-rich and contains stretches of repeating sequence. Protein BLAST 
searches of this region against the T. brucei database identified two proteins that 
displayed strong similarity with the aforementioned repeating sequences, 
however, no functions have been assigned to these hypothetical proteins. If the
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functions of these proteins were known this may help to understand the role of 
this C-terminal extension of MCA5. The fact the repeating motif QPPxxA was 
identified in the MCA5 C-teiminal extension and two further hypothetical T. 
brucei proteins, which, apart this modular homology, do not have any identity to 
the metacaspases, leads us to believe that this repeating module may fulfil some 
form of specialised role within the parasites. MCA5 also possesses a predicted N- 
terminal signal sequence, but there is no experimental evidence to confirm 
whether this is a true targeting signal.
Of the metacaspase genes examined experimentally in T. brucei, we have shown 
that MCA2 and MCA3 expression is stage-regulated while MCA5 is 
constitutively expressed in vitro. MCA2 and MCA3 were detected on SDS- 
PAGE gels by Western blotting at around their predicted sizes of 38 and 39 kDa, 
respectively, demonstrating that neither protein undergoes any large-scale 
processing events in vitro. However, there does appeal' to be a greater separation 
than 1 kDa between the two proteins as assessed by SDS-PAGE and this might 
suggest some differential post-translational modifications. MCA2 and MG A3 
both have a single predicted N-glycosylation site and neither are predicted to 
possess a signal peptide. MGA5 was detected at around 60 kDa, which is 
significantly larger that its predicted size of 55 kDa. This increase in size may be 
the result of post-translational modifications, MGA5 being predicted to contain 8 
possible N-glycosylation sites. Many cysteine peptidases are processed upon 
maturation, with cleavage of the N-terminal most common. The papain family of 
cysteine peptidases, for example, undergoes cleavage of N-terminal polypeptide 
extensions of vaiious lengths which act as potent inhibitors toward the cognate 
enzyme (Fox et al., 1992). Gaspase maturation also involves proteolytic removal 
of a pro-domain together with cleavage into two subunits; these subunits 
subsequently dimerise to form the active enzyme (Rotonda et al., 1996).
If such a process were occurring to the metacaspases of T. brucei, we would not 
expect them to migrate so closely to their predicted molecular weights. We 
cannot rule out, however, that the metacaspases are capable of being processed 
under certain conditions, and that normal in vitro culture conditions do not 
stimulate their activation. Our attempts to induce processing were based on the
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hypothesis that the metacaspases may be involved in the apoptotic-like cell death 
that has been reported in trypanosomes and that they remain inactive until a 
specific stimulus provokes their activation. While the stimuli used did not induce 
any possessing, it is possible that certain stimuli may do so. The trigger for 
processing of the metacaspases may only be present under certain in vivo 
conditions, for example. Future analysis of extracts made from parasites isolated 
from either the mammalian host or insect vector may be able to address this 
possibility. Alternatively the metacaspases may bear no similarity, with regard to 
processing, to the caspases, being active as full-length proteins and requiring no 
processing to become active. Numerous unsuccessful attempts have been made to 
produce soluble recombinant metacaspase enzyme for use in biochemical studies 
to address this question (S.J Sanderson, unpublished). Future work, however, 
may reveal whether the T. brucei metacaspases are active as full-length proteins 
or require processing to become active.
The expression of MCA5 is distinct from that of MCA2 and MCA3 in that this 
protein was detected at approximately equivalent levels in both PCF and BSF 
parasites. Therefore MCA5 is constitutively expressed in T. brucei, wliile MCA2 
and MCA3 are only present in the BSF life stage. This suggests that MCA2 and 
MCA3 fulfil a specialised role in the BSF, wliile the function of MCA5 might be 
more basal. Interestingly, the only metacaspase gene identified to date in the L. 
major sequencing projects has been an MCA5 homologue and despite almost 
completion of the database, homologues of MCA 1-4 have not been identified. 
However, three metacaspase genes have been identified in the T, cruzi sequencing 
database (www.genedb.org). This organism possesses homologues of MCA2, 
MCA3 and MCA5. MCAl and MCA4 homologues have not been identified. 
These observations further support the idea that MCA5 is the basal metacaspase in 
all trypanosomatids and that the requirement for further metacaspase genes may 
be specific to trypanosomes.
This hypothesis can be extended further than the trypanosomatids to encompass 
other protozoa and yeast. Examination of the Apicomplexa genome databases 
(www.genedb.org) reveals that two metacaspase genes are present in several 
Plasmodium species, while Theileria annulata appears to have a single
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metacaspase. Within the genomes of both Saccharomyces cerevisiae and 
Schizosaccharomyces pombe there is also a single metacaspase gene, which is 
minored in the filamentous fungus Aspergillus nidulans. An alignment and 
compilation of a phylogenetic tree of all identified metacaspases from protozoa 
and yeast supports the idea that MCA5 represents the basal metacaspase gene. 
T6MCA5 is grouped along with the homologues from T. cruzi and L. major as 
expected. The metacaspases from Plasmodium, Theileria and Yeast are all more 
divergent, highlighted by their separation fiom the kinetoplastid metacaspases. 
However, these sequences share more in common with the MCA5 homologues 
than with any of the other metacaspases found in the trypanosomatids.
Analysis of the metacaspase protein sequences also led to the identification of 
predicted Class III WW binding domain motifs. There are four classes of these 
binding motifs; Class I is represented by the minimal core consensus Pro-Pro-X- 
Tyr, Class II by Pro-Pro-Leu-Pro, Class III by polyproline stretches flanked by 
either an Arg or Lys residue and Class IV by phosphor-Ser/Thr-Pro (Sudol and 
Hunter, 2000). These binding domains act as ligands for WW domains. The 
initials WW derives from the presence of two signature tryptophan residues that 
are spaced 20-23 amino acids apai1, there is also a conserved proline residue 
(Bork and Sudol, 1994; Andre and Springael, 1994). These WW domains fold as 
stable, triple stranded &-sheets (Macias et aL, 1996) that bind to proteins with 
WW binding domains which are rich in proline. They act as modules mediating 
protein-protein interactions in a diverse range of cellular processes (Sudol et aL, 
2001; Ingham et aL, 2004). There is only one published example of a protein 
with a WW domain in T. brucei', T6ZFP2 was shown to possess the characteristic 
dual tryptophan residues and conserved proline. The protein with which ZFP2 
interacts, with via this domain, has not been identified (Hendriks et aL, 2001). 
However, there are seven proteins within T. brucei that are predicted to possess 
WW domains (www.genedb.org). Six of these are hypothetical proteins, while 
one has been annotated as a putative myosin IB heavy chain. The absence of 
ZFP2 from this list highlights that the prediction software is unable to detect all of 
the WW domains present within T brucei and suggests that more proteins 
containing WW domains may be present.
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We have identified possible WW binding motifs in the N-terminal region of 
MCAl, MCA2 and MCA3 while in MCA5 a similar motif is located within the 
C-terminal extension (Figme 3.2). The minimum number of proline residues 
flanked by an arginine or lysine residues required to fulfil a Class III binding site 
is two. MCA2 possesses three prolines flanked by an arginine residue, while 
MCA3 possesses four prolines flanked by a lysine residue. Interestingly, MCAl 
possesses the bare minimum requirement of two prolines and is flanked by both a 
lysine and arginine residue, while MCA4 does not meet the requirement, with 
only one proline residue. At the relative N-terminal position of MCA5, there is 
also only one proline residue, however, located at the distal end of the C-terminal 
extension there are five prolines flanked by a lysine residue. We can speculate 
from this that MCAl, MCA2 and MCA3 may have functional WW binding 
domains, while MCA4 has lost the WW domain binding activity. MCA5 
meanwhile, has a predicted functional WW binding site within its unique C- 
terminal extension and therefore appear to have either lost, or not acquired, a 
binding site at its N-terminal region. The presence of these WW binding motifs 
suggests the metacaspases interact with other WW domain containing proteins as 
part of their normal function. The identification of numerous proteins possessing 
WW domains in the T. brucei database allows for this possibility and future 
experiments may be able to identify these partners.
Interestingly, recent two-hybrid screens have revealed tliat tlie yeast metacaspase 
(Mcalp, YOR197p) interacts with several proteins and among them Wwmlp 
(YFLOlOp) (Uetz et aL, 2000; Ito et aL, 2001). Additionally, the toxic effect of 
overexpression of Wwmlp in yeast was suppressed by the simultaneous 
overexpression of the yeast metacaspase (Szallies et aL, 2002). Wwmlp was 
characterised as a potential hydrophilin, which have been implicated in osmotic 
stress responses (Garay-Arroyo et aL, 2004). Wwmlp possesses an N-terminal 
WW domain and intriguingly shares some level of sequence identity to the 
77)MCA5 C-terminal extension. The relevance of these observations to the 
situation in trypanosomes is unclear'. The observations do suggest, however, 
some level of commonality between the metacaspase functions fi*om protozoa to 
yeast.
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It has been reported that yeast metacaspase showed proteolytic activity towards 
the mammalian caspase substrates VEID-AMC and lETD-AMC. This activity 
was completely abrogated by the addition of z-VAD-FMK, a broad-range caspase 
inhibitor (Madeo et al., 2002). Additionally, the mutation of the putative active 
site cysteine residue to alanine was shown to reduce this caspase-like activity 
(Madeo et a l, 2002). Also in yeast, where the ectopic expression of T6MCA4 
was reported to cause a loss of respiratory competence, the mutation of either of 
the putative active residues independently to alanine resulted in loss of this 
phenotype (Szallies et a l, 2002). These observations suggest that the 
metacaspases do possess peptidase activity and that the conserved histidine and 
cysteine residues function as the catalytic dyad. Examination of these putative 
active site residues within T6MCA1 and T6MCA4 initially suggested that they 
might not possess cysteine peptidase activity. Alignment of the T. brucei 
metacaspases with human caspase-3 and metacaspases from yeast and 
Plasmodium falciparum revealed that both TèMCAl and T6MCA4 have a serine 
substitution at the putative active site cysteine residue (Mottram et a l, 2003). 
Additionally, T6MCA1 also has a tyrosine substitution at the putative active site 
histidine position. However, positioned immediately adjacent to this serine 
substitution in both TèMCAl and T&MCA4 is located another cysteine residue. 
This second cysteine residue is conserved in all trypanosome and Leishmania 
metacaspases; however a serine is located at this position in yeast and 
Plasmodium falciparum. This raises two possibilities for T6MCA4 if it retains 
peptidase activity as reported (Szallies et al., 2002); firstly, that either of the 
adjacent positions can function as the active site cysteine, or, secondly, that it is 
an example of a mixed type peptidase. There is a precedent for this, Serine repeat 
antigen 5 (SERA5) from P. falciparum possess a central domain with a high level 
of sequence identity to papain and appears to be a Clan CA, family Cl cysteine 
peptidase. However, the protein has a serine residue at the position of the active 
site cysteine and it has been reported that this enzyme domain retains catalytic 
activity (Hodder et al., 2003).
While it is possible that T6MCA4 is an active peptidase, it is highly unlikely that 
T6MCA1, which also has the putative active site histidine replaced by a tyrosine 
residue, will be an active peptidase. The histidine residue is essential due to its
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imidazolimn group, required for stabilisation of the thiolate ion involved in the 
nucleophilic attack of the peptide bond. Tyrosine lacks this imidazole group and 
therefore it is predicted that T6MCA1 cannot possess peptidase activity.
This raises the possibility that either T6MCA1 and/or 77)MCA4 are examples of 
“dead” peptidases. Sequence identity between TbMCAl, T6MCA4 and the other 
T. brucei metacaspases remains high, especially aiound the active sites. This 
suggests that, although they may no longer possess peptidase activity, their 
function may still be reliant on substrate binding. A catalytically inactive 
structural homologue of caspase-8, termed I-FLICE, has been shown to inhibit 
both TNFRl and CD95 induced apoptosis in mammalian cells (Hu et aL, 1997). 
The conserved catalytic cysteine residue is absent from I-FLICE and there is a 
lack of conservation at key residues involved in substrate binding, however I- 
FLICE was able to form complexes with caspase-8. It was reasoned that I- 
FLICE, a naturally occurring inactive caspase, acts as a dominant negative 
inhibitor of apoptosis. Whether the “dead” metacaspases MCAl or MCA4 act in 
a similar was is unknown. No information is available concerning the expression 
profile of either gene, and there remains the possibility that they are simply 
pseudogenes.
Interestingly, a histidine to tyrosine substitution is not unique to 7%MCAI. P. 
falciparum contains two metacaspases genes, one encodes for a protein with the 
putative histidine and cysteine residues, while the other encodes for a protein with 
tyrosine and threonine at these respective positions. As was the case with 
77>MCAI, it is extremely unlikely that this P. falciparum metacaspase will 
possess peptidase activity. However, the presence of a tyrosine residue in both P. 
falciparum and T. brucei “dead” metacaspases may signify that this residue has a 
specialised role. For two divergent protozoa to both select the same residue at 
this equivalent position, and to then maintain it is unlikely by chance. It is also 
suggestive that both the tyrosine residue at this position and these “dead” 
peptidase themselves have an important role to play in die parasites. More 
generally, from the data currently available in genome sequencing projects, we 
can predict the possibility of “dead” metacaspases in T. brucei, Plasmodium, and 
Theileria annulata but not in yeast, Trypanosoma cruzi or Leishmania.
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3.6.2 Metacaspase localisation.
The apparent organellar localisation of the metacaspases was initially sniprising, 
based on what is known about caspases. Caspases are located free within the 
cytoplasm and are not associated with any known organellar structures (Miossec 
et aL, 1996). This initial observation of the metacaspases highlighted a major 
difference in the location of these proteins relative to the caspases, and suggested 
that they do not fulfil homologous roles. Tlie only other analysis of metacaspase 
localisation has been performed in yeast. In Saccharomyces cerevisiae a global 
analysis of protein localisation, using GFP as a label, localised the single yeast 
metacaspase to both the nucleus and cytoplasm (Huh et aL, 2003), while the 
ectopic expression of a T6MCA4-GFP fusion in yeast also revealed apparent 
nuclear localisation (Szallies et aL, 2002). These observations are different from 
what we have observed and it would be interesting to compare the localisation of 
metacaspases from T. brucei with other protozoa and plants.
The findings that MCA2, MCA3 and MCA5 all occupy an organellar location 
raised the question of whether these three proteins aie foimd in distinct 
compartments or are located together within the same compartment. As the 
MCA2/3 antibody detected several other proteins, this question was addressed 
using epitope-tagged versions of MCA2 and MCA3. These co-localisation 
studies revealed that MCA2, MCA3 and MCA5 are all located within the same 
structures in BSF parasites. The use of epitope-tagged versions of MCA2 and 
MCA3, however, raises the possibility of the incorrect targeting of these proteins. 
It is known that the addition of epitope tags can interfere with the cellular 
targeting machinery or affect protein-protein interactions, resulting in the 
incorrect localisation of tagged proteins. The co-localisation of MCA2HA and 
MCA3HA with MCA5 in BSF parasites provides good evidence that the HA tag 
does not alter the normal targeting of the metacaspases. It is extremely unlikely 
that the addition of an epitope tag would result in the targeting of MCA2HA and 
MCA3HA to the same compartment in which native MCA5 is localised.
One intriguing feature was turned up by our IFA comparison of the distribution of 
MCA5 in PCF and BSF parasites. Although Western blot analysis had revealed 
that MCA5 was expressed at equivalent levels in both PCF and BSF life stages
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this was not directly mirrored when we performed IFA on the parasites. MCA5 
labelling was shown to be much more extensive in the BSF as compared to the 
PCF. This suggests that the metacaspase positive compartment may be more 
active in the BSF.
An organellar system that is more active in BSF compared to PCF is the 
endosomal system. The main reason for this increased endosomal activity is 
primarily for the rapid recycling of the VSG surface coat. Recent studies showed 
that the parasites are able to endocytose an area equivalent to the whole plasma 
membrane within 12 minutes (Engstler et aL, 2004). Indeed, the BSF has one of 
the fastest rates of membrane turnover recorded. This contrasts with the PCF, 
where the rate of endocytosis is substantially lower (Liu et aL, 2000).
Therefore, with our hypothesis in mind regarding greater metacaspase 
requirement in the BSF and the location of the metacaspases within an organellar 
structure, we investigated various components of this system. However, initial 
attempts proved unsuccessful with regard to identification of the metacaspase 
compartment. Several compartments were ruled out; the data showing that the 
metacaspases were not associated with the early endosomal, the lysosomal (also 
termed late endosomes), or the Golgi compartments.
Another component of the endosomal system known to be highly active in the 
BSF is the recycling system (Engstler et a l, 2004). BSF parasites, which are 
exposed to the immune system within the mammalian host, use antigenic 
variation as the primary defence mechanism to evade attack. To ensure that host 
anti-VSG antibodies do not reach levels sufficient to clear the infection, the 
parasites periodically express distinct VSG isoforms during the course of 
infection (Pays et aL, 1994). However, host antibodies may be generated faster 
than the switching of VSG and it is believed that the rapid trafficking and 
recycling of VSG is also likely to be an important defence against the immune 
system (O'Beime et aL, 1998). The processes of exo- and endocytosis are highly 
polarised in trypanosomatids, and are limited to the flagellar pocket from where 
endocytosis of VSG occurs constitutively in T. brucei (Russo et a l, 1993). VSG 
is a very stable molecule and therefore the majority of the internalised VSG is
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recycled back to the surface (Seyfang et aL, 1990), while in contrast, the anti- 
VSG antibodies are extensively degraded. The addition of anti-VSG antibodies in 
vitro results in their rapid internalisation, degradation and recycling (O'Beirne et 
aL, 1998).
This recycling of VSG and anti-VSG antibodies has been shown to be mediated 
via two distinct compartments; internalisation occurring via Rab5 positive early 
endosomes and the recycling via Rabll positive recycling endosomes (Pal et a l,
2003). Rab proteins, a subgroup of the Ras superfamily of small GTPases, 
localise to the external membrane of specific compartments and are involved in 
the regulation of vesicle trafficking (Nuoffer and Balch, 1994). They are believed 
to be essential for correct vesicular trafficking and different members localise to 
specific membrane structures (Novick and Brennwald, 1993). For example, Rab5 
is found uniquely on early endosomal membranes (Bucci et aL, 1992), while 
Rabll has been shown to associated with recycling endosomes (Ullrich et aL, 
1996) in mammalian cells. T. brucei Rabll has also been characterised and 
shown to be associated with recycling endosomes, trafficking both VSG and the 
transferrin receptor in the BSF (Jeffries et a l, 2001).
The lack of co-localisation of MCA5 with tomato lectin had previously excluded 
the possibility of metacaspase association with early endosomes. Using an 
antibody raised against TèRabll, however, it was demonstrated that MCA5, and 
by inference MCA2 and MCA3, co-localise with R abll in both life stages. 
Rabl 1 is the only known Rab protein shown to be under life stage regulation in T. 
brucei, the expression levels of Rabl 1 being notably higher in the BSF compared 
to the PCF (Jeffries et a l, 2001). This was also confirmed in om studies. This 
differential expression is thought to be due, partially at least, to the increased 
requirement of recycling processes in the BSF as previously discussed. Recycling 
in PCF parasites is not well characterised, this life stage expresses neither VSG 
nor the transferrin receptor, and no surface molecules that are actively recycled 
have been identified (Borst and Fairlamb, 1998). It has been suggested, therefore, 
that the TèRabll compartment represents a developmentally regulated organelle 
dedicated principally to BSF recycling processes, and contributes to the survival 
of r. brucei within the mammalian host (Jeffries et a l, 2001).
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Our own analysis of R abll labelling by IFA confirms the study of Jeffries et al. 
(2001) that BSF parasites have a much more extensive recycling compartment 
than PCF parasites. This reflects the higher expression levels of TbRabll 
observed in BSF parasites and the much more active recycling processes which 
occur in this life stage. It is probable therefore that the metacaspases are involved 
somehow in the recycling of proteins in T. brucei, and it is logical to suggest that 
a greater complement of metacaspases may either be required or be more 
advantageous to the parasites. While Rabl 1 expression is upregulated to meet the 
increased recycling demands in BSF parasites, the strategy taken with relation to 
the metacaspases associated with these endosomes might not be to increase 
expression, but to increase tlie number of genes expressed.
One question that clearly arises from the identification of MCA2, MCA3 and 
MCA5 within the R abll positive compartment in the BSF is how they are 
targeted to that location. As previously discussed, MCA2 and MCA3, only 
diverge significantly at their N-tenninal region. It was initially believed that the 
small extension present on MCA3 might have been involved in differential 
targeting between MCA2 and MCA3. This does not appear to be the case, 
however, as both of proteins are associated with the same compartment. The N~ 
terminal region of MCA5, which itself is predicted to be a possible signal peptide, 
has no sequence identity to the N-terminal regions of either MCA2 or MCA3. 
These three proteins are targeted to the same compartment, therefore, without the 
presence of a conserved N-terminal targeting sequence. There are various models 
suggested to explain how proteins aie concentrated and targeted to differential 
organelles of the endocytic and secretory systems in eukaryotic cells (van Vliet et 
al., 2003). It is known that the targeting of proteins to specific locations occurs 
primarily at the trans-Golgi network (TGN) where cytosol-oriented sorting signals 
direct cargo to the appropriate export site (Traub and Kornfeld, 1997). Targeting 
signals that act as address codes, directing proteins to various intracellulai* 
compartments including endosomes and lysosomes, have been identified. They 
use a tyrosine-based sorting signal that conforms to a YXX0 motif (where 0  is an 
amino acid with a bulky hydrophobic side chain) (Marks et al., 2004). While 
such mechanisms have yet to be identified in protozoa, it is likely that there is a
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conserved motif within MCA2, MCA3 and MCA5 tliat is responsible for their 
targeting to the same compartment.
Immuno-electron microscopy data would be useful to support the localisation 
studies performed. Immunofluorescence analysis shows that the metacaspases are 
associated with an organellar structure; however, this technique is unable to 
ascertain where exactly within these structures the metacaspases are loeated. We 
predict that these proteins are located within the lumen of these structures as they 
have no transmembrane domains or membrane attachment motifs. Indeed, 
preliminary data suggest that MCA5 is located 'within the Imnen of these Rabl 1 
positive vesicles (Tetley, unpublished).
In addition, the partial co-localisation of MCA5 with internalised anti-VSG221 
antibodies confirmed that the metacaspase-positive compartment does indeed 
traffic molecules that are known to be recycled. These findings raise the 
possibility that the metacaspases may be involved in the cleavage and/or 
degradation of proteins contained within these recycling endosomes. Anti-VSG 
antibodies have been shown to be extensively degraded prior to secretion (Pal et 
al., 2003), and the addition of a cocktail of peptidase inhibitors resulted in a build 
up of internalised anti-VSG antibodies (Russo et a l, 1993), The enzymes 
responsible for this degradation have not been identified and no peptidases have 
been shown to reside within either the early or recycling endosomes in T. brucei. 
Therefore, the peptidases responsible for tlie degradation of anti-VSG antibodies 
may well be present within either the early or recycling endosomes. Interestingly, 
the slowing of recycling processes in T. brucei by the expression of mutant 
versions of Rab5 and Rabl 1 proteins were reported to increase the degradation of 
recycled material (Pal et a l, 2003), presumably due to an increased transit time 
through the endosomal system and greater exposure to proteolytic enzymes.
Caspases are highly specific in respect to their substrate specificity (Stennicke and 
Salvesen, 1998), and a similar feature has recently been demonstrated in the plant 
metacaspases (Vercammen et aL, 2004). One of the features of the Clan CD 
family of cysteine peptidase that have been classified so far is that they will only 
accept one specific residue at the PI position. For example, caspases will only
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cleave following an aspartate residue, while legumains require an asparagine 
residue at the PI position. There is one known exception to this rule, GPI8 is able 
to accept a range of residues in the PI position (Eisenhaber et aL, 2001). If the 
metacaspases do indeed follow this general rule, as recent evidence suggests, they 
would be expected to have specific substrate specificity and not make for an 
effective general degradative enzyme.
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Figure 3.1: Domain structure and predicted molecular masses of the 
Trypanosoma brucei MCA family.
The putative active site histidine (H) and cysteine (C) residues are indicated. 
These are substituted by tyrosine (Y) or serine (S) in MCAl and MCA4. 
Predicted Class III WW binding domain motifs are indicated (*) together with 
C-terminal extension of MCA5 (orange) and N-terminal extension of MCA2 
relative to MCA3 (yellow).
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Figure 3.2: Amino acid sequence alignment of T. brucei metacaspases.
MCAl, MCA2, MCA3, MCA4 and MCA5 were aligned using Align X 
(InforMax Inc.). Putative active site residues are highlighted by a blue box, a 
red box highlights regions identified as possessing predicted Class III WW 
binding domain motifs, and the black box highlights a predicted signal peptide. 
Non-similar residues are black, conservative or similar residues are blue, and 
identical residues are red with grey background.
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Figure 3.3: Amino acid sequence alignment of T. brucei MCA5 C-terminal 
extension with two predicted proteins.
The MCA5 C-terminal extension was used in a Blast Search against the T. 
brucei predicted protein database at GeneDB. Two proteins were identified that 
share sequence identity with this region and were aligned with the C-terminal 
extension of MCA5 using Align X (InforMax Inc.) Non-similar residues are 
black, conservative or similar are residues are blue, and identical residues are 
red with grey background.
79
1 1 Cd Z S sce 1 1 CD d z zd 1 1 Eh Cd zd 1 Z O e tQ 1 a z zb: 1 z >M 1 Cd CM1 oe d> 1 S Q1 O > z zQ 1 Z z z zCd 1 d z o od 1 1 < Cd z zEh 1 1 (u Cd > >Cd 1 1 EH Cd <U 1 1 CD d <> 1 1 Cd O EhQ 1 1 Z Z z ZCD 1 1 Q > z <CD 1 1 d O e t >O 1 ce z z Eh> 1 1 Cd CM > CDOi 1 1 >4 CD oed 1 Z ZCD 1 O <CD 1 oe z Cd< 1 d z Q2 1 1 ce > o Md 1 1 w u zoe 1 1 2 oe >Q 1 1 d H CDCd 1 1 < Zd 1 1 o EhCd z QZ 1 1 < z S2 1 1 u Q o Qce 1 1 d z Q2 1 1 W Cm >c* 1 1 O Cd <Cd 1 1 Cd Cm 2> 1 1 Cd CD d <2 1 1 Cd EH z Cdd 1 1 oe Eh z CdEH 1 d 2 Ol <2 1 < d z 2d 1 1 d d > d< 1 <Q 1 Cdæ 1 1 CD Cdæ 1 1 > 1 Md 1 1 < 1 ZiC 1 1 2 1 1 CdCd 1 1 d 1 1 dCd 1 1 ce 1 1 WCd 1 CD 1 1 CDCd 1 U 1 1 Cdd 1 Z 1 Mce 1 1 d 1 1 zCu 1 1 œ 1 1 oe2 1 1 w 1 1 zd 1 1 u 1 >Cd 1 1 d 1 1 CdOi 1 1 > 1 1 Cd1 1 Ol 1 1 aoe 1 1 EHd 1 1 ce 1 Cdce 1 1 Eh 1 1 <d 1 d 1 1 2> 1 CD 1 z< 1 W 1 <2 1 1 ce 1 1 CdCd 1 1 a 1 1 ceCd 1 1 < 1 1 z1 1 > 1 1 z< 1 1 ce 1 1 d2 1 1 d SCd 1 1 ce æCd 1 1 Q o< 1 1 EH >2 1 o z
c Co O■H -HtnC C<D 0)4-) do X Xo 0) 0)
(O un un< <CD CDS S
a i-H XJ XIEH JQ eh Xi Eh
o d Z tn
i i
wCO W
CJ o w z  CD >S 3 5O  co d CO Ou Wlai
l i is d d z CD CD d co WCD CD Ou Z  H  Hsi iz <2 2I i .z H >
CO
0) d  O
< 00(0 
S  *”• r-i
P
(D 1-H Om en m< OO 00O m  •
'2>e
EH
< 00 o  (O s •
S o  00
VD CTl (O  < 00(0  O  (O .
3 gEh
un cyi (O < 00 ro CD (O .
3 g
un cTi (O 
<  00 (O
S  ^  rH
3 g
< 00 ro CD (O •
3 g
EH
u m=^33
3 g
EH
80
s.
p.
T. c r u z i  M C A x  ( 1 3 8
T. c r u z i  M C A y  ( 1 3 8
T. b r u c e i  M C A 2 ( 1 2 8
T. b r u c e i  M C A 3  ( 1 3 8
T. b r u c e i  M C A 5  ( 1 1 7
T. c r u z i  M C A 5  ( 1 1 6
L .  m a j o r  M C A 5  ( 1 1 7
T. b r u c e i  M C A l  ( 1 3 8
T. b r u c e i  M C A 4 ( 1 3 4
c e r e v i s i a i  MC A  ( 2 1 1
S .  p o m b e  MCA ( 1 8 4
f a l c i p a r u m  M C A x  ( 3 7  4
P .  b e r g h e i  M C A x  ( 3 7 7
f a l c i p a r u m  M C A y  ( 1 5 7 4
P .  b e r g h e i  M C A y  ( 9 4  9
T. a n n u l a t a  MCA ( 5 4 7
[ V ]
D V L F M Q Y S G H C T Q T R A T S - D  
D V L F M H Y S G H G T Q T R A T S - D  
D V L F F H Y S G H G T Q C K S R G - D  
D V L F F H Y S G H G T Q C K S R G - D  
D V L F F H F S G H G A E T K G G R - D  
D V L F F H Y S G H G T E T K A E R - D  
D V L F F H F S G H G G Q A K A T R - D  
D A L F L H Y S G Y G A Q V R A E E - D  
D V L F F H Y S G H G T R A N A R D - D  
D S L F L H Y S G H G G Q T E D L D G D  
D A L F F H Y S G H G G Q T K D L D G D  
D I L F F L F S G H G S Q E K D H N H I  
D I F F F F Y S G H S Y K K Y D Y T C I  
D I L F F Y F C G Y S I K L I D S K F T  
D I L F F Y Y C G Y S T K I I D S K F S  
D F S V F F F S G H S V Q V D D L S G Y
[ V
L T V V F D C C -  
L T V V F D C C '  
L T A V F D C C  
L T A V F D C C '  
M T A V F D C C  
M T A V F D C C  
M T C V F D C C  
L T A V F D C S  
L T A V F D C S -  
L T A L F D S C -  
L T A L F D S C '  
L I A V V O S C  
L V S F I D C P
]
- - H S G S M L D L  
- - H S G S M L D L  
— H S G S I M D L  
- - H S G S I M D L  
— H S A S L L D L  
— H S A S L L D L  
— H S A S M L D L  
- - H A G T L L D L  
- - H S G S M L D L  
— H S G T V L D L  
— H S G G A L D L  
— N S G S S I D L  
— N S E G I L N L  
L C I I F D T T Y T S - Y F V P V P T S I  
L C V I F D T T Y S S - Y F V P T S I S I  
L N V F F D A S N L Q T V V G G S S R S G
Figure 3.4: Comparison of the metacaspases identified in parasitic protozoa 
and yeast.
Alignment of metacaspase sequences spanning the putative active site residues 
(indicated by arrows) were generated using Align X (InforMax Inc.). Non­
similar residues are black, conservative or similar residues are blue and identical 
residues are red with grey background. T. brucei, T. cruzi, Leishmania major, 
Plasmodium falciparum, P. berghei, Theileria annulata, Saccharomyces 
cerevisiae and Schizosaccharomyces pombe sequences are shown.
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Figure 3.5: Genomic locus of T. brucei MCA2 and MCA3 and amino acid 
sequence comparison of MCA2 and MCA3.
A) MCA2 and MCA3 are located in tandem on chromosome 6 with 
approximately 1.8 kb separating the two genes. B) Alignment of MCA2 and 
MCA3 was performed using Align X (InforMax Inc.). Identical residues are red 
while non-similar residues are black. Putative active site residues are blue. The 
green line illustrates the region of MC A2 chosen for generation of a peptide for 
antibody production. The black line indicates a possible glycosylation site on 
each protein.
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Figure 3.6: Phylogenetic tree of metacaspases identified in parasitic 
protozoa and yeast.
The central domains of T. brucei, T. cruzi, L. major, Plasmodium falciparum, P. 
berghei, Theileria annulata, Saccharomyces cerevisiae and 
Schizosaccharomyces pombe metacaspases were used to generate a 
phylogenetic tree using Align X (InforMax Inc.).
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Figure 3.7: Analysis of MCA2 and MCA3 expression in 71 bruceL 
Total cell lysates were prepared from T. brucei PCF (strain EATRO 795) and 
BSF (strain 427). 5x10 cell equivalents were then subjected to SDS-PAGE and 
transferred to PVDF membrane prior to immunoblotting with immunopurifed 
polyclonal rabbit anti-MCA2/3 antibodies. MCA2 and MCA3 are indicated, 
they were detected at around their predicted sizes of 38 and 39 kDa, 
respectively.
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Figure 3.8: Vector used to express MCA2 and MCA3 HA-tagged genes and 
analysis of MCA2HA and MCA3HA expression in BSF 71 bruceL
A) MCA2 and MCA3 with the addition a C-terminal HA tag were cloned 
individually into pGL884. This vector is designed for integration within the 
Pa-tubulin array, driving expression of inserted metacaspase gene and BLE 
from this locus. B) Total cell lysates were prepared from BSF wild type (strain 
427) and transgenic BSF (strain 427) parasites expressing an ectopic copy of 
either MCA2HA or MCA3HA from the tubulin locus. 5x10* cell equivalents 
were then subjected to SDS-PAGE and transferred to PVDF membrane prior to 
immunoblotting with a mouse monoclonal anti-HA antibody. MCA2HA and 
MCA3HA protein species are indicated at around their predicted sizes of 40 and 
41 kDa, respectively.
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Figure 3.9: Immunofluorescence detection of MCA2HA and MCA3HA in 
BSF T. brucei,
BSF parasites were fixed in -20°C methanol for 15 mins and permeabilised in - 
20°C acetone for 2 mins, prior to blocking with 5% (w/v) skimmed milk for 30 
mins. Slides were then incubated with a 1/200 dilution of monoclonal mouse 
anti-HA antibody, followed by anti-mouse TRITC conjugate and 1 pg/ml DAPl. 
A merged image of anti-HA and DAPI labelling is shown together with a DIG 
image of parasites.
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Figure 3.10: Coomassie blue stain of purified MCA5 His.
Total cell lysates of BL21 E. coli expressing full-length T. brucei MCA5-His 
were lysed and the pellet, containing MCA5-His, solubilised in 8 M Urea. This 
material was then bound to a nickel-agarose column and elution fractions 1 - 4 
at pH 6.3 and pH 4.5 collected.
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Figure 3.11: Analysis of MCA5 expression in T, bruceL
Total cell lysates were prepared from T. brucei PCF (strain EATR0795) and 
BSF (strain 427) forms. 5x10* cell equivalents were then subjected to SDS- 
PAGE and transferred to PVDF membrane prior to immunoblotting with sheep 
polyclonal anti-MCA5 antiserum. MCA5 is indicated at around the 55 kDa 
predicted size. Equal loading is demonstrated by an antibody against EFla..
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Figure 3.12: Immunofluorescence detection of MCA5 in BSF and PCF T, 
brucei,
T. brucei BSF and PCF parasites were fixed in -20°C methanol for 15 mins and 
permeabilised in -20°C acetone for 2 mins, prior to blocking with 5% (w/v) 
skimmed milk for 30 mins. Slides were then incubated with a 1/1000 dilution 
of sheep polyclonal anti-MCA5 antiserum, followed by anti-sheep FITC 
conjugate and 1 pg/ml DAPI. A merged image of anti-MCA5 and DAPI 
labelling is shown, together with DIC image of parasites.
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Figure 3.13: Immunofluorescence detection of co-localisation between
MCA2HA and MCA3HA with MCAS in BSF T. bruceL
T. brucei BSF parasites expressing either MCA2HA or MCA3HA proteins were 
fixed in -20°C methanol and permeabilised in -20°C acetone prior to blocking 
with 5% (w/v) skimmed milk. Slides were then incubated with the following; 
1/200 dilution of mouse monoclonal anti-HA, 1/1000 dilution of sheep 
polyclonal anti-MCA5 antiserum, followed by anti-mouse TRITC and anti­
sheep FITC conjugates together with 1 pg/ml DAPI. Labelling of anti-HA and 
anti-MCA5 is shown, together with a merged image of both signals, DAPI is 
included in all images. A DIC image of the parasites is also shown.
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Figure 3.14: Immunofluorescence analyses attempting to localise T.
brucei MCA5 with characterised organellar markers.
BSF parasites were incubated with several probes to specifically label 
organellar compartments. A) Early endosomes were labelled with a tomato 
lectin FITC conjugate (green), B) lysosomes were stained using Lysotracker 
(red), C) the Golgi apparatus was stained using BODIPY Ceramide (Red). 
Parasites were then fixed in -20°C methanol and permeabilised in -20°C 
acetone, prior to blocking with 5% skimmed milk. Slides were then incubated 
with sheep anti-MCA5 antiserum and anti-sheep FITC or TRITC conjugates 
together with 1 pg/ml DAPI. Individual images of MCA5 and probe labelling 
are shown for the separate experiments, together with a merged image. DAPI 
labelling is also included together with a DIC image of parasites.
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Figure 3.15: Metacaspases are associated with R abll positive recycling 
endosomes in T, bruceL
PCF and BSF wild type parasites were fixed in -20°C methanol and 
permeabilised in -20°C acetone, prior to blocking with 5% (w/v) skimmed 
milk. Slides were then incubated with the following; 1/200 dilution of 
immunopurified rabbit polyclonal anti-F^Rabl 1, 1/1000 dilution of sheep 
polyclonal anti-MCA5 antiserum, followed by anti-rabbit TRITC and anti­
sheep FITC conjugates together with 1 pg/ml DAPI. Labelling of anti- 
J&Rabll and anti-77>MCA5 is shown, together with a merged image of both 
signals, DAPI is included in all images, A DIC image of parasites is also 
shown.
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Figure 3.16: Comparison of R abll expression in PCF and BSF T. bruceL
Total cell lysates were prepared from BSF wild type (strain 427) and PCF wild 
type (stain EATRO 795). 5x10* cell equivalents were then subjected to SDS- 
PAGE and transferred to PVDF membrane prior to immunoblotting with an 
immunopurified rabbit polyclonal anti-Rabll antibody. Rabll is indicated; 
antibodies against EFla were used to indicate equivalent loading.
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Figure 3.17: Metacaspases positive structures traffic anti-VSG antibodies.
BSF wild type parasites were incubated with rabbit anti-VSG221 antisera at 4°C 
for 30 mins, and subsequently returned to 37°C for 30 mins. Parasites were 
fixed in -20°C methanol and permeabilised in -20°C acetone, prior to blocking 
with 5% (w/v) skimmed milk. Slides were then incubated with the following; 
1/1000 dilution of sheep polyclonal anti-MCA5 antiserum, followed by anti­
rabbit TRITC and anti-sheep FITC conjugates together with 1 pg/ml DAPI. 
Labelling of internalised anti-VSG221 antibodies and anti-MCA5 is shown, 
together with a merged image of both signals, DAPI is included in all images 
and a DIC image is shovm.
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Chapter 4 
RNAi on metacaspases
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4.1 Mechanism of RNA interference (RNAi).
In 1998 it was reported that, in Caenorhabditis elegans^ double stranded RNA 
(dsRNA) was more effective at gene silencing than the more commonly used 
technique of antisense RNA (Fire et aL, 1998). Since this discovery, the technique of 
RNAi has become an extremely useful tool to analyse gene function in a wide variety 
of eukaryotic organisms. For the mechanism of RNAi to function, the first step is the 
introduction of gene-specific dsRNA to the target cells. This dsRNA is then cleaved 
into 20-26 base-pair fragments, termed siRNAs, by an RNAse Ill-related enzyme 
termed Dicer (Bernstein et aL, 2001). These siRNA fragments are then transferred to 
a multi-protein complex termed RISC, or RNAi-induced silencing complex 
(Hammond et aL, 2000). In Drosophila, a protein with two dsRNA binding domains, 
named R2D2, and which is also homologous to the C elegans RNAi protein RDE-4, 
was shown to associate with DICER and facilitate siRNA transfer from Dicer to 
RISC (Liu et al., 2003). The bound siRNA fragments are then unwound in an ATP- 
dependent reaction (Nykanen et aL, 2001), resulting in exposure of the antisense 
gene sequence, complex activation, followed by recognition and degradation of 
target mRNA. The universal components of RNAi have been identified, through 
biochemical and genetic studies, as the previously described DICER enzyme and 
members of the Argonaute (AGO) family that are components of RISC. The 
Argonaute family was first identified in Arahidopsis thaliana (Bohmeit et aL, 1998) 
and has been shown to be linked to RNAi through studies in both C. elegans (Tabara 
et aL, 1999) and Drosophila (Hammond et aL, 2001). AGO family members possess 
two characteristic domains. The first is a PAZ domain, which structural studies have 
defined as an RNA binding module (Yan et aL, 2003) thought to possibly function as 
the siRNA attachment site (Ma et aL, 2004). The second is a Piwi domain, 
displaying similarities to a RNase H domain leading to speculation that AGO 
proteins function as the nuclease responsible for mRNA degradation (Liu et aL, 
2004; Song et aL, 2004). The RNAi mechanism is thought to be highly specific, 
mismatches of more than one nucleotide within the siRNA fragments were shown to 
effectively disrupt degradation of the target mRNA (Elbashir et aL, 2001). It is also 
believed that RNAi evolved as a protective mechanism against parasitic DNA
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sequences such as transposons (Sijen and Plasterk, 2003) and viruses (Joost Haasnoot 
et al., 2003),
The discovery that RNAi was also functional in T. brucei (Ngo et ah, 1998) followed 
quickly after the initial identification within C. elegans (Fire et al, 1998). It was 
observed that expression or introduction of dsRNA homologous to a-tubulin mRNA 
resulted in a dramatic drop in tubulin expression, and that this was due to mRNA 
degradation. In T. brucei, the mechanism by which RNAi occurs is less well 
characterised than in other organisms. Although siRNAs have been identified and a 
DICER activity detected (Djikeng et al., 2001), a putative DICER homologue has not 
been identified in the genome database. One AGO member, termed T6AG01, has 
been identified in T. brucei, however, and shown to be essential for RNAi (Shi et al., 
2004). Shortly after the discovery of RNAi in T. brucei, several groups 
independently developed vectors designed for production of dsRNA within the 
parasites (LaCount et ah, 2000; Shi et ah, 2000; Wang et ah, 2000; Bastin et ah, 
2000). In our study, the production of dsRNA within T. brucei utilised the p2T7^' 
vector, constructed by Doug la Count and John Donelson (LaCount et al, 2000) 
(Figure 4.1 A). This vector uses opposing T7 RNA polymerase promoters to drive 
the production of dsRNA, insertion of the chosen sequence between these promoters 
specifies the dsRNA produced. T7 polymerase terminators have also been 
engineered to ensure that only the inserted gene sequences are transcribed into RNA. 
To allow the production of dsRNA to be inducible, a tetracycline operator was 
engineered downstream of the T7 promoters. For selection purposes, the bleomycin 
resistance gene is present under the control of a trypanosomal ribosomal RNA 
(rRNA) promoter and the vector is designed for integration within transcriptionally 
silent ribosomal DNA (rDNA) spacer regions of the T. brucei genome. For the 
RNAi system to function, parasite cell lines are required that have been engineered to 
express both T7 RNA polymerase and the tetracycline repressor protein (TetR). In 
these experiments, we have used both PCF (427 pLewl3pLew29) and BSF (427 
pLewl 3pLew90-6) cell lines which already contains both of these proteins (Wirtz et 
ah, 1999) (Figure 4.1B).
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T7 RNA polymerase, a bacterial polymerase, is non-toxic in T. brucei and is able to 
produce high levels of expression from T7 promoter sites in the parasite (Wirtz et ah,
1994). The TetR protein, which forms a homodimer, is also a vital component of this 
system, binding with a high affinity to the tetracycline operator (Wirtz and Clayton,
1995). Once the RNAi cassette has been integrated within the parasite genome, the 
TetR protein binds to the tetracycline operator and blocks transcription. The TetR 
protein also has an affinity for tetracycline (in complex with a divalent cation), which 
upon binding results in a conformational change in the TetR protein and loss of DNA 
binding affinity. This removal of repression allows the T7 RNA polymerase to begin 
transcribing the inserted DNA sequence and dsRNA is produced. Thus the 
production of dsRNA can be controlled via the addition of tetracycline to the parasite 
culture medium.
4.2 RNA interference on MCA2 and MCA3 in T, bruceL
RNAi on MCA2 and MCA3 was performed only in the BSF parasites due to the 
stage-regulated expression of these two genes. As previously discussed, MCA2 and 
MCA3 are located as a tandem repeat on chromosome 6, displaying 91% identity at 
the DNA level with the only divergence occurring within the 5’ region of the two 
genes (Chapter 3). This high level of homology, with the two genes being 100% 
identical over the majority of their DNA sequences, allowed us to silence both genes 
simultaneously. Two oligonucleotides, OL904 and OL905, were designed to amplify 
by PGR a 668 base-pair fragment for which there is 100% sequence identity between 
both MCA2 and MCA3 (Figure 4.2). This fragment was subsequently cloned from T. 
brucei genomic DNA (strain 427), sequenced to ensure fidelity, and sub-cloned into 
the p2T7^‘ RNAi vector. Following linearisation, this vector was used to transfect the 
BSF RNAi parasite cell line (427 pLew 13pLew90-6) and clonal populations attained 
by limiting dilution using bleomycin as the selection marker. Three separate clones 
were chosen and RNAi induced by the addition of 50 ng ml ' tetracycline to the 
culture medium. Growth curves were generated over a four-day period to determine 
if the silencing of MCA2 and MCA3 was detrimental to the parasites (Figure 4.3). Of
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the three clones induced with tetracycline, two distinct growth effects were observed. 
Clones 1 and 3 showed no alteration in growth rate following induction, with the 
growth curves almost exactly mirroring the non-induced controls over the course of 
the induction. In addition, there were no obvious gross morphological changes to the 
parasites following the induction. In clone 2 however, the addition of tetracycline 
resulted in a pronounced reduction in growth rate, while control parasites continued 
to grow normally. This reduction in growth rate was accompanied by a drastic 
alteration in the parasites morphology, the cells becoming large, misshapen and 
multiflagellate. It was also observed that a small proportion of parasites in the non­
induced cultures of clone 2 displayed these morphological alterations, although the 
majority of parasites had a normal appearance.
Western blot analysis was then performed to determine whether MCA2 and MCA3 
expression had been successfully silenced in all of the clones. Whole cell extracts 
were prepared from induced and non-induced parasites at 24 hours post addition of 
tetracycline or ethanol controls, respectively. These extracts were then subjected to 
SDS-PAGE, transferred to PVDF membrane and probed with the immunopurified 
anti-MCA2/3 antibodies (Figure 4.4). In extracts prepared from clones 1 and 3, for 
which no alteration in either growth rate or morphology had been observed, it was 
clear that silencing of MCA2 and MCA3 expression had been successful. The 
probing of non-induced extracts detected four proteins and two of these were absent 
in the induced extracts. It is worth noting, that previous Western blots using this 
anti-MCA2/3 antibody detected three major proteins in BSF parasite extracts, with 
the fourth protein detected being at a low level (Figure 3.7). Whether this difference 
in level of expression of the fourth protein has any relation to the transfection of 
parasites with the RNAi cassette or is due to a strain difference is unknown. The 
proteins that had disappeared in the induced extracts closely corresponded with the 
predicted sizes of MCA2 and MCA3 of 38 and 39 kDa, respectively. Clearly the 
RNAi technique was functioning effectively as MCA2 and MCA3 were silenced 
specifically, compared to the other two proteins detected. The situation with clone 2, 
for which both a rapid onset reduction in growth rate and alterations in morphology
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had been observed, was shown to be distinct from clones 1 and 3. Examination of 
these extracts by Western blotting revealed that both MCA2 and MCA3 were absent 
from not just the induced but also from the non-induced parasites, while the cross 
reacting proteins were present in both extracts. Therefore it appeared that MCA2 and 
MCA3 expression had been silenced prior to induction in this clone.
4.3 RNA interference on MCA5 in T. brucei.
While the MCA2/3 RNAi was performed exclusively in the BSF, MCA5 was known 
to be expressed in both BSF and PCF parasites (Chapter 3). This permitted RNAi 
experiments to be performed in both life stages. To target MCA5, oligonucleotides 
OL944 and OL945 were generated to amplify by PCR a 416 base-pair fragment of 
MCA5 (Figure 4.5). Following amplification from T. brucei genomic DNA (strain 
427), the fragment was sequenced to ensure fidelity and subsequently sub-cloned into 
the p2T7 '^ RNAi vector. Following linearisation, this vector was used to transfect 
both PCF (427 pLewl3pLew29) and BSF (427 pLewl3pLew90-6) RNAi cell lines 
and clonal populations obtained by limiting dilution using bleomycin as the selection 
marker. Induction of RNAi was performed by the addition of 50 ng ml ' tetracycline 
in both life stages.
4.3.1 RNA interference on MCA5 in PCF T. brucei.
Four clones were chosen for the PCF MCA5 RNAi induction and growth curves were 
generated over a period of seven days. Two distinct phenotypes were seen (Figure 
4.6). A reduction in growth rate in clones 2 and 4 (clone 2 is shown) was observed. 
Clones 1 and 3, however, displayed no alteration in growth rate over the period of the 
experiment with induced cultures mirroring their non-induced counterparts (clone 3 
is shown). No morphological alterations were observed in any of the clones either " 
before or after induction.
Western blot analysis was then performed to determine whether MCA5 expression 
was effectively being silenced. Whole cell extracts were prepared from clones 2 and 
3 at 0, 2 and 4 days post-induction with tetracycline or ethanol controls. Extracts
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were then subjected to SDS-PAGE and transferred to PVDF membrane and probed 
with anti-MCA5 antiserum (Figure 4.7). The analysis revealed that the induction of 
RNAi resulted in the sole protein detected by the anti-serum being absent from 
induced parasites, while the expression was unchanged in non-induced parasite 
extracts. This confirmed the specificity of the antiserum and demonstrated that the 
RNAi of MCA5 was functioning efficiently in both clones.
While both clones showed that MCA5 levels were reduced following addition of 
tetracycline, there does appear to be a difference in expression levels of MCA5 
between the two clones. By loading 5x10* cell equivalents for both clones 2 and 3, it 
is clear that the expression of MCA5 in non-induced parasites was lower within the 
former (Figure 4.7). It is interesting to note that clone 2 was also the clone for which 
a growth phenotype was detected.
4.3.2 RNA interference on MCA5 in BSF T. brucei.
To examine the effect of MCA5 RNAi in the BSF, three clones were selected, 
induced, and growth curves generated over a 24 hour period. Again, two distinct 
growth phenotypes were observed (Figure 4.8). One in which the addition of 
tetracycline had no effect on parasite growth, and a second, in which this induction 
resulted in a rapid growth arrest. Clones A and C (clone C shown in figure 4.8) 
showed no adverse affects of tetracycline addition with growth rates mirroring those 
of the control parasites. With clone B, however, following the addition of 
tetracycline the parasites failed to increase in number over the next 24 hour period. 
In addition, these parasites took on a mutant morphology highly similar to that 
described previously for the MCA2 and MCA3 BSF RNAi, the parasites becoming 
large, misshaped and multiflagellate. Again, similarly to MCA2 and MCA3 BSF 
RNAi, it was observed that a small proportion of the clone B uninduced cells also 
displayed this mutant morphology.
To analyse the effectiveness of the silencing of MCA5, whole cell extracts were 
prepared from clones B and clone C following an 18-hour induction with either
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tetracycline or ethanol control. These were then subjected to SDS-PAGE, transferred 
to PVDF membrane and probed with anti-MCA5 antiserum (Figure 4.9). This 
demonstrated that the RNAi mechanism was functioning effectively, with an 
equivalent reduction in protein levels at the 18 hour time point observed for both 
clones.
4.4 Specificity of RNAi.
The RNAi mechanism is believed to be highly specific, the siRNA fragments must 
almost exactly match the mRNA to cause degradation of the message (Elbashir et al, 
2001). Although unlikely, it was possible that targeting of MCA2 and MCA3 by 
RNAi may also target the MCA5 mRNA and vice versa. To determine if this was the 
case. Western blot analysis on the whole cell lysates from the previous RNAi 
experiments was performed. To check the specificity of the MCA5 RNAi, BSF 
clones B and C cell extracts were subjected to SDS-PAGE, transferred to PVDF and 
probed with anti-MCA2/3 antibodies (Figure 4.10A). This demonstrated that upon 
induction of MCA5 RNAi, which was shown to drastically reduce MCA5 levels 
within the parasites, there was no alteration in the level of MCA2 or MCA3 within 
the parasites. The reverse experiment was also performed to check specificity of the 
MCA2/3 RNAi. BSF clones 1 and 3 extracts were subjected to SDS-PAGE, 
transferred to PVDF and probed with the anti-MCA5 antiserum (Figure 4.1 OB). It 
was clear from this analysis that the MCA2 and MCA3 RNAi was also specific, as no 
alteration in MCA5 levels were observed in the induced extracts compared to 
controls.
4.5 RNA interference on MCA2, MCA3 and MC45.
Having performed RNAi on both MCA2/3 and MCA5 successfully, a construct was 
generated that would be able to target all three genes simultaneously. Due to the 
stage-regulated expression of MCA2 and MCA3, this was only attempted in BSF 
parasites. Having shown that the individual fragments chosen for both the MCA2/3 
and MCA5 RNAi worked successfully, a fusion vector containing both of these gene 
fragments was created. To achieve this, the 668 base-pair MCA2/3 fragment was
105
cloned into the MCA5 RNAi vector so that it was immediately adjacent to the 408 
base-pair MCA5 fragment (Figure 4.11). Therefore this new construct, following 
transfection and induction with tetracycline, should produce dsRNA from both 
MCA2/3 and MCA5 fragments.
The generation of clonal populations with this linearised vector, however, was found 
to be more difficult than the generation of MCA2/3 or MCA5 RNAi clones. Although 
an equivalent amount of linearised DNA was used in the transfection, as compared to 
the previous MCA2/3 and MCA5 RNAi transfections, there was a large discrepancy 
in the number of clones attained. When the single RNAi BSF transfections were 
performed, typically it was possible to generate in excess of 10 clonal transformants. 
However, when the MCA2/3I5 RNAi transfection was performed the number of 
transformants generated was very low. The transfection was performed twice with 
only a single clone generated in each attempt. Although not a controlled experiment, 
these observations suggest that either the integration efficiency of this vector was 
reduced or that the background expression of the vector, without induction, may be 
toxic to the parasites. In addition, although the two clones generated generally 
appeared healthy, it was notable that a small proportion of the parasites displayed a 
similar mutant phenotype to that described previously in both the MCA2/3 and MCA5 
RNAi experiments in the BSF.
With two clones generated, it was possible to perform the triple MCA RNAi 
experiments in the BSF. Clones I and 2 were induced with 50 ng ml ' tetracycline 
and growth cui'ves generated over a three-day period (Figure 4.12). Induced 
parasites underwent a rapid onset growth arrest, while controls continued to grow 
normally. Also notable was that the parasites took on the by now familiar 
morphological alterations, becoming large, misshaped and multiflagellate. These 
observations were highly similar to the phenotype described upon induction in the 
MCA2/3 and MCA5 RNAi experiments.
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To validate that all three genes were being silenced, Western blot analysis on clone 1 
was performed. Whole cell lysates were prepared at 0, 24 and 48 hours post­
induction with tetracycline or ethanol controls. These extracts were then subjected to 
SDS-PAGE, transferred to PVDF and probed with both anti-MCA2/3 antibodies and 
anti-MCA5 antiserum (Figure 4.13). These results showed that the simultaneous 
silencing of MCA2, MCA3 and MCA5 had been successful. MCA5 was not detected 
following 24 hours induction, while expression was unaffected within the control 
parasites. The silencing of MCA2 and MCA3 was, however, distinct, at 24 hours 
post-induction it was still possible to detect MCA2 although MCA3 was absent. 
After 48 hours the amount of MCA2 had also fallen to barely detectable levels, while 
expression of both proteins was unaffected in control extracts. This differential 
reduction in MCA2 and MCA3 expression had not been observed when MCA2/3 
RNAi had been performed previously, as both MCA2 and MCA3 could not be 
detected at 24 hours post-induction (Figure 4.4).
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4.6 Discussion.
Of the five metacaspase genes identified in T. brucei, this study has examined the 
function of MCA2, MCA3 and MCA5 by the technique of RNAi. These are the three 
metacaspases for which antibodies have been raised and their expression profile 
determined, thus allowing direct quantification of the functionality of the RNAi. 
MCAl and MCA4, for which antibodies are not available against the gene products, 
have not been examined in this study.
Our analysis of the MCA2/3 RNAi clones generated within BSF parasites revealed 
that the silencing of MCA2/3 resulted in two distinct phenotypes. Of the three clones 
examined, two showed no detrimental effects in terms growth rate or gross 
morphology, while Western blot analysis revealed that levels of MCA2 and MCA3 
were dramatically reduced. In the remaining clone, however, the results obtained 
were very different: upon induction, parasites underwent a rapid onset reduction in 
growth rate and took on a highly mutant morphology with the cells becoming large, 
misshaped and multiflagellate. In addition. Western analysis revealed that MCA2 
and MCA3 expression had also been effectively silenced in the non-induced 
parasites. Based upon the observations that two of the clones analysed were able to 
withstand silencing of both MCA2 and MCA3 without the detection of any obvious 
detrimental effects, it seems reasonable to conclude that the growth arrest and altered 
morphology phenotype observed within the one clone is most likely a non-specific 
artefact.
These results raise several possibilities. Firstly, that the silencing of MCA2 and 
MCA3 expression did not affect the parasite’s normal cellular process in such a way 
that was immediately obvious or detrimental. The lack of an observable phenotype 
does not mean that one was not present, the silencing of the two genes might have 
resulted in a subtle phenotype that was not detected by the gross analysis performed. 
Alternatively, it may be that the level of expression of MCA2 and MCA3 within the 
induced parasites, although drastically reduced, was sufficient to retain normal 
functions. Indeed, longer exposures of the Western blots revealed that MCA2 and
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MCA3 remained detectable in the parasite extracts following induction. These are 
not physical knockouts, and it has been reported that it is not possible to completely 
ablate target mRNA within T. hrucei using RNAi (Shi et al, 2000). Therefore the 
production of gene products can never fully be switched off and the reduced level of 
expression may still be enough to prevent any detrimental effects of gene silencing 
becoming evident. With T. brucei, RNAi has been used successfully against 
enzymes (Besteiro et aL, 2002; Lillico et ah, 2003; Luo et al., 2004), structural 
proteins (Bastin et ah, 2000; Hutchings et aL, 2002; Allen et ah, 2003; McKean et 
aL, 2003) and non-catalytic components of complexes (Hammarton et aL, 2003; 
Hammarton et aL, 2004). However, a resistant mRNA component could 
theoretically place limitations on the RNAi system, particularly with regard to 
enzymes which may be able to operate adequately at highly reduced concentrations. 
Moreover, as negative results are rarely published, it is difficult to assess whether this 
is the case. It remains a possibility therefore, that, despite a large decrease in MCA2 
and MCA3 expression, the nominal amount remaining within the parasites retains the 
ability to function sufficiently. The third possibility is that other metacaspases are 
able to functionally compensate for the reduction in MCA2 and MCA3 expression. 
We have shown previously that MCA2 and MCA3 are associated with the same 
compartment as MCA5 in BSF parasites (Chapter 3). It is possible, therefore, that 
MCA5 is able to offset any detrimental effects resulting from the silencing of MCA2 
and MCA3, It is known that multi-gene families can compensate for each other from 
previous RNAi studies. It has been shown that GLH-1 and GLH-4, RNA helicases 
involved in germline development in C. elegans, were able to compensate for each 
other. To induce sterility, the silencing of both genes simultaneously was required 
(Kuznicki et aL, 2000). Also in C. elegans, three redundant CCCH-type zinc-finger 
genes were identified which when silenced singly produced no phenotype, while 
double or triple RNAi induced defects in oocyte maturation (Shimada et aL, 2002). 
Additionally, MCA5 is not the only other metacaspase that could theoretically negate 
the silencing of MCA2 and MCA3 expression. T, brucei also possesses two other 
metacaspase genes, MCAl and MCA4, for which expression profiles are unknown. It
109
is possible, therefore, that these two genes might provide further levels of 
redundancy and be responsible for the lack of an observable phenotype.
Induction of MCA5 RNAi in the BSF yielded similar results to that which had been 
previously obseiwed for the MCA2 and MCA3 RNAi. Of the three clones induced, 
two showed no ill effects, while the remaining clone underwent a rapid onset 
reduction in growth rate and took on highly similar morphological alterations to 
those seen with the MCA2 and MCA3 RNAi. Upon analysis of parasite extracts, it 
became apparent that the silencing of MCA5 was occurring independently of the two 
distinct effects. The tentative conclusion drawn is that the mutant phenotype 
observed was another non-specific artefact of the RNAi system.
Therefore it appears that the silencing of MCA5 does not result in any obviously 
detrimental effects to the BSF parasites. The possible explanations for this are 
identical to those described for the MCA2 and MCA3 RNAi. A more detailed 
analysis may have been required to detect a phenotype or alternatively the reduced 
levels of MCA5 expression may be sufficient to maintain normal cellular functions. 
It was suggested that there might have been compensation in the MCA2 and MCA3 
RNAi experiments, similarly, it is possible that there were compensatory 
mechanisms for MCA5 also. This could feasibly occur via MCA2 or MCA3, which 
we know are expressed, or MCAl and MCAA for which expression has not been 
determined.
On performing MCA5 RNAi in the PCF, the results, although not identical, were 
similar to those observed for both the MCA2I3 RNAi and MCA5 RNAi in the BSF. 
Upon induction, again two distinct phenotypes were observed. Of the four clones for 
which growth curves were generated, two showed no reduction in growth rate over 
the period of the induction, while in the remaining two clones a reduction in growth 
rate was apparent. However, unlike in the BSF, there were no morphological 
alterations associated with the reduced growth rate. Similarly, an analysis of protein 
levels revealed that these two separate phenotypes appeared to be independent of the
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silencing of MCA5, We can conclude from this that, similarly to the BSF RNAi 
experiments, the silencing of MCA5 in the PCF does not appear to have any 
obviously detrimental effects and, based on the information available, it appears that 
the clones where a reduction in growth rate was observed are most likely artefactual.
It is possible that the MCA5 RNAi induces a subtle phenotype that was not revealed 
by our analysis or that the reduced level of protein expression retains enough 
enzymatic activity to maintain normal functions. It has been shown, however, that 
MCA2 and MCA3 are not expressed in the PCF parasites (Chapter 3), thus there is no 
possibility that MCA2 and MCA3 can complement for the loss of MCA5 in the PCF. 
However, as MCAl and MCA4 expression has yet to be determined there remains the 
possibility that these two genes could nullify any detrimental effects of MCA5 
silencing.
The MCA2/3 and MCA5 RNAi investigations did demonstrate, however, that the 
RNAi-induced gene silencing was specific for the target metacaspases. No reduction 
in MCA2 or MCA3 expression was detected when MCA5 RNAi was performed and 
vica versa. This was not too surprising as an alignment of the DNA sequences of the 
two fragments revealed that the largest domain of homology between the two regions 
chosen extends for only 7 base pairs. It is believed that for RNAi to function the 
siRNA fragments may only differ by one or two base pairs (Elbashir et ah, 2001). 
Also of note, is that the silencing of MCA2/3 or MCA5 does not result in the up 
regulation of MCA5 or MCA2/3 expression, respectively. If the metacaspase family 
is redundant, we might have expected to see increased expression of the remaining 
metacaspases upon RNAi induced silencing, which was not observed. The RNAi 
data so far discussed is suggestive that MCA2 and MCA3 in the BSF and MCA5 in 
both the BSF and PCF are non-essential to general parasite health or survival in vitro. 
As this study does not examine the other identified metacaspase genes MCAl and 
MCA4, this was as far as the work was taken in the PCF.
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It was possible, however, to investigate the possibility of eomplementation or 
redundancy in the BSF through the triple RNAi of MCA2, MCA3 and MCA5. Upon 
induction, both of the clones generated underwent a rapid growth arrest and took on 
the familiar mutant morphology - parasites becoming large, misshaped and 
multiflagellate. Examination of protein levels revealed that the silencing of both the 
MCA2/3 and MCA5 loci had been successful. Taken in isolation, the triple 
metacaspase RNAi observations might have appeared an attractive and promising 
phenotype to study. However, as the same morphological alterations and rapid 
growth arrest had been observed in the previous RNAi experiments which were 
concluded to be artefactual, it was felt that this phenotype may also be artefactual. 
Additionally, while the growth arrest and mutant phenotype occurred extremely 
rapidly, the analysis of protein levels revealed that MCA2 remained detectable at 24 
hours post-induction, a time at which the mutant morphology was apparent. This 
result further questioned the validity of the phenotype. If as hypothesised, MCA2, 
MCA 3 and MCA5 are redundant, then a phenotype resulting from their silencing 
should only become apparent once all three genes had been effectively silenced.
While the RNAi study has illustrated that the metacaspases do not appear to be 
essential genes in vitro, the results have highlighted several points of concern 
regarding the technique of RNAi in T. brucei. As described, in both the MCA2/3 and 
MCA5 RNAi experiments, the mutant phenotypes were independent of gene 
silencing and therefore must reflect other events. Our hypothesis to explain this is 
that following induction, and switching on of dsRNA production, the parasites 
experience a non-specific toxic effect. Non-specific toxic effects of dsRNA 
production have been reported. The introduction of dsRNA has been shown to evoke 
a strong antiviral mechanism, including stimulation of the interferon synthesis, in 
higher eukaryotes, resulting in an inhibition of cell growth or activation (Kumar and 
Carmichael, 1998). The apparent toxicity in T. brucei appeared to manifest 
differentially between the BSF and PCF parasites. In the BSF there appeared to be a 
failure in the cellular division process, the increase in size of the parasites and 
appearance of many flagella suggesting that the parasites were continuing to attempt
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replication but for some reason are unable to physically divide. In the PCF, a less 
severe growth reduction with no associated morphological changes was obseiwed. 
The differential manifestation may be due to the PCF being better able to withstand 
high levels of dsRNA production. It is known that the PCF is better able to 
withstand higher concentrations of antibiotics than the BSF, indicating that it may be 
generally more resistant to toxic conditions.
However, attempting to understand the reasons why this effect was detected in some 
but not all of the clones generated is arguably more important. The ability to silence 
MCA2 and MCA3 expression in the BSF, and MCA5 expression in both the BSF and 
PCF, without any detrimental effects illustrates that the production of high 
concentrations of metacaspase specific dsRNA are not inherently toxic to the 
parasites. Therefore, there must be something distinct occurring to explain the 
mutant phenotypes observed in the some of the clones generated. The situation with 
the MCA2/3 RNAi provides some clues as to what this might be. The lower level of 
MCA2 and MCA3 expression prior to induction indicates that sufficient levels of 
dsRNA are being produced to silence both genes without the addition of tetraeycline, 
and therefore that the inducible control of the RNAi cassette had either been lost or 
was not functioning. The level of dsRNA being produced must have been at least 
equivalent to that produced in the two clones where no phenotype was observed upon 
induction. In fact it may even have been higher, the small proportion of mutant 
parasites obseiwed within the non-induced cultures suggests that the level of dsRNA 
production prior to induction were approaching toxic levels. Although only 
speculation, it is plausible to suggest that following addition of tetracycline, with the 
removal of the TetR protein from the tetracycline operator site likely to remove any 
remaining barriers to dsRNA production, the production of dsRNA would have 
crossed a toxicity threshold. If massive amounts of dsRNA were then being 
produced, there are several possible reasons as to why this may have caused toxicity 
to the parasites. The very presence of this much dsRNA may simply have swamped 
the cell and prevented normal metabolism from occurring, or alternatively the energy
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required to produce this much dsRNA may have placed a drain on other essential 
resources required to maintain normal cellular processes.
The silencing of both MCA2 and MCA3 from the non-induced parasites for which no 
tetracycline had been added suggests that there is leaky expression of the RNAi 
cassette within this clone. Leaky expression from the RNAi system refers to the 
production of dsRNA without the addition of exogenous tetracycline and switching 
on of T7 RNAse polymerase transcription. There are several possible explanations 
for such leaky expression. It is possible that tetracycline from external sources may 
have found its way into the experiment. A possible route with which this may have 
occurred is via the foetal calf serum (PCS) used to supplement the culture medium. 
However, the same media preparations were used for all of the MCA2 and MCA3 
RNAi clones analysed, ruling out the possibility that changes in exogenous 
tetracycline were behind the leaky expression. If tetracycline concentrations were 
the same in all non-induced cultures, there must be another explanation for the leaky 
expression from the RNAi cassette. All three clones were generated from the same 
RNAi cassette preparation, and indeed were generated from the same transfection. 
This would appear to rule out the possibility that the apparent differential level of 
leaky expression was the result of alterations in the expression or functionality of 
either the TetR protein or T7 RNA polymerase genes already present within the 
parasites.
Although only the MCA2 and MCA3 RNAi has been used to suggest possible 
explanations for the differential phenotypes observed, parallels can easily be drawn 
for the MCA5 RNAi in both BSF and PCF parasites. In the BSF, although there was 
no evidence of leaky expression, the phenotype observed was virtually 
indistinguishable, suggesting the same process of dsRNA toxicity was the cause. In 
the PCF, there was also evidence of leaky expression from the RNAi cassette prior to 
induction in the clones which presented a growth phenotype.
114
It is likely, that the distinct phenotypes observed in this RNAi study are the result of 
differential integration positions of the RNAi cassette within the genome. The RNAi 
cassette used in this study was designed for integration within the ribosomal DNA 
(rDNA) spacer region. The T. hrucei genome contains numerous ribosomal loci 
which the RNAi cassette vector may integrate into, and all of these are believed to be 
transcriptionally silent. From these sites the production of dsRNA should therefore 
be under the sole control of the T7 RNA polymerase driven from the T7 promoter 
site. However, one explanation for the silencing observed prior to induction may be 
that not all of the ribosomal spacer regions are completely silent. If this is the case, 
read through may occur from the ribosomal locus and this maybe strong enough to 
overcome the TetR system. Alternatively, the insertion of the RNAi vector into 
certain ribosomal spacer loci may result in instability, resulting somehow in the 
disruption of the tetracycline repression system. This might de-regulate control over 
the RNAi cassette and could explain the apparent constitutive expression of dsRNA 
in the MCA2/3 RNAi. However, the addition of tetracycline clearly induced further 
changes to the parasites and, as previously discussed, is most likely due to further 
increases in dsRNA production. For this increase to occur upon tetracycline 
addition, the repression system must retain a certain level of functionality, with the 
addition of tetracycline pushing levels of dsRNA production above a toxicity 
threshold.
It is also possible that the RNAi cassette integrated into a locus other than the 
ribosomal spacer region. It has been reported that vectors utilising these rDNA 
spacer regions for targeted homologous recombination occasionally integrate at other 
loci within the genome that are homologous to the insert rather than the rDNA spacer 
region (Bastin et aL, 1998; Motyka et aL, 2004). The result of such integrations 
would be difficult to predict due to orientational rearrangement of the elements 
within the RNAi cassette. No analysis was performed to check whether integration 
of the RNAi cassette occurred at the rDNA spacer region in the clones analysed, and 
a future analysis to examine this possibility may be of interest.
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One unfortunate result of these apparently artefactual results is that it is not possible 
to be sure whether the silencing of MCA2, MCA3 and MCA5 is lethal or detrimental 
to the parasites. It cannot be said with certainty whether the obseived phenotype is 
artefactual, or real, or whether there is a real phenotype which is being masked. The 
similarity of the growth arrest and morphological changes does strongly suggest that 
the hypothesised non-specific dsRNA toxicity is the reason behind the observed 
phenotype, while the difficulty in achieving clones suggests that disruption of these 
three genes may be detrimental to the parasites. To further these investigations, null 
mutants were generated and these are discussed later (Chapter 5).
What is clear from these RNAi investigations is that while this technique clearly can 
work efficiently in T. brucei, and no clones were generated where silencing of target 
metacaspase did not occur, there are clearly problems associated with the technique 
which need addressing. These artefacts may be specific to the vector itself and not 
the technique of RNAi as no similar artefacts have been reported by other researchers 
working on T. brucei. Additionally, although the vector used in this study might 
have problems associated with it, it is still suitable for RNAi studies. The generation 
of clones that did not display signs of the artefact were generated, and had an obvious 
phenotype been present these could have been used to analyse metacaspase function. 
Additionally there are several publications were this vector has been used 
suecessfully (LaCount et aL, 2000; Lillico et aL, 2003; Hammarton et aL, 2004) 
highlighting the usefulness of this technique.
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Figure 4.1: Illustration of the domain structure of the inducible RNAi vector 
and parasite cell lines required for this system.
A) The RNAi cassette from the p2T7^' vector (LaCount et aL, 2000). B) The cell 
lines used in this study were: PCF (427 pLewl3pLew29) and BSF (427 
pLewl3pLew90-6) (Wirtz et aL, 1999).
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Figure 4.2: Region of MC42 & MCA3 chosen for RNAi.
MCA2 & MCA3 are located as a tandem repeat, sharing 91% identity at the DNA 
level. A 668 bp stretch o f MCA2 and MCA3 was chosen over which the two genes 
share 100% identity. The oligonucleotides OL905 and OL905 were used to amplify 
this gene f r a ie n t  by PCR from genomic DNA (strain 427) for subsequent cloning 
into the p2T7 ' RNAi vector.
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Figure 4.3: Analysis of growth rates following induction of MCA2/3 RNAi in 
BSF T. brucei.
MCA2/3 BSF RNAi clones 1, 2 and 3 were grown in the absence or presence o f 50 
ng ml * tetracycline and cell numbers monitored over a period o f 4 days. Initial 
cultures were seeded at 5x10* cells mf' and cell counts made daily, with cultures 
being re-seeded to 5x10* cells ml ' as and when required to maintain cultures in a 
logarithmic growth phase.
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Figure 4.4: Analysis of MCA2 and MCA3 expression following RNAi induction 
in BSF T. brucei.
Total cell lysates were prepared from MCA2/3 BSF RNAi clones 1, 2 and 3 
following a 24 hour induction with 50 ng ml ' tetracycline or ethanol control. 5x10^ 
cell equivalents were then subjected to SDS-PAGE and transferred to PVDF 
membrane prior to immunoblotting with immunopurified polyclonal rabbit anti- 
MCA2/3 antibodies. MCA2 and MCA3 are indicated.
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Figure 4.5: Region of MCA5 chosen for RNAi.
A 416 bp stretch o f MCA5 was chosen as the region of the gene to target by RNAi. 
The oligonucleotides OL944 and OL945 were used to amplify this gene fragment by 
PCR from genomic DNA (strain 427) for subsequent cloning into the p2T7^‘ RNAi 
vector.
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Figure 4.6: Analysis of growth rates following induction of MCA5 RNAi in PCF 
T. brucei.
MCA5 PCF RNAi clones 2 and 3 were grown in the absence or presence o f 50 ng ml' 
' tetracycline and cell numbers monitored over a period of 7 days. Initial cultures 
were seeded at 1x10  ^ cells ml'* and cell counts made, with cultures being re-seeded 
to 5x10^ cells ml'* as and when required to maintain cultures in a logarithmic growth 
phase.
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Figure 4.7: Analysis of MCA5 expression following RNAi induction in PCF T. 
brucei.
Total cell lysates were prepared from MCA5 PCF RNAi clones 2 and 3 induced with 
50 ng ml * tetracycline or ethanol control for 0, 2 and 4 days. 5x10* cell equivalents 
were then subjected to SDS-PAGE and transferred to PVDF membrane prior to 
immunoblotting with sheep anti-MCA5 anti serum. MCA5 is indicated.
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Figure 4.8: Analysis of growth rates following induction of MCA5 specific RNAi 
in BSF T. brucei.
MCA5 BSF RNAi clones B and C were grown in the absence or presence of 50 ng 
ml * tetracycline and cell numbers monitored over 24 hour period. Initial cultures 
were set up at 5x10* cells ml * and cell counts made after 7 and 24 hours.
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Figure 4.9: Analysis of MCA5 expression following RNAi induction in BSF T, 
brucei.
Total cell lysates were prepared from MCA5 BSF RNAi clones B and C following an 
18 hour induction with 50 ng ml * tetracycline or ethanol control. 5x10^ cell 
equivalents were then subjected to SDS-PAGE and transferred to PVDF membrane 
prior to immunoblotting with sheep anti-MCA5 antiserum. MCA5 is indicated.
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Figure 4.10: Analysis of RNAi specificity in BSF T. brucei.
A) Total cell lysates were prepared from MCA5 BSF RNAi clones B and C following 
a 18 hour induction with 50 ng ml * tetracycline or ethanol control. 5x10*^  cell 
equivalents were then subjected to SDS-PAGE and transferred to PVDF membrane 
prior to immunoblotting with immunopurified polyclonal rabbit anti-MCA2/3 
antibodies. MCA2 and MCA3 are indicated. B) Total cell lysates were prepared 
from MCA2/3 BSF RNAi clones 1 and 3 following a 24 hour induction with 50 ng 
ml * tetracycline or ethanol control. 5x10^ cell equivalents were then subjected to 
SDS-PAGE and transferred to PVDF membrane prior to immunoblotting with sheep 
polyclonal anti-MCA5 antibodies. MCA5 is indicated.
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Figure 4.11: Strategy utilised to enable knockdown ofA/C42, MCA3 and MCA5 
by RNAi.
The fragment o f MCA5 previously used in the single RNAi studies was cloned into 
the MCA2/3 RNAi vector, so that both fragments were located back to back and 
between the two T7 RNA polymerase promoters. pGL670 was digested with Hindlll 
and the MCA2/3 fragment cloned into pGL714 pre-digested with Hinchll. This 
vector, upon integration and induction will produce dsRNA specific to both the 
MCA2/3 and MCA5 mRNA.
127
aIs
u
Clone 1
8
7
6
5
4
3
2
1
0
3210
-♦— Tet
Tet
Days (post induction)
Clone 2
7
6
5
4
3
2
1
0
2 310
-♦— Tet - 
-« — Tet +
Days (post induction)
Figure 4.12: Analysis of growth rates following induction oiMCA2^ MCA3 and 
MCA5 RNAi in BSF T. brucei.
MCA2, MCA3 and MCA5 BSF RNAi clones 1 and 2 were grown in the presence or 
absence of 50 ng mf^ o f tetracycline and cell numbers monitored over a 3 day period.
cells ml** and cell counts made daily, with 
■* as and when required to maintain cultures
Initial cultures were seeded at 5x1 O'* 
cultures being re-seeded to 5x10'* cells ml 
in a logarithmic growth phase.
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Figure 4.13: Analysis of MCA2, MCA3 and MCA5 expression following RNAi 
induction in BSF T. brucei.
Total cell lysates were prepared from MCA2, MCA3 and MCA5 BSF RNAi clone I 
following induction with 50 ng ml * tetracycline or ethanol control for 0, 24 and 48 
hours. 5x10* cell equivalents were then subjected to SDS-PAGE and transferred to 
PVDF membrane prior to immunoblotting with A) immunopurified polyclonal rabbit 
anti-MCA2/3 antibodies or B) polyclonal sheep anti-MCA5 antiserum. MCA2, 
MCA3 and MCA5 are indicated.
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Chapter 5
Gene knockouts and phenotype analysis
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5.1. Knockout of MCA2 and MCA3 in BSF T. brucei.
The study of MCA2 and MCA3 by RNAi had suggested that these were non-essential 
genes for the BSF in vitro (Chapter 4). To test this hypothesis and gain further 
insights into metacaspase function, the generation of MCA2 and MCA3 deletion 
mutants was attempted. MCA2 and MCA3^ being both single copies genes and 
located sequentially on chromosome 6, enabled a strategy to be pursued whereby 
both genes could be simultaneously deleted. Utilising flanking regions surrounding 
the MCA2 and MCA3 locus, the targeted deletion of both genes in a single 
recombination event would theoretically be possible. Examination of the MCA2 and 
MCA3 locus, however, revealed that not only are the genes highly homologous, as 
previously discussed (Chapter 3), but so too are the immediate 5’ and 3' flanking 
regions of both genes. Therefore, the utilisation of regions immediately adjacent to 
MCA2 and MCA3 as flanking regions would result in a variety of recombination 
events being possible and the deletion of both genes simultaneously would not be 
guaranteed. To avoid these complications and ensure knockout of both MCAl and 
MCA3, unique flanking regions were chosen outside of these homologous regions 
while avoiding encroachment into the reading frames of either the upstream or 
downstream genes (Figure 5.1 A).
Oligonucleotides were synthesised and PCR performed on genomic DNA (strain 
427) to generate these flanking regions, which were then sequenced to ensure fidelity 
and cloned into a T. brucei knockout vector (Figure 5.IB) first described by Cross et 
al. (2002). These vectors contain tubulin intergenic regions to facilitate trans­
splicing and polyadenylation of mNRA and ensure translation of the resistance 
markers. The two markers utilised to delete the native alleles were the blasticidin 
{BSD) andpuromycin {PAG) resistance genes. Wild type BSF (strain 427) parasites 
were transfected with one of the knockout cassettes excised from either the BSD- or 
FWC-containing knockout vector. Clones were attained by limiting dilution in 24- 
well plates, using the appropriate antibiotics. The replacement of the MCA2 and 
MCA3 locus with the BSD knockout construct was straightforward, the construct 
integrating efficiently with approximately 90% of transformants having the correct
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integration as assessed by PCR. The generation of single allele replacement mutants 
using the f^C-contalning knockout cassette, however, was not so straighifomard. 
The generation of resistant clones required a much-increased DNA concentration and 
the percentage of correct recombination events was reduced to approximately 15%,
Due to the difficulties, described above, encountered with the use of the PAC- 
knockout construct, attempts at generating MCA2 and MCA3 null mutants were 
performed only with the /MC-containing heterozygotes already generated. Two 
independent PAC heterozygotes were transfected with the BSD knockout cassette 
and clones attained, by limiting dilution, that were resistant to both antibiotics. 
Analysis demonstrated that two, of the six clones generated, had lost both copies of 
the MCA2 and MCA3 locus. The remaining four clones, although resistant to both 
antibiotics, still possessed a copy of the native MCA2/3 locus.
To illustrate both the correct integration of the knockout cassettes and deletion of the 
MCA2 and MCA3 locus, a PCR analysis was performed on genomic DNA isolated 
from the mutant parasites (Figure 5.2). To confirm the correct integration of the 
knockout cassettes, oligonucleotide primers were designed to be specific to regions 
immediately upstream and downstream, respectively, of the 5’ and 3’ flanking 
regions used in the knockout strategy. These were then used in combination with 
BSD and PAC gene-specific primers to illustrate the correct integration of the 
knockout cassettes in both the single allele heterozygotes and bmca2/3 mutants. To 
show loss of the MCA2 and MCA3 locus, PCR was performed using primers specific 
to these genes. The predicted product sizes for the 5’ and 3’ BSD integration PCRs 
were 792 and 900 base pairs, respectively. For the 5’ and 3’ PAC integration PCRs 
the predicted products were 792 and 1052 base pairs, respectively, while the MCA2 
and MCA3 specific primers produce a product of 641 base pairs. The analysis 
revealed that both the single allele and two independent knockout mutants had the 
correct integration of resistance markers, and also that MCA2 and MCA3 were no 
longer detectable in the IS,mca2/3 parasites.
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To further confirm these knockouts, a Southern blot analysis was performed on 
genomic DNA prepared from mutant parasites. Physical maps of the native locus, 
and the modified locus upon replacement with either BSD or PAC knockout cassettes 
were generated, allowing prediction of the fragment sizes generated upon digestion 
with the restriction enzyme Kpnl (Figure 5.3A). Upon probing the Southern blot 
with the 5’ flanking region used in the knockout strategy, gene fragments of the 
predicted sizes were detected. A fragment of approximately 9 kb, as predicted for 
the native locus, was detected in both wild type and the single allele heterozygotes, 
but was absent from the two independent null mutants. Fragments of 1,7 and 1.9 kb, 
as predicted for the BSD and PAC replacement loci, respectively, were detected in 
the appropriate single allele heterozygotes and the two independent null mutants 
(Figure 5.3B). Despite a high stringency wash step, an additional faint band of 
approximately 4 kb, of unknown identity, was also detected in all extracts. These 
data further confirmed the correct integration of the knockout cassettes and deletion 
of both MCA2 and MCA3.
Western blot analysis was also performed on wild type and the two independent 
tamcallZ mutants to confirm loss of protein. Whole cell lysates were prepared, 
subjected to SDS-PAGE and transferred to PVDF membrane prior to probing with 
anti-MC42/3 specific antibodies (Figure 5,4). Proteins running at approximately the 
predicted sizes of MCA2 and MCA3, of 38 and 39 kDa respectively, were detected 
in wild type extracts but were absent from the two independent lSmca2/3 parasites, 
termed clones 1 and 2. This analysis further illustrated the deletion of MCA2 and 
MCA3 from the Amca2/3 parasites. The non-specific cross-reacting protein detected 
in the Western blots acts as an in built loading control and demonstrates equal 
loading.
5.2 Re-expression of MCA2 and MC43 in Amca2/3 BSF parasites.
The generation of Amca2/3 mutants made it possible to generate parasites re­
expressing either MCA2 or MCA3 independently. Both MCA2 and MCA3 had 
previously been cloned, sequenced to ensure fidelity and used in E. coli expression
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work by Gareth Westrop and Sanya Sanderson (University of Glasgow). These 
genes were individually sub-cloned into the T. brucei re-expression vector designed 
for integration into the a|3 tubulin array, as previously described in chapter 3. 
AmcallS clone 1 was transfected with each of these constructs and clones obtained 
by limiting dilution using bleomycin as the selection drug. Whole cell extracts were 
then prepared from both Amca2/S:MCA2 and Amca2/3\MCA3 clones, subjected to 
SDS-PAGE, transferred to PVDF membrane and probed with anti-MC42/3 
antibodies (Figure 5.5). The Western blot analysis illustrated that the re-expression 
of both genes was successful and that the protein levels were similar to wild type 
parasites. This experiment further confirmed the identity of MCA2 and MCA3.
5.3 In vitro and in vivo analysis of Amca2/3 parasites.
The ability to generate Amca2/3 parasites demonstrated that these two genes are non- 
essential in vitro, as the previous RNAi experiments had suggested. These mutant 
parasites displayed no obvious phenotypic or morphological alterations as a result of 
loss of the two metacaspase genes, and a comparative analysis of growth rates in 
vitro revealed no pronounced alterations (Figure 5.6A). To determine whether 
MCA2 and MCA3 might be more important in a natural infection, wild type parasites 
were compared to Amca2f3 clone 1 in vivo using the mouse strain BALB/c as a 
model. Both wild type and Amca2l3 clone 1 parasites were initially passaged 
through mice, parasitaemia determined and a group of six mice for both lines 
injected interperitoneally with a parasite load of 1x10  ^per animal and parasitaemia 
monitored over the course of the infection. Only two time points could be recorded 
(days 3 and 4 (Figure 5.6B)), as the experiment had to be terminated on day 4 due to 
the high parasitaemia within the animals and numbers were too low on day 2 to 
make a recording. The data obtained illustrate that the deletion of MCA2 and MCA3 
from BSF parasites does not appear to affect either the virulence or growth rate of 
Amca2/3 parasites in BALB/c mice.
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5.4 Knockout of MCAS in BSF and PCF T, brucei.
MCA5 is a single copy gene and is expressed in both PCF and BSF parasites 
(Chapter 3). Previous RNAi experiments had suggested that knockout of MCA5 in 
both of these life stages would be possible. However, the RNAi experiments also 
suggested that generation of a triple metacaspase null mutant might not be possible 
(Chapter 4). To test this hypothesis a similar strategy was adopted for the knockout 
of MCA5 to that which had been used successfully for the deletion of MCA2 and 
MCA3. Oligonucleotides were designed to amplify regions of approximately 750 
base pairs flanking the MCA5 gene (Figure 5.7A) and PCR performed on genomic 
DNA (strain 427). These flanking regions were then sequenced to ensure fidelity 
and exchanged for the MCA2/3 flanking regions in pGL802, the BSD knockout 
vector used in the Amca2/3 generation. To allow for the possible generation of 
Amca2/3Amca5 parasites it was necessary to replace the two resistance genes used 
previously, BSD and PAC, with two distinct markers. The two chosen were HYG 
and NEO, and the sequences for these genes were exchanged for the BSD gene in 
pGL802 to generate pGL906 and pGL907 (Figure 5.7B).
Initially these constructs were used to attempt deletion of MCA5 from both wild type 
BSF (strain 427) and PCF (EATRO 795) parasites. Both BSF and PCF parasites 
were transfected with the knockout cassettes excised from pGL906 and pGL907, and 
clones attained by limiting dilution using the appropriate antibiotics. Single allele 
MCA5 replacements were generated easily in both BSF and PCF parasites with all 
clones analysed having the correct integration as assessed by PCR. These 
heterozygotes were then used for a second round of transfections to generate AmcaS 
parasites in both life stages. Two independent clones, termed clones 1 and 2, were 
generated for both life stages.
To illustrate both the correct integration of the knockout cassettes and deletion of the 
MCA 5 locus, a PCR analysis was performed on parasite genomic DNA isolated from 
mutant parasites. Oligonucleotide primers were designed to be specific for regions 
immediately upstream and downstream of the 5’ and 3’ flanking regions used in the
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knockout strategy. These were used in combination with HYG~ and NEO~ specific 
primers to test for correct integration of the knockout cassettes in both the single 
allele heterozygotes and AmcaS mutants (Figure 5.8). The predicted product sizes 
for the 5’ and 3’ HYG integration FCRs are 2246 and 2545 base pairs, respectively. 
For the 5’ and 3’ NEO integration PCRs the predicted products were 2023 and 2098 
base pairs, respectively, while the MCA5 gene-specific primers produce a product of 
1500 base pairs. The analysis revealed that both the Amca5 clones generated in the 
BSF and PCF had the correct integration of resistance markers, and also that MCA5 
was no longer detectable (Figure 5.9). All further discussion related to the AmcaS 
BSF and PCF parasites will refer to clone 1 unless otherwise stated.
To confirm the deletion of MCA5, whole cell lysates were prepared from BSF and 
PCF wild type and AmcaS parasites. These were then subjected to SDS-PAGE, 
transferred to PVDF membrane and immunoprobed with anti-MC45 antiserum 
(Figure 5.9). The Western analysis shows that the single protein running at 
approximately the predicted size of MCA5, 55 kDa, was present in wild type but 
absent from the AmcaS extracts. This confirmed that MCA5 deletion was possible in 
both life stages.
5.5 In vitro analysis of AmcaS parasites.
The generation of AmcaS mutants in both BSF and PCF parasites confirmed that, as 
suspected, MCAS is a non-essential gene in both life stages. AmcaS parasites 
displayed no gross morphological alterations relative to wild type and a comparison 
of the growth rates of wild type and AmcaS in both the PCF and BSF parasites 
revealed that there were no pronounced alterations in growth rate (Figure 5.10). 
Therefore it appears that the deletion of MCAS results in no obviously detrimental 
effect to T. brucei in vitro.
5.6 Knockout of MCAS in Amca2/3 BSF parasites.
While the ability to generate single Amca2/3 and AmcaS parasites had been predicted 
from the RNAi studies (Chapter 4), the situation with the triple deletion of all three
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genes in the BSF was less clear. Unlike the MCAH3 and MCA5 RNAi studies, no 
clones had been analysed where silencing of the all three metacaspases using RNAi 
did not adversely affect the parasites. Although this was suspected to be at least 
partially due to an artefact of the technique, the data available were insufficient to 
conclude this with certainty.
To address these questions, the Amca2l3 BSF clone 1 previously generated was 
transfected with either the HYG and NEO MCA5 knockout cassettes and clones 
attained by limiting dilution using the appropriate antibiotics. Analysis of resistant 
parasites illustrated that all of the heterozygotes generated had the correct integration 
of the knockout cassettes as assessed by PCR. Second round transfections were then 
subsequently performed in both the HYG and NEO heterozygotes and two 
independent, double-resistant clones attained, termed clones 1 and 2. A PCR 
analysis, using the same strategy as illustrated in figure 5.8, was performed to 
demonstrate correct integration of the knockout cassettes and loss of MCA5 (Figure 
5.12). The analysis revealed that both the Amca2/3AmcaS clones generated had the 
correct integration of resistance markers, and also that MCAS was no longer 
detectable. All further discussion related to the Amca2/3AmcaS parasites will refer 
to clone 1 unless otherwise stated.
To confirm the deletion of MCAS, whole cell lysates were prepared from both wild 
type and Amca2l3AmcaS clone 1 BSF parasites, subjected to SDS-PAGE, transferred 
to PVDF membrane and immunoprobed with both 2lvY\-MCA2/3 antibodies and anti- 
MCAS antiserum (Figure 5.13B). The Western analysis confirmed that the parasites 
lacked MCA5 and illustrated that MCAS deletion is possible in Amca2/3 parasites.
5.7 Re-expression of MCA2, MCA3 and MCAS in Amca2/3AmcaS BSF parasites. 
With the generation of Amca2/3AmcaS mutants, it was possible to generate parasites 
expressing any of MCA2, MCA3 or MCAS independently. The constructs required 
for MCA2 and MCA3 re-expression had already been generated (pGL867 and 
pGL868 (Chapter 3)), although it was necessary to create a vector for the MCAS re-
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expression. MCA5 had already been cloned, sequenced to ensure fidelity and used to 
produce recombinant protein within E. coli for the generation of antibodies (Chapter 
3). The sequence for MCA5 was now sub-cloned into the T. brucei re-expression 
vector designed for integration into the ap tubulin array (previously described in 
chapter 3) to generate pGL927. Amca2!3Amca5 parasites were transfected 
individually with the three re-expression cassettes, excised from their respective 
vectors, and clones obtained by limiting dilution using bleomycin as the selection 
drug. Whole cell extracts were then prepared from Amca2/3Amca5\MCA2, 
Amca2/3Amca5:MCA3 and Amca2/3Amca5:MCA5, subjected to SDS-PAGE, 
transferred to PVDF membrane and probed with both anti-MCA2/3 antibodies and 
anti-MCA5 antiserum (Figure 5.13). The Western blot analysis illustrated that the 
re-expression of all three genes had been successful and at similar protein levels to 
wild type parasites.
5.8 In vitro and in vivo analysis of AmcaliSAmcaS BSF parasites.
The ability to generate Amca2/3AmcaS parasites demonstrates that MCA2, MCA3 
and MCAS are non-essential genes (at least under the conditions tested) and further 
questions the validity of the RNAi phenotype discussed in chapter 4. Interestingly, 
while the generation of AmcaHSAmcaS BSF parasites was possible, a phenotype was 
observed upon their generation. Amca2/3mcaS mutants initially displayed a reduced 
growth rate, taking a longer time than expected for the clones to grow following the 
transfection. Usually BSF (strain 427) parasites require passaging approximately six 
days after transfection and cloning, due the rapid growth rate of this strain. In the 
Amca2/3AmcaS parasites, however, this period was extended to 13 days. This 
phenomenon was also observed in Amca2/3 AmcaS clone 2. A comparison of growth 
rate of the Amca2/3AmcaS and wild type parasites was performed, which highlighted 
this reduced growth rate (Figure 5.14A). This reduced growth rate was not 
permanent, however, and after approximately two weeks of culturing and successive 
passages the growth rate returned to wild-type levels (Figure 5.14B). This 
phenomenon had not been observed in the single MCAS knockouts in either the BSF 
or PCF.
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To determine whether there might be a difference between wild type and 
Amca2/SAmcaS with regard to infectivity or growth rate in vivo, a comparison 
between growth of the two lines in ICR mice was performed. This was carried out 
following the apparent adaptation period, and at which time both wild type and 
Amca2/3AmcaS had equivalent growth rates in vitro. Each cell line was passaged 
once through a mouse, parasitaemia determined and a group of six mice for both 
lines injected interperitoneally with a total of 1x10  ^parasites per animal. The course 
of infection was followed by 24-hourly assessments of infected blood from the third 
day post injection onwards (Figure 5.14C). The data illustrate that the 
Amca2/3AmcaS parasites showed no reduction in either virulence or growth rate 
compared to wild type parasites.
5.9 Analysis of recycling processes in Amca2/3AmcaS BSF parasites.
As the metacaspases were found to be associated with Rabll positive recycling 
endosomes (Chapter 3), further phenotype analysis on the Amca2/3AmcaS parasites 
focused upon recycling processes. Recycling of surface molecules has been well 
characterised in the BSF, while in the PCF very little is known and no molecules that 
are actively recycled have been identified. In the BSF there are two cell surface 
molecules known to be actively recycled, VSG (Seyfang et al., 1990) and the 
transferrin receptor (Kabiri and Steverding, 2000).
5.9.1 VSG recycling is unaffected in Amca2/3AmcaS parasites.
The rapid recycling of VSG is considered essential for survival of the BSF in vivo, as 
it is viewed as a secondary defence against the immune response by clearing host 
anti-VSG antibodies from the cell surface. It has been reported that the rate of 
endocytosis in T. brucei is extremely rapid, the total VSG cell surface pool can be 
turned over in 12 minutes (Engstler et al., 2004). Due to the high stability of VSG, 
the majority of this internalised VSG is recycled back to the surface (Seyfang et al, 
1990), while host anti-VSG antibodies are degraded and secreted (O'Beirne et al., 
1998) via Rabll positive endosomes (Pal et al., 2003).
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A comparison between wild type and Amca2/3Amca5 parasites was performed to 
determine whether the metacaspases might be involved in the recycling of VSG. To 
examine VSG recycling, the parasite’s surface coat was biotinylated with NHS-SS- 
Biotin at 4°C for 10 mins prior to returning to 37°C for 5 mins to allow endocytosis 
to reach a steady state (GrUnfelder et al., 2003). The removal of any biotin label 
remaining on the cell surface was facilitated through the incubation of parasites with 
50 mM glutathione for 7 mins at 4°C, resulting in the cleavage of the disulphide 
bond present within the biotin label. Whole cell extracts were prepared at this point, 
subjected to SDS-PAGE, transferred to PVDF membrane and probed with a 
streptavidin-HRP conjugate (Figure 5.15A). A single protein, with an equivalent 
intensity, was detected in both wild type and Amca2/3AmcaS extracts, demonstrating 
that the endocytosis of Biotin-VS G was still functional following deletion of the 
metacaspases. Following the cleavage of cell surface biotin, parasites were 
resuspended in HMI-9 at 37°C for 1 hour to allow time for internalised Biotin-VSG 
to be recycled back to the cell surface. Parasites were then prepared for IFA and 
Biotin-VSG detected using a streptavidin-TexasRed conjugate. Parasites were also 
co-stained using rabbit anti-Rabl 1 antibodies (Figure 5.15B). This analysis revealed 
that in both wild type and Amca2/3AmcaS parasites internalised Biotin-VSG co­
localised with Rabll. Additionally, following the 1 hour chase period, both wild 
type and Amca2/3AmcaS parasites were able to recycle this internalised VSG and 
return it to the cell surface. Therefore, it appears that the loss of MCA2, MCA3 and 
MCA5 does not prevent endocytosis of VSG, the trafficking through Rabl 1 positive 
vesicles or its subsequent return to the cell surface.
5.9.2 Anti-VSG antibody degradation is unaffected in Amca2/3AmcaS parasites.
Having shown that MCA2, MCA3 and MCA5 do not appear to be essential for the 
recycling of VSG, the possibility of a role in anti-VSG antibody degradation was 
examined. It has been documented previously that internalised anti-VSG antibodies 
partially co-localised with Rabll recycling endosomes (Jeffries et al., 2001) and 
therefore, by inference, with MCA5, which we have confirmed (Chapter 3).
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To study these processes, it was first necessary to determine the VSG isoform 
expression in both the wild type and Amca2/3AmcaS parasites. The BSF 427 strain, 
in which the knockouts were performed, is a monomorphic laboratory-adapted cell 
line. The VSG switching rate in this cell line is extremely low, estimated to be 
around 1 per 10^  cells, compared to a pleomorphic line, where switching occurs at 
around 1 per 10^  cells (Turner and Barry, 1989). Additionally, the absence of 
selective pressure in vitro will result in the VSG expression remaining highly stable. 
Previous work on this strain has identified that VSG221 is the predominant isoform 
expressed, and polyclonal antibodies against this are readily available. As the 
generation of null mutants required several rounds of transfection and subsequent 
cloning, there was a possibility that the Amca2/3AmcaS parasites, which had been 
cloned four times, may have switched to a differential VSG isoform. To examine 
this possibility, whole cell lysates prepared from wild type, Amca2/3, AmcaS, and 
Amca2/3AmcaS parasites were subjected to SDS-PAGE, transferred to PVDF 
membrane and probed with polyclonal rabbit anti-VSG221 antibodies (Figure 5.16). 
Although overexposed, the Western blot revealed that all of the metacaspase 
knockout mutants generated were expressing the same VSG isoform as wild type 
parasites, namely VSG221. This observation was important, as a direct comparison 
of wild type and mutant parasites with regard to anti-VSG degradation requires them 
to be expressing the same VSG isoform.
The peptidases responsible for the degradation of anti-VSG antibodies have not been 
characterised, nor has the compartment where this occurs been identified. The 
localisation of the metacaspases within recycling endosomes, which traffic these 
anti-VSG antibodies, raises the possibility that they might be involved in the process. 
To investigate this hypothesis, parasites were labelled with a polyclonal rabbit anti- 
VSG221 antibody at 4°C for 30 mins, washed extensively and incubated at 37°C for 
a further 30 mins. Following this period, parasites were examined by IFA to confirm 
that no significant amounts of antibody remained on the surface (Figure 5.Î7A). 
Whole cell lysates (Figure 5.I7B) and TCA precipitations of the culture medium 
(Figure 5.18) were then subjected to SDS-PAGE, transferred to PVDF membrane
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and probed with an anti-rabbit HRP conjugate to determine the fate of these 
antibodies.
Examination of cell-associated anti-VSG221 antibodies illustrated that there was no 
build up of anti-VSG221 antibodies within Amca2/3AmcaS parasites compared to 
wild type parasites (Figure 5.17B). A single protein was detected at equivalent 
levels in both cell lines. It is believed to be rabbit heavy chain IgG, which has a 
predicted size of 45 kDa. Analysis of the secreted products illustrated that the 
degradation of the anti-VSG antibodies was unaffected in Amca2/3 AmcaS parasites 
(Figure 5.18). While there was some intact heavy chain detected, there were 
degradation products as well. However, the degiadation profile is identical in both 
wild type and Amca2/3AmcaS parasites. These data show that the Amca2/3AmcaS 
parasites are still functional with regard to anti-VS G antibody internalisation, 
degradation and secretion and shows that the absence of MCA2, MCA3 and MCA5 
from recycling endosomes does not affect this process.
5.9.3 Transferrin uptake is unaffected in Amca2/3AmcaS parasites.
Rabl 1 positive recycling endosomes have also been characterised with regard to the 
recycling of the T. brucei transferrin receptor (Pal et al, 2003). The T. brucei 
transferrin receptor is a low abundance protein, encoded by two homologous genes 
ESAG6 and ESAG7 (Steverding et al., 1994; Salmon et al., 1994), limited in its 
distribution to the flagellar pocket (Steverding et al, 1994). Following 
internalisation of the receptor-transferrin complex, the reduction in pH within the 
endosomal system is believed to cause dissociation of transferrin from the receptor 
(Dautry-Varsat et al., 1983; Maier and Steverding, 1996). The transferrin receptor is 
then recycled back to the flagellar pocket via Rabll positive recycling endosomes 
(Jeffries et al., 2001) and degraded transferrin secreted (Steverding et al., 1995; Pal 
et al., 2003). To investigate whether the metacaspases might be involved in this 
pathway, a comparison of transferrin uptake, degradation and secretion was 
performed in wild type and Amca2/3AmcaS. BSF parasites were incubated with a 
human transferrin-biotin conjugate and whole cell lysates prepared following 5, 10,
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15 and 60 mins, together with a 10 mins chase. These lysates were then subjected to 
SDS-PAGE, transferred to PVDF and probed with a streptavidin-HRP conjugate 
(Figure 5.19A). The Western analysis revealed that both wild type and 
Amca2/3AmcaS parasites were able to internalise approximately equal levels of 
transferrin over the time points examined. If a defect in transferrin receptor 
recycling was evident we might have expected to see less internalised transferrin 
over the period, this was not observed. Following the 10 mins chase period no 
transferrin was detectable in either wild type or Amca2/3AmcaS parasites, suggesting 
that the degradation of transferrin was also unaffected by loss of MCA2, MCA3 and 
MCA5. To examine the degradation products of transferrin, TCA precipitation was 
also performed on the culture medium following the chase period. Upon probing, 
however, there were found to be barely detectable levels of the transferrin biotin 
conjugate and no detectable degradation products, as had been seen in the 
comparable anti-VSG antibody experiment (not shown). It has been reported that T. 
brucei is able to regulate the expression of the transferrin receptor dependent on the 
availability of transferrin within the culture medium (Fast et ah, 1999; Mussmann et 
ah, 2004). If the transferrin uptake pathway was detrimentally affected by 
metacaspase deletion, then the expression of the transferrin receptor might, 
theoretically, be up regulated. Therefore, whole cell lysates were prepared from wild 
type and Amca2/3AmcaS clones 1 and 2. These lysates were then subjected to SDS- 
PAGE, transferred to PVDF membrane and immunoprobed with anti-transferrin 
receptor antibodies (Figure 5.19B). The Western analysis detected both ESAG6 and 
ESAG7 at approximately equivalent levels in wild type and mutant parasites. The 
presence of double bands represents differential glycoyslation of the proteins 
(Steverding D. 2004). In conclusion, the data gathered on the transferrin pathway 
suggest that the deletion of MCA2, MCA3 and MCAS does not affect normal 
transferrin uptake or degradation in BSF parasites.
5.10 Responses to stressful stimuli in wild type and Amca2/3Amca5 parasites.
Having been unable to detect any differences between wild type and Amca2/3 AmcaS 
with regard to recycling processes, other possibilities for metacaspase function were
143
investigated. As discussed earlier there have been reports of metacaspase
involvement in apoptotic-like phenomenon in yeast (Madeo et ah, 2002; Szallies et 
ah, 2002; Herker et ah, 2004; Wadskog et ah, 2004), although none specifically 
within T. brucei. Additionally there have been numerous reports of apoptotic-like 
cell death occurring within protozoa, including T. brucei, following a variety of 
stressful stimuli, although none of these have been linked directly with metacaspase 
function (for review see Debrabant et ah, 2003).
The exposure of parasites to such stimuli had previously been performed when 
attempts were made to activate processing of the metacaspases in wild type parasites 
(Chapter 3). The stimuli used to compare wild type and Amca2/3Amca5 parasites 
responses to stressful conditions were heat shock and exposure of parasites to salt 
stress.
5.10.1 Comparison of response to heat shock.
It has been reported that L. amazonensis upon heat shock undergo cell death 
displaying markers of apoptosis similar to higher eukaryotes (Moreira et ah, 1996). 
Although such a process has not been characterised in T. brucei, a comparative 
analysis of wild type and Amca2/3Amca5 BSF parasites was performed following an 
exposure to elevated temperatures. Both cell lines, at the same density, were 
incubated for 2 hours at 42°C and subsequently returned to normal growth 
conditions of 37°C. The 2 hour incubation period was chosen as incubations under 
this period had little apparent effect on parasite growth. Cell densities were counted 
on return to the 37°C temperature and again after a 4 hour period (Figure 5.20A). 
The control cells, which had not been subjected to the heat shock, continued to grow 
normally, while the density of the parasites exposed to the 2 hour heat shock did not 
increase over the 4 hours recovery at 37°C. Parasites were then re-suspended at 
5x10"^  cells m f’ in fresh medium with cell counts and re-seeding performed at 24 
hour intervals (Figure 5.20B). The analysis revealed that during the three-day period 
over which growth rates were monitored, the parasites exposed to the heat shock 
began to recover and approach control parasite growth levels. Importantly, however,
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both wild type and Amca2/3AmcaS parasites behaved in a similar manor with regard 
to the initial response to the heat shock and the more long term recovery.
5.10.2 Comparison of response to salt stress.
It has recently been documented that apoptotic-like cell death in yeast induced via 
salt stress was inhibited following metacaspase deletion (Wadskog et ah, 2004). In 
an attempt to determine if a similar relationship exists in T. brucei, a comparative 
analysis between wild type and Amca2/3AmcaS BSF parasites was performed. 
Cultures of both cell lines were set up at equal densities and grown in normal HMI-9 
or with the addition of 125 mM NaCl (Figure 5.21A). Cell densities were monitored 
over a 5 hour period with the analysis revealing that this salt concentration was 
highly toxic to the parasites. However, reducing the concentration to 62.5 mM was 
observed to have little effect on parasite culture densities over the same period (not 
shown). A comparison of the growth curves for both wild type and Amca2/3 AmcaS 
revealed that cell death occurred at a similar rate in both cell lines over the period 
examined. Parasites were then washed extensively and re-seeded at 5x10^  ^cells ml'  ^
in fresh medium with cell counts and re-seeding performed at 24 hour intervals 
(Figure 5.21B). The analysis revealed that the recovery from salt stress, although not 
completed during the period of examination, occurred similarly in both wild type and 
Amca2/3AmcaS parasites.
5.10.3 Recovery from high cell densities.
While maintaining BSF wild type and Amca2/3AmcaS mutants in culture it was 
observed that mutant parasites upon reaching late log giowth phase took longer to 
recover when re-seeded than their wild type counterparts. BSF parasites cultures in 
vitro begin to plateau, with regard to growth rate, when cell density exceeds 1.5x10  ^
cells ml"\ It is possible to grow parasites to densities in excess of 5x10^ cells ml \  
although cultures rapidly begin to die at this stage. To investigate these observations 
further, a comparison of this phenomenon was performed in wild type, Amca2/3, 
AmcaS and Amca2/3AmcaS BSF mutants. Parasites were maintained in culture until 
apparent stationary phase was reached. Although it was not possible to have all
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cultures reaching the exact same density, all cultures were grown in excess of 4x10^ 
cells ml"\ These cultures were then re-seeded in fresh medium at 5x10"^  cells ml’’, 
cell counts made and re-seeded at SxlO"*^  cells/ ml'  ^ every 24 hours to monitor the 
recovery (Figure 5.22A).
An analysis of the growth curves revealed that the wild types parasites were able to 
return to normal growth rates fairly rapidly. The growth rate over the first 24 hour 
period after re-seeding was much reduced but after this period growth rate returned 
to normal levels. This was not observed, however, in either the Amca2/3 or 
Amca2/3AmcaS parasites. The return to status quo took much longer, growth rates 
in these two mutants not returning to wild type levels until 7 days after the initial re­
seeding, Both of these clones behaved very similarly, suggesting that this phenotype 
is the result of MCA2 and MCA3 deletion alone. The Amca2/3AmcaS parasites, 
generated from the Amca2/3 parasites, showed no further reduction in their ability to 
recover. As further evidence that this phenotype was the result of MCA2 and MCA3 
deletion, the AmcaS mutant behaved much more similarly to wild type parasites with 
a return to normal growth occurring after 48 hours.
Having previously generated individual MCA2 and MCA3 re-expressers in the 
Amca2/3 parasites, experiments were performed to test if expression of individual 
genes could complement this phenotype. The growth curves were repeated with 
wild type, Amca2/3 clone 1, together with Amca2/3:MCA2 and Amca2/3:MCA3 
parasites, with recovery rates monitored over 4 days (Figure 5.22B). As shown 
previously, Amca2/3 parasites did not return to the same growth rate as wild type, 
however no complementation of this phenotype was observed as both of the re- 
expressers showed similar giowth rates to the Amca2/3 parasites.
5.10.4 Ability to adapt to reduced serum concentrations.
In addition to observations regarding recovery from high densities, another 
phenotype identified with the mutant parasites was an inability to adapt to reduced 
serum concentrations. Normal BSF HMI-9 medium contains a final volume of 20%
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(v/v) serum; this is made up of 10% FCS and 10% serum plus. The rationale for 
performing these experiments was that the metacaspases, shown to be associated 
with the Rabll positive recycling compartment, might have been involved in the 
transferrin uptake pathway. Transferrin is provided to the parasites exclusively in 
serum and by reducing the serum concentration the amount of available transferrin 
will be reduced. For these experiments it was decided to reduce serum concentration 
by 10-fold from 20% (v/v) to a final concentration of 2%. Wild type, Amca2/3, 
AmcaS and Amca2/3AmcaS parasites were seeded at 5x10"^  cells/ml in HMI9 
containing a final serum concentration of 2%. Growth rates were followed with re­
seeding at 5x10"^  cells/ml performed daily (Figure 5.23A).
This analysis revealed that all of the parasite cultures showed a much decreased 
growth rate over the first 24 hours. However, while Amca2/3 and Amca2/3AmcaS 
parasites continued to grow at this reduced rate, wild type and AmcaS parasites 
seemed better able to adapt to these conditions and in subsequent periods the growth 
rate increased significantly. Therefore this phenotype again appeared to be 
dependent only upon MCA2 and/or MCA3 deletion and not MCAS deletion. 
Additionally, this phenotype was detected in the two independent Amca2/3 clones 
generated (Figure 5.23B). This further analysis also highlighted that this apparent 
adaptation in wild type parasites was not permanent. On day 4 it was observed that 
growth rate began to decline in the wild type parasites and it was observed that 
maintenance in conditions of reduced serum for an extended period ultimately 
resulted in death of all cultures.
This again appeared a promising phenotype to investigate, however all attempts to 
complement this phenotype also failed. The Amca2/3:MCA2 and Amca2/3:MCA3 
parasites showed no complementation (Figure 5.23C), with the growth rate of the re- 
expressers closely matching those of the Amca2/3 parasites.
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5.11 Dual re-expression OÎMCA2 and MCA3 in Amca2/3 parasites.
Whilst none of the attempts to complement either of the observed phenotypes had 
been successful, we wondered whether the re-expression of both MCA2 and MCA3 
might be required for complementation. This was attempted in the Amca2/3 
parasites for several reasons. Firstly, as described both phenotypes were present in 
Amca2/3 parasites and the additional deletion of MCA5 did not acerbate either 
phenotype. Secondly, the dual re-expression of MCA2 and MCA3 in the Amca2/3 
parasites would return the full complement of metacaspase genes to the parasites and 
therefore should enable a determination of the reality of this phenotype. Thirdly, for 
practical reasons the re-expression of MCA2 and MCA3 in the Amca2/3AmcaS 
parasites would require the use of six drug resistance markers, four used to generate 
the mutant and one for each of the re-expressed genes. There are not currently this 
many drug resistance markers for use in T. brucei BSF.
To perform the dual re-expression of MCA2 and MCA3, Amca2/3:MCA2 parasites 
were transfected with the MCA3 re-expression cassette. However, to permit 
selection it was necessary to exchange the BLE resistance gene within the MCA3 re­
expression construct for the HYG resistance gene, the Amca2/3:MCA2 parasites 
already being resistant to bleomycin. The modified MCA3 re-expression cassette 
was then excised from the vector (pGL1079), used to transfect Amca2/3:MCA2 
parasites and clones attained by limiting dilution.
To determine if the re-expression of MCA3 had been successful, whole cell lysates 
were prepared from wild type, Amca2/3, Amca2/3:MCA2, Amca2/3:MCA3 and the 
newly generated Amca2/3:MCA2:MCA3 parasites. These extracts were then 
subjected to SDS-PAGE, transferred to PVDF and probed with anti-MCA2/3 
antibodies (Figure 5.24). The Western blot analysis confirmed that the dual re­
expression of MCA2 and MCA3 in the Amca2/3 parasites had been successful, with 
the expression from the tubulin locus producing levels of expression similar to wild 
type parasites. With the generation of dual re-expressers it was possible to test the 
hypothesis that both genes might be required for complementation of the observed
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phenotypes. Both the recovery from high densities and reduced serum experiments 
were repeated in wild type, Amca2/3, Amca2/3:MCA2, Amca2/3:MCA3 and 
Amca2/3:MCA2:MCA3 parasites (Figure 5.25). However, despite the re-expression 
of both metacaspases genes, and a return to a full complement of metacaspases, there 
was no rescue of either of the phenotypes.
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5.12 Discussion.
5.12.1 Generation of mutants.
The genetic knockouts of the metacaspases were able to answer some of the 
questions raised from the RNAi studies. The RNAi experiments on MCA2 and 
MCA3 in the BSF had suggested that these were non-essential genes. This could not 
be claimed definitively, however, because the possibility remained that even with a 
highly reduced expression of MCA2 and MCA3 their functions might still be 
sufficiently fulfilled. The generation of knockout mutants however, confirmed that 
MCA2 and MCA3 are non-essential genes in vitro, the clones generated being 
indistinguishable from their wild type progenitors in terms of growth rate and gross 
morphology. Similarly the deletion of MCA5 in both PCF and BSF parasites 
confirmed what had been suggested by the RNAi studies, namely that MCA5 is also 
a non-essential gene in vitro. The deletion of MCA5 having no obviously apparent 
affects on either growth rate or morphology. We have previously speculated that 
there might be redundancy within the metacaspase family, particularly in the BSF 
where all three of the studied metacaspases are expressed. The knockout of MCA5 
in the PCF without any apparent detriment to the parasites suggests that these 
parasites can function adequately in the absence of the metacaspases. However, with 
no information of the expression profile of the two remaining metacaspases, MCAl 
and MCA4, this tentative conclusion may not hold up to further study.
Due to the expression of a larger number of the studied metacaspases, and the more 
active recycling system that the proteins have been shown to co-localise with, the 
analysis of mutants concentrated on the BSF. Although the Amca2/3 parasites 
showed no obvious phenotype in vitro, it was plausible to suggest that the 
metacaspases might be involved in interactions with the host in vivo. Cysteine 
peptidases of parasitic protozoa have been implicated in a variety of biological 
events, including immune evasion, pathogenesis and virulence. The CPB array of 
Leishmania mexicana, for example, has been shown to be involved in successful 
invasion and establishment in vivo (Denise et al., 2003), with a marked decrease in
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lesion size and parasite growth in mice observed upon deletion of this array. In 
Plasmodium falciparum, specific falcipain-1 inhibitors blocked parasite invasion of 
host erythrocytes (Greenbaum et ah, 2002). Metacaspase association with Rabll 
positive recycling endosomes also suggested that a role in vivo might be important. 
One of the features absent under normal in vitro culturing is an immune challenge. 
The removal of host antibodies bound to the parasite surface is facilitated during the 
active recycling of VSG for which Rabll positive recycling endosomes are 
intimately involved (Jeffries et al, 2001). If metacaspases were involved only in 
immune evasion, for example, the deletion of MCA2 and MCA3 might not be 
expected to manifest in vitro. However, when a comparison of wild type and 
Amca2/3 was performed in an in vivo mouse model of infection there was no 
difference between the two lines, the Amca2/3 parasites being able to establish an 
infection and grow at wild type levels. This suggests that MCA2 and MCA3 are truly 
non-essential genes and their functions are either not majorly important or can be 
compensated for. Upon generation of Amca2/3AmcaS BSF parasites, the in vivo 
study was repeated. It was decided to use adapted Amca2/3AmcaS parasites that 
were growing at wild type levels so any differences between the cell lines could be 
distinguished from the initial slow growth phenotype observed in vitro. However, as 
had been seen with the Amca2/3 parasites, the mutants were able to establish an 
infection and showed no reduction in growth rate in vivo.
There are limitations, however, with the in vivo model that was used in this study. 
The BSF 427 strain used to generate the null mutants is a laboratory-adapted 
monomorphic cell line (Cross and Manning, 1973) and is thus easy to maintain in 
vitro, which is obviously advantageous when performing work in vitro such as gene 
knockouts or RNAi studies. Unfortunately, this strain is not particularly practical in 
vivo, due to its rapid growth rate. The parasites replicate so rapidly that the mouse’s 
immune system is unable to react fast enough to control the infection and 
parasitaemia very rapidly reaches a point were the animal has to be killed. Natural 
T. brucei infections are typically chronic, with waves of parasitaemia occurring 
periodically. Chronic infections can be modelled in mice in vivo using pleomorphic
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parasites (Turner, 1999) although these are typically much more demanding with 
regard to in vitro culturing. It is debatable, therefore, whether the immune challenge 
is a major factor during the period in which the infections were followed in the BSF 
427 parasites. If the metacaspases are somehow involved in clearing host immune 
antibodies, as the subcellular location might suggest, it may be that the model used 
was simply not sensitive enough to detect this.
While a detailed analysis of Anca2/3 parasites had not been performed in vitro, as at 
least one further metacaspase is expressed in the BSF (namely MCA5) it seemed 
prudent to attempt the further gene deletion of MCA 5 before further phenotype 
analysis was performed. Whether the deletion of MCA5 would actually be possible 
from Amca2/3 parasites was open to question as the RNAi experiments suggested 
that the deletion of MCA2, MCA3 and MCA5 from the BSF might be either seriously 
detrimental or result in lethality (Chapter 4). Associated with this hypothesis was the 
idea of functional redundancy within the metacaspase family and it remained to be 
seen whether this redundancy hypothesis would hold up when the knockout of 
MCA5 in the Amca2/3 backgi'ound was performed. The ability to generate 
Amca2/3AmcaS mutants, however, illustrated that deletion of all three metacaspase 
genes was not lethal and that they are therefore non-essential genes in vitro. One 
observation of note, however, was the reduced initial growth rate (and the 
subsequent return to normal growth rate after successive passages) that was observed 
in two independent Amca2/3AmcaS clones. This phenomenon had not been 
observed when MCAS was deleted from BSF and PCF wild type parasites.
These observations would appear to suggest that the metacaspase do indeed have 
some level of functional redundancy, with the reduction in growth rate only being 
observed upon deletion of all three genes. It might be that in the BSF MCA2, MCA3 
and MCAS fulfil similar roles, such that if MCAS is deleted then MCA2 and MCA3 
are able to compensate and vica versa. However, when all three genes are deleted 
this creates a deficiency which manifests as a reduced growth rate. This could also
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be taken as evidence that MCAl and MCA4 are either not expressed or have separate 
functions to those of MCA2, MCAS and MCA5.
It was unfortunate for our analysis that this effect on growth rate was only a transient 
phenotype, with parasites apparently adapting to deletion of the metacaspases. One 
conclusion that can be drawn from this phenotype, however, is that, whatever the 
function of the metacaspases, they are active as full-length proteins and do not 
appear to be inducible, but are constitutively active. Caspases typically remain 
inactive within the cytoplasm and are only activated following cell surface receptor 
activation (Cohen, 1997) or cytochrome C release from mitochondria (Cai et al,, 
1998) - at which point cleavage into two subunits occurs. It has been reported that 
the single metacaspase (YCAl) in yeast was activated following exposure to reactive 
oxygen species (Madeo et ah, 2002). They reported both the processing of the 
metacaspase, concurrent increase in caspases-like activity and concluded therefore 
that YCAl acts similarly to caspases. Additionally, processing of Arabîdopsîs 
thaliana type II metacaspases following expression in E, coli has been reported 
(Vercammen et ah, 2004). Our data conflicts with these observations, the T. brucei 
metacaspases being apparently active without the requirement of processing.
The apparent adaptation of these mutants to loss of MCA2, MCA3 and MCA5 is 
intriguing. When the growth rate of the newly generated Amca2/3Amca5 parasites 
was initially compared to wild type there was a marked reduction. However, 
gradually over the subsequent period of around 2 weeks the growth rate of the 
parasites increased to match wild type levels. A simple selection process could 
explain how this occurred, with sequential passages positively selecting faster 
growing parasites. However, the mechanism underpinning this increased growth rate 
is uncertain. Adaptation has previously been discussed in the guise of 
complementation. The hypothesis formed was that the loss of MCA2 and MCA3 or 
MCA5 would not detrimentally affect the parasites, or the remaining metacaspases 
could fill in for their absence, or, in other words, adapt to the deletion. This type of 
adaptation occurred either immediately or extremely rapidly as no prominent
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phenotype was detected in either the Amca2/3 or AmcaS parasites. The adaptation 
following Amca2/3 AmcaS generation occurred over an extended period, suggesting a 
distinct process is occurring. The most obvious explanation for adaptation to loss of 
MCA2, MCA3 and MCAS would be MCAl and MCA4. These two metacaspases 
have not been examined in this study and nothing is known about them except their 
gene sequences. MCAl and MCA4 may have been upregulated in Amca2/3AmcaS 
parasites, but no antibodies are available at present to investigate this possibility.
5.12.2 Potential role in recycling endosomes.
In an attempt to discover a more robust and less transient phenotype than the sole 
observation of an initial reduction in growth rate, a detailed analysis of mutants was 
performed in relation to recycling endosomal functions. There are only two 
characterised recycling processes in T. brucei - involving VSG (Seyfang et ah, 1990) 
and the transferrin receptor (Kabiri and Steverding, 2000). VSG, the major surface 
coat molecule in T. brucei, is the primary defence against the immune response in 
the mammalian host through the process of antigenic variation (Cross et ah, 1980). 
The transferrin receptor, involved in the uptake of transferrin in the BSF, is a 
heterodimer encoded by ESAG6 and ESAG7 and its surface distribution is limited to 
the flagellar pocket (Steverding et ah, 1994).
The ability to generate Amca2/3AmcaS BSF parasites suggested that deletion of the 
metacaspases, whatever their possible functions, did not severely affect the recycling 
system. If the system had been affected, it is reasonable to assume that an adverse 
effect might manifest either in vitro or in vivo. Due to the high rate of endocytosis of 
VSG, the total surface pool being turned over in 12 mins (Engstler et ah, 2004), and 
its metabolic stability, it has been suggested that >95% of the internalised protein is 
recycled to the cell surface (Seyfang et ah, 1990; Engstler et ah, 2004). If this 
recycling was completely disrupted, the energy demands placed on the parasite 
through the de novo synthesis of sufficient VSG molecules would presumably be 
rather constrictive and wasteful. There remained the possibility, however, that the
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recycling processes may have been hindered in a way which could be detected 
through a more detailed analysis of the mutants.
An analysis of VSG recycling in vitro, however, revealed that the Amca2/3AmcaS 
parasites were still fully functional with regard to VSG recycling. This pathway was 
studied through the following of internalised Biotin-VSG, trafficking through Rabl 1 
positive recycling endosomes and subsequent return to the cell surface in both wild 
type and Amca2/3AmcaS BSF parasites. With no defect in the recycling of the VSG 
detected, the analysis shifted to the process of removal and degradation of host anti- 
VSG antibodies. The exact mechanism by which anti-VSG antibodies are separated 
from VSG and degraded during the recycling process is unknown. Whether the 
dissociation of antibodies from VSG occurs via a proteolytic clipping event or via a 
pH reduction has not been determined. Additionally, the peptidases involved in the 
degradation of these antibodies and the compartment where this occurs have yet to 
be characterised. Anti-VSG antibodies are known to be recycled via Rabl 1 positive 
recycling endosomes (Pal et ah, 2003; Grunfelder et ah, 2003) and we believe that 
the metacaspases are located within the lumen of these endosomes (Tetley, 
unpublished). Therefore, the metacaspases may physically interact with material 
present within these structures. Additionally, it has been reported that incubation of 
parasites with a cocktail of peptidase inhibitors resulted in a build up of internalised 
anti-VSG antibodies detected within vacuoles situated between the nucleus and the 
flagellar pocket (Russo et ah, 1993). This cocktail of inhibitors was made up of 
leupeptin, E64, chymostatin and antipain; a combination which should inhibit a wide 
range of both serine and cysteine peptidases. Our analysis revealed, however, that 
the Amca2/3AmcaS parasites displayed no equivalent build up of internalised anti- 
VSG antibodies and so suggests that inhibition of the metacaspases were not 
responsible for the build up of antibodies reported.
An analysis of antibody degradation products also revealed that the metacaspase are 
not required for the degradation of anti-VSG antibodies. The profile of the secreted 
antibody fragments exactly matching in both wild type and Amca2/3AmcaS
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parasites. This result was not too unexpected based, on what is known about the 
substrate specificities of other Clan CD peptidases. Unlike general proteolytic 
cysteine peptidases. Clan CD peptidases are more specific with regard to substrate 
specificity. Clostripain and asparaginyl endopeptidases are specific for asparagine at 
the PI position, gingipain R and separase show specificity toward arginine, while for 
the caspases an aspartate is preferred (Mottram et al., 2003). Additionally, it has 
been reported that the metacaspases also follow this rule of PI specificity, the A. 
thaliana metacaspases cleaving exclusively after arginine or lysine residues 
(Vercammen et a l, 2004).
As the data showed that metacaspases were not apparently involved in VSG and 
anti-VSG antibody recycling, we next examined the transferrin pathway. It is 
possible to directly follow transferrin receptor recycling through expression of 
tagged versions of the receptor with an inducible gene expression (Kabiri and 
Steverding, 2000). However, due to a lack of further resistance markers this strategy 
could not be pursued in the Amca2/3Amca5 parasites already generated. The 
strategy utilised to investigate transferrin receptor recycling pathway had to be 
indirect, therefore, and was performed via the following of transferrin uptake. The 
T. brucei transferrin receptor is a relatively low abundance protein estimated to be 
present at approximately 3000 molecules per cell (Steverding et aL, 1995) and the 
cycling time has been estimated at around 11 mins (Kabiri and Steverding, 2000). It 
was assumed in our analysis that a defect in recycling of the receptor would result in 
a reduced rate of transferrin uptake over time. However, no difference in the levels 
of cell associated Biotin-transferrin were detected between wild type and 
Amca2/3 AmcaS parasites over the course of the experiment (1 hour). This suggests 
that there is no defect in the recycling of the transferrin receptor, although due to the 
indirectness of the analysis this cannot be stated with certainty. It might be that the 
de novo synthesis of receptors is able to match any defect in recycling.
The rate of degradation of the transferrin-biotin conjugate was also not altered in the 
Amca2/3 AmcaS parasites relative to wild type. Following a 10 mins chase period, no
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transferrin biotin conjugate was detected within the parasites. This suggests that the 
degradation of transferrin occurs very rapidly within the parasites and that the 
metacaspases are not involved in the degradation process. Like the anti-VSG 
antibodies, the compartment in which transferrin is degraded has not been fully 
categorised. It has been reported that transferrin, following internalisation is routed 
to lysosomal-like structures for degradation (Grab et aL, 1992; Steverding et aL, 
1995). However, more recently it has been suggested that the degradation of 
transferrin occurs within either the early or recycling endosomes. The proteolysis of 
transferrin was increased by the expression of the mutant Rab proteins that slowed 
the overall recycling rate, while a decrease in proteolysis was observed by the over 
expression of Rabl 1 which accelerated recycling (Pal et al, 2003).
Despite questions regarding the compartment where degradation takes place it is 
accepted that the degraded products are secreted from the parasites (Steverding et al., 
1995; Pal et al, 2003). Attempts to detect these fragments and perform a 
comparison between wild type and Amca2/3AmcaS were unsuccessful. No 
degradation products were detected within the parasites similar to what was seen 
with the anti-VSG antibodies experiment. However, unlike the anti-VSG antibody 
experiment, no degradation products were detected in the TCA medium 
precipitations. In previous experiments degradation products of transferrin have 
been detected in the medium (Pal et a l, 2003), although these utilised FITC- 
transferrin and the failure to detect degraded fragments may be due to the biotin 
probe not being suitable for this purpose.
This phenotype analysis was performed on the Amca2/SAmcaS after the apparent 
adaptation period, and once the growth rate had returned to wild type levels. With 
hindsight, it might have been more prudent to perform these experiments on newly 
generated Amca2/3AmcaS parasites which were still exhibiting the reduced growth 
rate. It is feasible to suggest that a defect in either VSG or transferrin receptor 
recycling might manifest as a reduced growth rate. With regard to VSG pathway, 
this could be through an increased de novo synthesis of VSG, while for the
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transferrin pathway this could theoretically occur via a reduction in available iron, an 
essential co-factor in a variety of enzymes. One possible explanation for the 
adaptation observed could be that the parasites are able to compensate by returning 
recycling rates to wild type levels. Therefore, future work could address this 
possibility by repeating these experiments in newly generated àmca2/3lsmca5 
parasites. Stringent controls would be required, however, as any reduction in 
recycling rate might simply be a secondary effect of metacaspase deletion and not 
directly related to a defect in the actual recycling process.
One possible route of adaptation that could be tested was upregulation of transferrin 
receptor expression. It has been reported that BSF parasites are able to upregulate 
expression of the transferrin receptor under conditions of reduced transferrin 
availability (Mussmann et ah, 2004). An analysis of transferrin receptor expression 
in the Amca2/3â^mca5 parasites did not show any such increase following the 
apparent adaptation period, however, appearing to rule this out as a possible 
explanation. Alternatively another nutrient that is taken up, trafficked through, and 
its receptor recycled via Rabll positive endosomes may be responsible for the 
reduction in growth rate. Transferrin is the only such nutrient molecule known in T. 
brucei that is taken up via this route, although it is possible that there are others that 
are as yet unidentified.
Despite the failure to detect a phenotype directly related to categorised recycling 
processes, the identification of two phenotypes in the BSF Amca2/3 parasites (a 
reduced ability to recover from high densities and a diminished ability to adapt to 
low serum concentrations) were initially promising. These phenotypes were initially 
identified in Amca2/3Amca5 parasites although later it was discovered that these 
phenotypes were also present in the Amca2/3 but not the Amca5 parasites. These 
phenotypes appeared therefore to be specific to the deletion of MCA2 and/or MCA3.
With regard to the reduced ability to recover from high densities, a similar 
phenomenon has been claimed for metacaspase function in yeast. The deletion of
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the yeast metacaspase resulted in an initial increased survival of chronologically 
aged cultures, however these surviving cells lost the ability to re-grow (Herker et ah, 
2004). It was suggested that the yeast metacaspase is involved in the elimination of 
unfit cells by apoptosis, thus leaving only the youngest, fittest, and best adapted cells 
for further growth. How this is related to our observations is uncleai', Amca2/3 
parasites did not show an initial increased survival although they did display a 
reduced ability to re-grow.
However, conjecture about what these phenotypes might represent is only important 
if some form of complementation can be achieved and unfortunately this was not 
possible. Even the dual re-expression of both MCA2 and MCA3 in the Amca2/3 
mutants did not result in complementation the two phenotypes. The pertinent 
question therefore is whether these detected phenotypes are related to metacaspase 
function. It is clear that the re-expression of the metacaspases to approximately wild 
type levels was successful, thus ruling out differences in expression levels as the 
reason behind the failure to complement the phenotypes. All of the metacaspases 
used in the re-expressions had been cloned from wild type (strain 427) genomic 
DNA and sequenced to ensure that there were no introduced errors. The failure of 
complementation therefore is unlikely to be the result of a loss of activity. It was 
also shown that HA-tagged version of MCA2 and MCA3 were targeted to their 
native location (Chapter 3), therefore we can assume that the re-expressed untagged 
versions should also target to the correct compartment. This leads to the distinct 
possibility that the described phenotypes are not directly related to the deletion of 
MCA2mAMCA3,
Although these experiments were performed in the absence of antibiotics, it is 
possible that the presence of the PAC and BSD gene products may be causing these 
effects through a non-specific mechanism unrelated to MCA2 and MCA3 deletion. It 
is difficult to determine what the reasons for these phenotypes are, although for the 
time being will have to be classified as artefactual. In addition, do the two different 
phenotypes stem from the route cause and are they simply different manifestations of
159
the same deficiency. This being that the Amca2/3 mutants are unable to cope with 
stressful conditions for some reason, but one which is not related to absence of 
MCA2 and MCA3 from recycling endosomes.
Another possible role for the metacaspase, that has not been investigated, may be 
that they are not involved in recycling processes themselves but are involved in the 
cleavage or processing of nascent proteins destined for the cell surface or secretion. 
The endosomal system of yeast is believed to sit at a junction between the endocytic 
and secretory pathways (Lemmon and Traub, 2000). In T. brucei  ^ the return of 
internalised VSG and transferrin receptor to the cell surface has been shown to occur 
via Rabll positive recycle endosomes (Pal et al,  ^ 2003; Grunfelder et a/., 2003), 
although the route for the delivery of de novo cell surface proteins in 
trypanosamatids is not well defined. It is believed to occur directly from the trans 
Golgi network (TGN) to flagellar pocket, although the nature of the transport 
intermediates are not well defined (McConville et ai., 2002). In Leishmania, 
however, it has been suggested that the secretory and endocytic pathways converge 
(Ghedin et al., 2001). Rabll positive recycling endosomes may therefore be at a 
cross roads between the recycling of cell surface molecules and the normal secretory 
system. It is plausible to suggest that the metacaspases are located within Rabll 
positive endosomes to facilitate the activation of an unknown secreted protein. A 
future comparative analysis of the secretion profile of wild type and Amca2/3Amca5 
parasites may be able to address this possibility.
5.12.3 Potential involvement in cell death processes.
Due to the failure to detect any phenotypes related to recycling processes, the 
possibility of metacaspase involvement in cell death, as have been claimed in the 
literature (Szallies et al., 2002; Hoeberichts et al., 2003; Wadskog et al., 2004; 
Suarez et al., 2004), was investigated. Deciding on suitable stimuli to use was 
difficult as the evidence for apoptotic-like machinery or a process being present in 
any single cellular organism is far from concrete, and there have been no such 
reported experiments performed in BSF T. brucei. As detailed in chapter 1, claims
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of detection of some form of regulated cell death in single cell organisms have 
usually involved some form of stressful stimuli in order to induce the reported 
responses. The inherent problem with the stimuli used in these reports is that they 
are usually themselves toxic. In contrast, apoptosis in higher eukaryotes can be 
stimulated via the activation of specific receptors, but none of the reports of 
apoptotic-like death in single cell organisms have been shown to be due to 
stimulation of such a specific pathway. The induction of an apoptotic-like 
mechanism in single cell organisms with inherently toxic stimuli could therefore be 
considered a questionable approach. Despite these reservations, attempts were made 
to reproduce several toxic stimuli that have been claimed to induce such phenomena. 
The only stimuli used in this limited study were heat shock and salt stress, adapted 
from studies in Leishmania (Moreira et al., 1996) and yeast (Wadskog et al, 2004), 
respectively.
In these experiments the determination of whether the stressful stimuli were actually 
resulting in features associated with apoptotic-like cell death, such a chromatin 
condensation, phosphatidyl serine externalisation or DNA fragmentation were not 
evaluated. These experiments were simply a quick determination of whether the 
metacaspases might be involved in cell death. Amca2/3Amca5 parasites showed no 
significant differences in response to the stressful stimuli or the subsequent recovery 
as compared to wild type parasites. To rule out the possibility that the metacaspases 
might be involved in a cell death pathway, however, would be premature. These 
investigations were far from thorough and the stimuli used may have been too harsh 
to determine any subtle differences between the wild type and Amca2/3Amca5 
parasites. If an apoptotic-like phenomenon does exist in T. brucei it might be that 
the trigger is only present in vivo and that mimicking of this in vitro may not be 
possible. More detailed studies on cell death in trypanosomatids are required before 
it will be possible to determine if the metacaspases are involved.
In general, however, what has been identified in T brucei about the metacaspases 
does not immediately stand out as suggesting an involvement in an apoptotic-like
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pathway. Firstly, the association with recycling endosomes is not immediately 
suggestive of a role in such a phenomenon. Secondly, the observation of an initial 
slow growth upon Amca2/3Amca5 generation would tend to suggest that the 
metacaspases are constitutively active. A role in cell death would presumably 
require them to remain inactive until stimulated and this does not appear to be the 
case.
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Figure 5.1: Illustration of knockout strategy for MCA2 and MCA3,
A) To permit replacement of the MCA 2/3 locus, flanking regions downstream of 
MCA2 and upstream of MCA3 were chosen (highlighted in red) avoiding the 
regions of homology immediately surrounding both genes and avoiding 
encroachment into the adjacent ORFs. B) These 5’ and 3’ regions were then 
amplified by PCR and subsequently subcloned into the knockout vectors shown 
using Xbal and Apal, respectively. The knockout cassette was cleaved from the 
vector using Notl and Xhol. This knockout vector contains tubulin intergenic 
regions to facilitate trans-splicing and polyadenlylation and to ensure translation 
of the two resistance genes used, BSD and PAC.
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Figure 5.2: Strategy used to show correct integration of MCA2/3 knockout 
cassettes and the PCR analysis.
Cartoon illustration of A) MCA2/3 native locus and the loci following 
replacement with knockout cassettes containing B) PAC and C) BSD resistance 
genes. Open reading frames are highlighted in blue, while flanks used for 
targeting of knockout cassettes are highlighted in red. Also shown are primers 
used to confirm correct integration of knockout cassettes at both the 5’ and 3’ 
regions together with primers used to show deletion of both MCA2 and MCA 3. 
D) Genomic DNA was prepared from 1) wild type, 2) BSD heterozygote, 3) 
PAC heterozygote, 4) Amca2/3 clone 1 and 5) Amca2/3 clone 2. PCR analysis 
was performed to confirm the correct integration of the knockout cassettes at 
both the 5’ and 3’ regions and to illustrate loss of the MCA2/3 locus in Amca2/3 
mutants.
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Figure 5.3: Predicted fragments sizes and Southern blot analysis 
confirming MCA2/3 knockout.
Cartoon illustration of A) MCÂ2/3 native locus and the loci following 
replacement with knockout cassettes containing B) PAC and C) BSD resistance 
genes. Open reading frames are highlighted in blue, while flanks used for 
targeting of knockout cassettes are highlighted in red. Predicted Kpnl restriction 
sites are indicated together with size of fragments resulting from digestion with 
this enzyme. D) Genomic DNA was prepared from BSF (strain 427) 1) wild 
type, 2) PAC heterozygotes, 3) BSD heterozygotes, 4) Amca2/3 clone 1 and 5) 
Amca2/3 clone 2. 3 pg of DNA were digested with Kpnl, genomic fragments 
separated by electrophoresis, transferred to Hybond-P and probed with the 
MCA2/3 5’ flanking region.
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Figure 5.4: Confirmation of MCA2 and MCA3 deletion in BSF T. brucei.
Total cell lysates were prepared from T. brucei BSF (strain 427) wild type and 
Nmca2/3 clones 1 and 2. 5x10^ cell equivalents were then subjected to SDS- 
PAGE and transferred to PVDF membrane prior to immunoblotting with 
immunopurified polyclonal rabbit anti-MCA2/3 antibodies. MCA2 and MCA3 
are indicated, the upper protein also detected by the antibody acting as a loading 
control.
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Figure 5.5: Re-expression of MCA2 and MCA3 in Amca2/3 BSF parasites.
Total cell lysates were prepared from T. brucei BSF (strain 427) wild type, 
bjnca2/3 clone 1, Amca2/3 clone 2, /Smca2/3:MCA2 and Amca2/3:MCA3 
parasites. 5x10^ cell equivalents were then subjected to SDS-PAGE and 
transferred to PVDF membrane prior to immunoblotting with immunopurifed 
polyclonal rabbit anti-MCA2/3 antibodies. MCA2 and MCA3 are indicated, the 
upper protein also detected by the antibody acting as a loading control.
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Figure 5.6: In vitro and in vivo growth curve analysis of wild type and 
Amca2/3.
A) The growth rate of BSF (strain 427) wild type and àmca2/3 clone 1 in vitro 
were monitored over a period of 4 days. Cultures were seeded at 5x10"^  cells 
ml'* and cell counts made daily, with cultures being re-seeded to 5x1 O'* cells ml ' 
each day to maintain cultures in a logarithmic growth phase. B) The growth rate 
of BSF (strain 427) wild type and Amca2/3 clone 1 were evaluated in vivo. Both 
lines were passaged once through mice and 1x10  ^parasites injected into a group 
of six mice. Parasitaemia was determined on days 3 and 4 post-infection. 
Average parasites densities, converted into logarithms, are plotted together with 
error bars indicating standard deviation.
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Figure 5.7: Illustration of knockout strategy for MCAS,
A) 5’ and 3’ flanking regions were chosen (highlighted in red) immediately 
surrounding the MCA5 locus. B) These 5’ and 3’ regions were then amplified 
by PCR and subsequently subcloned into the knockout vectors shown using 
NotVXhdl and Apal, respectively. The knockout cassette was cleaved from the 
vector using Not\ and EcoRW. This knockout vector contains tubulin intergenic 
regions to facilitate trans-splicing and polyadenlylation and to ensure translation 
of the two resistance genes used, HYG and NEO.
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Figure 5.8: Illustration of strategy used to show correct integration of 
MCAS knockout cassettes.
Cartoon illustration of A) MCA2/3 native locus and the loci following 
replacement with knockout cassettes containing B) HYG resistance gene and B) 
NEO resistance gene. Open reading frames are highlighted in blue, while flanks 
used for targeting of knockout cassettes are highlighted in red. Also shown are 
primers used to confirm correct integration of knockout cassettes at both the 5’ 
and 3’ regions, together with primers used to show deletion of both MCA 2 and 
MCA3.
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Figure 5.9: PCR analysis confirming correct integration of MCAS knockout 
cassettes and deletion of MCAS in PCF and BSF.
A) Genomic DNA was prepared from BSF (strain 427) 1) wild type, 2) AmcaS 
clone 1 and 3) AmcaS clone 2. B) Genomic DNA was prepared from PCF 
(EATRO 795) 1) wild type, 2) AmcaS clone 1 and 3) AmcaS clone 2. PCR 
analysis was performed to confirm the correct integration of the knockout 
cassettes at both the 5’ and 3’ regions and to illustrate loss of the MCAS locus in 
AmcaS mutants as illustrated in figure 5.8.
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Figure 5.10: Confirmation of MCAS deletion in PCF and BSF T, brucei.
Total cell lysates were prepared from A) BSF (strain 427) wild type and AmcaS 
clone 1. B) PCF (EATRO 795) wild type and AmcaS clone 1. 5x10^ cell 
equivalents were subjected to SDS-PAGE and transferred to PVDF membrane 
prior to immunoblotting with polyclonal sheep anti-MCA5 antibodies.
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Figure 5.11: In vitro growth analysis of wild type and âjncaS in both BSF 
and PCF parasites.
A) The growth rate of BSF (strain 427) wild type and AmcaS clone 1 were 
monitored over a period of 4 days. Cultures were seeded at 5x10^  ^cells ml'* and 
cell counts made every 24 hours, cultures were re-seeded to 5x1 O'* cells ml'* 
daily to maintain cultures in a logarithmic growth phase. B) The growth rate of 
PCF (EATRO 795) wild type and AmcaS clone 1 were monitored over a period 
of six days. Cultures were seeded at 5x10^ cells ml * and cell counts made every 
24 hours, cultures were re-seeded to 5x10^ cells ml * every 2 days to maintain 
cultures in a logarithmic growth phase.
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Figure 5.12; PCR analysis confirming correct integration of MCAS 
knockout cassettes and deletion of AfC45 in BSF Amca2/3 clone 1.
Genomic DNA was prepared from BSF (strain 427) 1) Amca2/3, 2) HYG 
heterozygote, 3) NEO heterozygote, 4) Amca2/3AmcaS clone 1 and 5) 
Amca2/3AmcaS clone 2. PCR analysis was performed to confirm the correct 
integration of the knockout cassettes at both the 5’ and 3’ regions and to 
illustrate loss of the MCAS locus in AmcaS mutants as illustrated in figure 5.8.
176
A)
B)
4----------MCA3
" MCA2
kDa 4 ^  ^  ^
MCA5
Figure 5.13: Western blot of Amca2/3AmcaS parasites.
Total cell lysates were prepared from BSF (strain 427) wild type, Amca2/3 clone 
1, AmcaS clone 1, Amca2/3AmcaS clone 1, Amca2/3 AmcaS :MCA2, 
Amca2/3AmcaS:MCA3 and Amca2/3AmcaS:MCAS parasites. 5x10^ cell 
equivalents were then subjected to SDS-PAGE and transferred to PVDF 
membrane prior to immunoblotting with A) polyclonal rabbit anti-MCA2/3 
antibodies and B) polyclonal sheep anti-MCA5 antiserum. MCA2, MCA3 and 
MCA5 are indicated.
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Figure 5.14: Growth analysis of Amca2/3AmcaS parasites in vitro and in 
vivo.
A) The growth rate of BSF (strain 427) wild type and Amca2/3Amca5 clone 1 
was monitored in vitro over a period of 6 days immediately following 
generation of mutant parasites. Cultures were seeded at 5x1 O'* cells ml * and cell 
counts made daily, with cultures being re-seeded to 5x1 O'* cells ml"* each day, to 
maintain cultures in a logarithmic growth phase. B) The growth rate of BSF 
(strain 427) wild type and Amca2/3AmcaS clone 1 following successive 
passages in vitro were monitored over a period of 4 days. Cultures were seeded 
at 5x1 O'* cells ml"* and cell counts made daily, with cultures being re-seeded to 
5x10'* cells ml * each day, to maintain cultures in a logarithmic growth phase. 
C) The growth rate of BSF (strain 427) wild type and Amca2/3AmcaS clone 1 
was evaluated in vivo following in vitro adaptation period and return to 'wild 
type growth levels. Each line was passaged once through a mouse and 1x10  ^
parasites then injected into a group of six mice. Parasitaemia was determined on 
days 3, 4 and 5 post-infection. The average cell counts are plotted together with 
error bars indicating standard deviation.
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Figure 5.15: Analysis of VSG recycling in BSF T. bruceL
BSF (strain 427) wild type and Amca2/3AmcaS clone 1 were biotinylated at 4°C 
in TDB prior to incubation at 37°C for 5 mins in HMI-9. Remaining surface 
label was then cleaved by incubation with 50 inM glutathione for 7 mins at 4°C.
A) Whole cell lysates were prepared and 5x10^ cell equivalents subjected to 
SDS-PAGE and transferred to PVDF membrane prior to immunoblotting with a 
streptavidin-HRP conjugate. EF-la serves as loading control to illustrate 
equivalent loading. B) Parasites were prepared for IF A both immediately after 
the glutathione incubation and following a 1 hour chase period in HMI-9. 
Parasites were fixed in -20°C methanol for 15 mins and permeabilised in -20°C 
acetone for 2 mins, prior to blocking with 1% (w/v) BSA for 30 mins. Slides 
were then incubated with a 1/1000 dilution of streptavidin-TexasRed conjugate, 
1/200 dilution of rabbit miti-Rabll antibodies, followed by miti-rabbit-FITC 
conjugate and 1 pg/ml DAPI. Biotin-VSG and Rabll labelling is shown 
together with a merged image, DAPI labelling is also shown. A DIG image of 
parasites is also provided.
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Figure 5.16: Confirmation of VSG221 expression.
Total cell lysates were prepared from BSF (strain 427) wild type, Amca2/3, 
AmcaS and Amca2/3AmcaS parasites. 5x10^ cell equivalents were subjected to 
SDS-PAGE and transferred to PVDF membrane prior to immunoblotting with 
polyclonal rabbit anti-VSG221 antiserum. The position of VSG221 is indicated.
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Figure 5.17: Analysis of cell associated anti-VSG antibodies.
BSF (strain 427) wild type and Amca2/3Amca5 clone 1 were labelled with 
polyclonal rabbit anti-VSG221 antibodies for 30 mins at 4°C in HMI-9. 
Parasites were then extensively washed and incubated at 37°C for 30 mins in 
HMI-9 to allow parasites to internalise and clear the surface coat of antibodies. 
A) Parasites were fixed in -20°C methanol for 15 mins and permeabilised in - 
20°C acetone for 2 mins, prior to blocking with 5% (w/v) skimmed milk powder 
for 30 mins. Slides were then incubated with an anti rabbit-TexasRed conjugate 
and 1 pg/ml DAPI. Anti-VSG221 and DAPI labelling is shown together with 
Die images of the parasites. B) Whole cell lysates were prepared and 5x10* cell 
equivalents subjected to SDS-PAGE and transferred to PVDF membrane prior 
to immunoblotting with anti rabbit-HRP conjugate. EF-la serves as a loading 
control to illustrate equivalent loading. Anti-VSG antibodies are indicated.
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Figure 5.18: Analysis of secreted anti-VSG221 degradation products.
BSF (strain 427) wild type and àmca2/3^mca5 parasites were labelled with 
polyclonal rabbit anti-VSG221 antibodies for 30 mins at 4°C in HMI-9. 
Parasites were then extensively washed and incubated at 37°C for 30 mins in 
HMI-9 to allow parasites to internalise and clear the surface coat of antibodies. 
TCA precipitations of culture medium were resuspended and subjected to SDS- 
PAGE and transferred to PVDF membrane prior to immunoblotting with an anti 
rabbit-HRP conjugate. Also shown are negative (control) and positive (VSG221 
Ab) controls. Rabbit immunoglobulin heavy chain and degradation products are 
indicated.
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Figure 5.19: Analysis of transferrin uptake and receptor expression.
A) BSF (strain 427) wild type and I^mca2/3lsmca5 clone 1 were incubated with 
50 mM transferrin-biotin conjugate for 5, 10, 15 and 60 mins in serum free 
HMI-9 followed by a 10-mins chase. Whole cell lysates were prepared and 
5x10* cell equivalents subjected to SDS-PAGE and transferred to PVDF 
membrane prior to immunoblotting with a streptavidin-HRP conjugate. EF-la 
serves as a loading control to demonstrate equivalent loading. B) Whole cell 
lysates were prepared form BSF wild type and tjnca2/3bjnca5 clones 1 and 2. 
5x10* cell equivalents were subjected to SDS-PAGE, transferred to PVDF 
membrane prior to immunoblotting with anti-transferrin receptor antibodies. 
The positions of ESAG6 and ESAG7 are indicated.
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Figure 5.20: Response of T, brucei to a 2 hour heat shock at 42°C.
BSF (strain 427) wild type and t^mca2/3lSmca5 clone 1, at a density of 5x10^ 
cells ml'*, were exposed to a 42°C heat shock for 2 hours or control at 37°C. A) 
Parasite densities were determined following this 2 hour period and counts made 
4 hours subsequently. B) The rate of recovery of parasites following this heat 
shock relative to controls was also determined. Parasites were re-seeded at 
5x10^ cells ml'* and counts made every 24 hours with re-seeding at 5x10* cells 
ml * daily.
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Figure 5.21: Response of T, brucei to salt stress.
BSF (strain 427) wild type and lSmca2/3tSmca5 clone 1 at a density of 4x10^ 
cells ml ' were exposed to 125 mM NaCl in HMI-9. A) Parasite densities were 
determined following 1, 3 and 5 hour exposure periods. B) The rate of recovery 
of parasites following this salt stress was also determined. Parasites were 
extensively washed in HMI-9 prior to re-seeding at 5x10^ cells ml ' and counts 
made every 24 hours with re-seeding at 5x1 O'* cells ml ' daily.
187
A ) Recovery of parasites from late log cell densities
9
8
0  7
6
1  5B 4 sa 3
S
Wild type 
®  Amca2/3
♦  AmcaS
*  Amca2/3Amca52
1
0
76532 410
Time (days)
B) Recovery of parasites from late log cell densities
o
Wild type 
Amca2/3 Clone I 
Amca2/3:MCA2 
Amca2/3\MCA3
0 —
Time (days)
Figure 5.22: Analysis of recovery following growth to late log densities.
BSF (strain 427) parasites were cultured to densities in excess of 4x10^ cells 
m V\ reaching an apparent stationary growth phase. Cultures were then re­
seeded at 5x10^ cells/ml and counts made every 24 hours with re-seeding daily 
to 5x10^ cells ml '. A) Wild type, tsmcal/S clone 1, àmca5 clone 1 and
Amca2/3Amca5 clone 1. 
Amca2/3 :MCA 3.
B) Wild type, Amca2/3 clone 1, tsmca2/3\MCA2 and
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Figure 5.23: Analysis of growth rate under conditions of serum deprivation.
The growth rate of BSF (strain 427) parasites was monitored in culture medium 
with a 10-fold reduction in serum to a final concentration of 2% (v/v). Parasites 
cultures were seeded at 5x10^ cells ml ' and counts made every 24 hours with re­
seeding at 5x10^ cells ml ' daily. A) Wild type, Amca2/3 clone 1, Amca5 clone
1 and Amca2/3Amca5 clone 1. B) Wild type, Amca2/3 clone 1 and clone 2. 
Wild type, Amca2/3 clone 1, Amca2/3\MCA2 and Amca2/3:MCA3.
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Figure 5.24: Dual re-expression of MCA2 and MCA3 in BSF Amca2/3,
Total cell lysates were prepared from T. brucei BSF (strain 427) wild type, 
Amca2/3 clone 1, Amca2/3:MCA2, Amca2/3:MCA3 and Amca2/3:MCA2:MCA3 
parasites. 5x10^ cell equivalents were then subjected to SDS-PAGE and 
transferred to PVDF membrane prior to immunoblotting with immunopurifled 
polyclonal rabbit anti-MCA2/3 antibodies. The upper protein also detected by 
the antibody acts as a loading control. MCA2 and MCA3 are indicated.
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Figure 5.25: Attempts to complement phenotypes in dual re-expressers.
A) BSF (strain 427) wild type, tsmcalB  clone 1, Nrnca2/3\MCA2, 
tsmca2/S'MCA3 and Amca2/i:MCA2:MC4i were cultured to densities in excess 
of 4x10^ cells ml'^ reaching an apparent stationary growth phase. Cultures were 
then re-seeded at 5x1 O'* cells ml * and counts made every 24 hours with re­
seeding daily to 5x1 O'* cells ml *. B) The growth rate of BSF (strain 427) wild 
type, tsmca2/2, I^mca2/3:MCA2, Amca2/3:MCA3 and Amca2/3:MCA2:MCA3 
parasites was monitored in culture medium with a 10-fold reduction in serum to 
a final concentration of 2% (v/v). Parasites cultures were seeded at 5x10'* cells 
ml * and counts made every 24 hours with re-seeding at 5x10'* cells ml * daily.
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Chapter 6 
Discussion
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6.1 Do the metacaspases function similarly to caspases?
At the beginning of this investigation nothing was known about metacaspase 
function in any organism. Insights into their possible functions have been 
attained during the three years of this study, and other researchers have also 
published their findings in this time. Various links between apoptotic-like 
phenomena and metacaspases have been drawn from studies on yeast and it has 
been suggested that the metacaspases may have caspase-like activity and 
functions (Madeo et al., 2002; Szallies et al., 2002; Herker et al., 2004; 
Wadskog et al., 2004). Similarly it has also been suggested that the 
metacaspases are involved in the hypersensitivity response of plants, a 
phenomenon of developmentally regulated cell death with some similarities to 
programmed cell death (PCD) (Suarez et ah, 2004; Bozlikov et ah, 2004).
It is easy to see why this path of investigation for metacaspase function has been 
pursued, as no true caspase genes have been identified in either yeast or plants 
despite continued reports of PCD/apoptotic-like phenomenon (Eisler et ah, 
2004; Fabrizio et ah, 2004; Chen and Dickman, 2004; Hatsugai et ah, 2004). 
Indeed, it is also an attractive proposition to postulate that the metacaspases in 
trypanosomatids might be responsible for the reports of apoptotic-like cell death 
that have been reported in the literature (Moreira et al., 1996; Ameisen et ah, 
1996; Welburn et ah, 1997; Ridgley et ah, 1999; Das et ah, 2001; Lee et ah, 
2002; Amoult et al., 2002; Sen et ah, 2004). To believe that the metacaspases 
are involved in some form of PCD/apoptotic-like pathway is to presumably 
assume that the metacaspases are able to bring about cell death, and over the 
course of evolution became modern day caspases found in multicellular 
organisms. If the reports in both yeast and plants are to be believed, this would 
imply that a common ancestor that possessed metacaspases also had at least a 
rudimentary suicidal mechanism. This is a controversial hypothesis as many 
people believe that apoptosis/PCD is only a plausible phenomenon in 
multicellular organisms.
The basis for hypothesising that the metacaspases may have similar functions to 
the caspases stems from the fact that of all the other Clan CD peptidases, they 
are predicted to be most similar to the caspases in regards to evolutionary
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origins (Uren et al., 2000). However, the precedent set from another family in 
Clan CD, Cl 3, which contains both the legumains and the 
glycosylphosphatidylinositol (GPI) transamidases, suggests that attempting to 
extrapolate functions based upon sequence similarities can not always be relied 
upon. These two classes of peptidase, although having widely distinct functions 
are grouped in the same family. While the legumains are proteolytic enzymes, 
GPI transamidases, although still proteolytic, catalyse the nucleophilic attack of 
the activated carbonyl group with an NH2 group of a pre-formed GPI anchor. 
Additionally, legumains have been characterised as having seperate functions in 
different organisms. In human B-cells they are lysosomal enzymes, involved in 
foreign antigen degradation and the generation of suitable peptides to form 
complexes with the class II major histocompatibility complex (Manoury et ah, 
1998). In the blood fluke Schistosoma mansoni, it has been proposed that they 
proteolytic activate CBl, the major papain-like cysteine peptidase detected in 
the lumen of the schistosome gut and which is involved in haemoglobin 
degradation (Sajid et al., 2003). In plants they can be localised to the vacuole, 
where they have been implicated in storage protein breakdown during 
germination and seedling growth (Muntz and Shutov, 2002).
Cleary there are precedents then for Clan CD peptidases within families to have 
different functions, and even for different organisms to use homologous proteins 
for divergent roles. Therefore, while hypothesising that the metacaspases might 
have a role in apoptosis or PCD-like phenomena based upon their evolutionary 
relationship to caspases might be attractive, the reality may be different. 
Indeed, this study has provided evidence that MCA2, MCA3 and MCA5 are 
associated with recycling endosomes in T. brucei. However, the deletion of 
MCA2, MCA3 and MCA5 did not appear to affect either of the characterised 
recycling processes in BSF parasites, with no disruption of the VSG and 
transferrin receptor recycling pathways being detectable. There are several 
possible reasons as to why no phenotypes related to recycling were detected in 
this study. The metacaspases may either be involved in an uncharacterised 
recycling process, or be involved in a component of the VSG or transferrin 
pathway not examined in our analysis. Additionally, there is the possibility that 
that the metacaspases have a high level of redundancy and that MCAl and/or
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MCA4 may be compensating for the deletion of MCA2^ MCA3 and MCA5. 
Another possibility is that despite association with recycling endosomes, 
metacaspase function might be unrelated to recycling processes.
Although a specific function has not been assigned to the metacaspases in this 
investigation, their association with recycling endosomes does not immediately 
suggest a role in cell death or other cellular processes that are known to involve 
caspase functions. Indeed, our investigations into possible metacaspase 
involvement in cell death in T. brucei, although far from extensive, were unable 
to detect any differences between wild type and àmca2/3/S.mca5 parasites. As 
previously discussed, the only suggestions made in the literature for 
metacaspase function relate to apoptotic/PCD-like phenomena. In 
Saccharomyces cerevisiae a global analysis of protein localisation, using GFP 
as a label, localised the single yeast metacaspase to both the nucleus and 
cytoplasm (Huh et al., 2003), and the ectopic expression of a T6MCA4-GFP 
fusion in yeast also revealed apparent nuclear localisation (Szallies et al., 2002). 
If this localisation is to be believed, this is markedly different from what we 
have observed in T. brucei in that no nuclear or cytosolic localisation was 
detected for MCA2, MCA3 or MCA5. It is possible, therefore, that the different 
localisations could represent divergent function of the metacaspases between 
yeast and T. brucei.
The lack of any apparent processing of the metacaspases in our study is also 
different to what has been reported in yeast and plants. Processing has been 
reported following overexpression of the FLAG-tagged single yeast 
metacaspase (Madeo et ah, 2002), and has also been observed following 
expression of polyhistidine XeiggQà. Arapidopsis thialiana type II metacaspases in 
E. coli (Vercammen et ah, 2004). In both of these reports the processing was 
dependent on the putative active site residues, as no processing was observed 
when these were mutated. This evidence suggests that the metacaspases have 
similarities to caspases in that they appear to autocatalytically process. 
Determination of the A. thialiana type II metacaspase activity also suggested 
that this processing was required to generate active peptidase (Vercammen et 
ah, 2004). However, in our study no large scale processing events were
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observed for any of the metacaspases examined. MCA2, MCA3 and MCA5 
were invariably detected at sizes closely corresponding to the full-length protein 
predictions, despite various attempts to induce processing through exposure to 
stressful stimuli. Additionally, the initial slow growth rate phenotype observed 
in the newly generated /Smca2/?iiSmca5 parasites suggests that they are active 
under normal in vitro conditions and do not require processing. We 
hypothesise, therefore, that unlike the plant type II metacaspases the T. brucei 
metacaspases are active as full-length proteins. Plant type II metacaspases are 
categorised by the possession of an insertion of approximately 200 amino acids 
(Uren et ah, 2000). This insertion appears to be unique to plant type II 
metacaspases and is not present in any other the metacaspases identified in yeast 
or protozoa. The autocatalytic cleavage site identified with the type II 
metacaspases is found within this insertion domain (Vercammen et ah, 2004), 
and the A. thaliana type I metacaspases which lack this insertion did not display 
processing when expressed in E. coli. This might explain the absence of 
processing in the T. brucei metacaspases, as they do not possess a similar 
cleavage site.
6.2 Comparison of RNAi versus gene knockout to study function
The functions of the metacaspases were examined in this study by two 
techniques. Initially, RNAi was performed on MCA2, MCA3 and MCA5 and 
then later various null mutants were generated. The RNAi system used in this 
study, as previously discussed, appears to be prevalent with non-specific 
artefacts. These artefacts, present in the MCA2/3 and MCA5 RNAi were shown 
to be independent of gene silencing, which was further confirmed when the 
generation of both the MC42/5-deficient and MC45-deficient mutants were 
shown to be possible without any detrimental effects. However, there was a 
question regarding the growth arrest and difficulty in attaining clones when the 
triple RNAi of MCA2, MCA3 and MCA5 was performed. It was hypothesised 
that the silencing of all three genes might indeed be detrimental to the parasites. 
Indeed, the slow initial growth rate observed upon generation of àmca2/3AmcaS 
parasites suggests that metacaspase function is important to parasite growth, 
even though they appear to be able to adapt to the loss over time and regain 
normal growth rates. As suspected, however, the morphology changes seen in
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the triple RNAi would appear to be nothing to do with metacaspase deletion, as 
no similar changes were observed in the triple null mutants.
6.3 Possible role of * dead peptidases”
The identification of metacaspase genes that appear to have substitutions at the 
putative active site residues raised the possibility that they might have a 
function independent of cysteine peptidase activity. This has echos with a 
recent study, which has identified numerous inactive enzyme homologues in 
metazoan databases, and for which their presence was suggested to be the rule 
rather than the exception (Pils and Schultz, 2004b). For example, it was 
demonstrated that within the protein tyrosine phosphatase family some members 
possess putative non-catalytic phosphatase domains (Pils and Schultz, 2004a). 
These variants were still able to bind substrates, and due to the loss of catalytic 
activity, these become trapped and were protected from other active 
phosphatases. Another example is phospholipase A2 (PLA2) and its inhibitor. 
These share two out of the three catalytic residues, with the third having been 
substituted in the inlnbitor (Bartlett et ah, 2003). This inhibitor no longer 
possesses catalytic activity, but forms an inactive heterodimeric complex with 
PLA2, and thus regulates the enzyme. The majority of these inactive enzyme 
homologues identified were involved in regulatory processes (Pils and Schultz, 
2004b). Their effects are achieved either directly, with the inactive enzyme 
homologue acting as a regulatory subunit as in the PLA2 example, or 
alternatively via antagonisation of the active enzyme, as in the phosphatase 
example. In MCAl and MCA4, which are predicted to have active site 
substitutions, there remains a high conservation of residues aiound these sites. 
This suggests that if these two proteins are acting as modulators of metacaspase 
activity, this is likely to be occurring through the antagonisation model.
6.4 Future studies
The identification of predicted WW binding domains within MCA2, MCA3 and 
MCA5 suggests that the metacaspases may interact with other cellular proteins 
via this domain, and WW domains have been identified within nine annotated 
proteins in T. brucei (www.genedb.org). To further our understanding of 
metacaspase function, attempts to identify interacting partners may be useful.
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Within yeast there have been several independent comprehensive studies 
performed examining protein-protein interactions through the yeast two-hybrid 
system (Uetz et al., 2000; Ito et al., 2001; Hazbun et al., 2003). The most recent 
study, Hazbun et al. 2003, identified 10 proteins with which the yeast 
metacaspase interacted (Table 6.1).
Systematic Name Standard Name Description Homologue in T. brucei
YBLt06C SR077 Suppressor o f  defect in the small GTPase Rho3p No
YIL113W SDPl Stress-inducible dual specificity phosphatase Yes (r604.lH19.900)
YKI.0i2W PRP40 U1 snRNP protein involved in splicing No
YKR096W Unknown Hypothetical (7611.02.2360 )
YLR371W ROM2 GDP/GTP exchange protein for Rliolp and Rho2p No
YLR410W VIPl Interactions witlr actin No
YMR257C P E T lll Specific translational activator for the COX2 niRNA No
YNL075W IMP4 Component o f the SSU processome Yes (r606.5F5.280)
YNL339C YRFl Helicase Yes (7611.12,0011)
YPL137C Unknown Hypothetical (7608.10J17.380)
Table 6.1: List of proteins thought to interact with yeast metacaspase (from 
Hazbun et al. 2003).
While none of these potential partners have been validated through co­
localisation studies, this type of approach may further aid in the understanding 
of metacaspase function. Attempts to identify interacting partners of the T. 
brucei metacaspases could be pursued through either immunoprécipitations or 
via the tandem affinity purification (TAP) method (Rigaut et al., 1999). If 
successful, any proteins identified could be subjected to mass spectrometry and 
identified from the T. brucei database. These could also be compaied to what 
has been found in yeast as several of the interacting proteins identified in yeast 
are homologous to T. brucei proteins (Table 6.1).
A theme running throughout this study has been the possible redundancy within 
the metacaspase family, and in particular through the uncharacterised MCAl
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and MCA4. The production of specific antibodies to determine the expression 
profile of these two genes could provide insights into this possibility. It would 
be interesting to determine whether they are expressed, and, if they are, if there 
is a differential expression profile between the life stages - as there is for MCA2 
and MCA3. Additionally, it would be interesting to determine whether MCAl 
and/or MCA4 also localise to the same compartment as the other characterised 
metacaspases.
Assuming that MCAl and/or MCA4 are expressed in the parasites, it would be 
attractive to ftirther delete these genes to investigate this redundancy hypothesis. 
Expanding upon the strategy already utilised, it is theoretically possible to 
delete one further gene from the PCF AmcaS parasites, although no further 
deletions will be possible in the BSF Amca2/3AmcaS parasites. This is due to 
the limited number of antibiotic resistance markers available for the generation 
of transgenic parasites. However, the generation of multiple null mutants via 
the recycling of resistance markers might be possible. This could be achieved 
through the utilisation of a similar strategy as has been reported for Leishmania 
(Denise et al., 2004). This technique used the hygromycin resistance gene as a 
positive marker and a thymidine kinase gene as a negative marker. This 
teclinique allows null mutants to be generated without the addition of any 
exogenous DNA, and thus allows the resistance marker to be re-used. If this 
strategy was shown to be successful in T. brucei, it would be possible to delete 
multiple metacaspase genes. Alternatively, it should be possible to silence all 
five genes by RNAi. While this study has highlighted problems with the RNAi 
technique utilised, it may be that these were vector-specific and performing 
RNAi with another vector may not have the same problems. We were able to 
show that the silencing of three metacaspase genes was possible by RNAi and 
therefore it should be possible to silence five simultaneously in the BSF if 
required.
Unfortunately, biochemical characterisation of the metacaspases was not 
pursued in this study due to problems of solubility with the recombinant 
enzymes. The successful refolding of cysteine peptidases from inclusion bodies 
has been performed successfully (Sanderson et al., 2000), although attempts to
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perform this with the metacaspases were unsuccessful (S. Sanderson -  
unpublished). Further attempts at generating soluble recombinant enzymes in 
E. coli or Pichia could be pursued to solve these problems. Wliile the A. 
thaliana type II metacaspases have been shown to be specific for arginine/lysine 
at the PI position (Vercammen et ah, 2004), it would be interesting to perform a 
similar study on the T. brucei metacaspases. This could answer whether they 
possess the same specificity and whether they are active as full-length proteins 
or require processing. Additionally, this could also address the question of 
whether MCAl and/or MCA4 are active peptidases or inactive enzyme 
homologues.
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